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The misuse and disordered use of alcohol and illicit drugs in the United States 
creates serious consequences for people and their families and communities, such as 
severe physical health issues (Substance Abuse and Mental Health Administration 
[SAMHSA], 2017a) and costs to society approaching $440 billion annually (National 
Institute on Drug Abuse [NIDA], 2018).  Yet, few people receive the treatment they need 
(Grant et al., 2015; Grant et al., 2016).  Instead, they overuse hospital stays and 
emergency care, among the most expensive medical services (Bernardino, Baird, Liu, & 
Merchant, 2015; Hankin, Daugherty, Bethea, & Haley, 2013). 
White and Kelly’s (2011) Addiction Recovery Management theoretical 
framework suggests that the historical partitioning of medical and mental health care 
hinders detection, intervention, coordination of services, and recovery from substance 
misuse and disordered use.  Given that most U.S. citizens see a physician at least once 
per year (Sacks et al., 2016), a technique developed for medical settings is Screening, 
Brief Intervention, and Referral to Treatment (SBIRT) (SAMHSA, 2013).  SBIRT by 
medical providers is effective for helping patients of clinics and emergency departments 
reduce alcohol misuse (Jonas et al., 2012; Schmidt et al., 2015), but not effective for 
patients with disordered alcohol use (Mdege & Watson, 2013; Schmidt et al., 2015), 
patients with drug use (Saitz et al., 2014), or patients admitted to medical hospitals 
(Mdege & Watson, 2013). 
Recent efforts to integrate medical and mental health care practices have 
incorporated SBIRT conducted by mental health professionals (Collaborative Family 
Health Association [CFHA], 2017).   Outcomes from early investigations show promise 
for populations and settings not responsive to SBIRT by medical providers (Barbosa et 
al., 2017; Watkins et al., 2017).  Professional counseling, in particular, aligns with 
SBIRT’s goals and guidelines (Babor & Higgins-Biddle, 2001; CACREP, 2015).  
Counselors endeavor to build therapeutic alliances with clients; in specialty treatment 
settings, this alliance predicts positive outcomes (Barber et al., 2001; Crits-Christoph, 
Johnson, Gibbons, & Gallop, 2013; Van Horn et al., 2015; Watts, O'Sullivan, & Chatters, 
2018).  Early results for counselor-provided SBIRT in an integrated care setting suggest 
efficacy for reducing substance use (Veach et al., 2018). 
This study extended the work of Veach et al. (2018) by determining if counselor-
provided SBIRT in integrated care settings is an effective treatment intervention, guided 
by Simpson’s (2004) Texas Christian University Treatment Model theoretical framework 
associating patient, program, and treatment factors with outcomes.  The study tested three 
hypotheses.  The first hypothesis predicted that interventions for hospitalized patients 
with alcohol or illicit drug misuse or disordered use were associated with fewer 
subsequent hospitalizations and emergency department visits.  The findings were not 
significant but did trend in a supportive direction.  The second hypothesis was that these 
outcomes differed by substance use type (alcohol or illicit drugs), substance use severity, 
and hospital clinical service unit.  Significant results were found for all three covariates, 
including significance for counselor-provided SBIRT and alcohol use.  The third 
hypothesis, given the substantial financial burden of substance misuse and disordered use 
on health care systems, predicted that counselor-provided SBIRT interventions reduced 
economic costs from the health system perspective.  The findings supported the third 
hypothesis with significance, but with caution relative to inconsistency in the results.  
Given these findings, health system administrators, physicians, and community leaders 
may support integrating professional counselors into hospital units and other medical 
settings, raising the likelihood that people who need help with their substance misuse or 
disordered use actually receive it. 
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 1 
CHAPTER I 
INTRODUCTION 
The misuse and disordered use of alcohol and illicit drugs in the United States 
creates serious consequences for people and their families, workplaces, and communities.  
People struggling with substance use are more likely to experience severe physical health 
issues, poor medical outcomes, and death (SAMHSA, 2017a).  Costs to society from 
substance-related crime, lost work productivity, and injury approach $440 billion 
annually (NIDA, 2018). 
Alcohol and illicit drug misuse and disordered use means millions of people are 
risking their lives and health.  More than 65 million U.S. residents binge drink – defined 
as drinking five or more drinks for men and four or more per women on one occasion – at 
least monthly (SAMHSA, 2017a).  Of these, about 15 million use alcohol at disordered 
levels, consistently consuming 14 drinks or more per week for men and seven or more for 
women while experiencing serious life consequences (SAMHSA, 2017a).  Alcohol-
related deaths exceed 88,000 per year (SAMHSA, 2017a).  About one in 10 people in the 
U.S., or 29 million, use drugs illicitly, primarily marijuana, prescription painkillers, and 
heroin; one-fourth are using illicit drugs at disordered levels, with uncontrollable 
cravings, drug-seeking behaviors, and losses of relationships and livelihoods (SAMHSA, 
2017a).  More than 64,000 people die annually from drug overdoses, with opioids such as 
painkillers and heroin accounting for 49,000 of these deaths (NIDA, 2018).  Most 
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overdose deaths are thought to be unintentional (NIDA, 2018) and are devastating to 
families and communities.  Mortality from prescription painkillers increased from 1.4 
deaths per 100,000 people in 1999 to 7.0 in 2015, while heroin-related deaths rose from 
0.7 to 4.1 (National Center for Health Statistics [NCHS], 2017).  Due to this distressing 
escalation in fatal overdoses, opioid disorders have been identified as a national public 
health emergency (White House Office of the Press, 2017). 
Despite the serious, life-altering, and expensive consequences of substance 
misuse and disordered use, most people do not receive the treatment they need.  People 
whose substance misuse is potentially harmful but not yet disordered have limited 
options, as most treatment programs are intended for people who already use substances 
at disordered levels (SAMHSA, 2017b).  Yet even for the disordered-use population, 
only about 6.3% of people with alcohol use disorders enter treatment each year (Grant et 
al., 2015), while 13.4% of those with drug use disorders are treated (Grant et al., 2016). 
The stigma associated with obtaining mental health services, particularly 
substance-related services, is a major barrier to treatment-seeking (Tai & Volkow, 2013).   
At least partly due to stigma, many people deny their need for treatment, or they attempt 
to self-manage their substance problems (SAMHSA, 2015).  For example, in a study of 
nearly 4,000 adult health center patients, researchers found that substance misuse and 
disordered use was considerable but patients’ willingness to enter treatment was very low 
(Lebrun-Harris, Tomoyasu, & Ngo-Metzger, 2014).  In this sample, at least 40% of 
patients had engaged in binge drinking in the past year and one out of every 10 patients 
were using alcohol at disordered levels.  During the prior three months, 14% had used 
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illicit drugs, with one in eight having a disorder.  However, when those with alcohol or 
drug disorders were asked if they wanted treatment, only 7% of these patients agreed to 
be helped. 
Another barrier to treatment-seeking is the historical separation of medical care 
from mental health care.  Medical care for substance-related physical problems occurs 
mainly in hospitals and clinics, while most mental health care for substance use takes 
place in specialty facilities (SAMHSA, 2017b).  This body-mind separation of care, along 
with strict federal privacy laws surrounding substance use treatment that forestall open 
communication among providers, creates fragmentation of services and failure to 
coordinate treatment plans (Fornili, 2016a).  The absence of coordinated care may be a 
significant factor in relapse rates.  Of people entering specialty treatment, 64% have done 
so at least once before (White & Kelly, 2011).  It takes an average of four-to-five years to 
recover from alcohol problems from the time people first seek help; for heroin and other 
opioids, the timeframe is even longer (White & Kelly, 2011).  The lifetime recovery rate 
from substance disorders is only 50-60% (White & Kelly, 2011), a systemic failure that 
brings enormous personal costs to families, communities, businesses, and governments 
(Everett & Benjamin, 2014). 
The adverse health consequences of chronic, relapsing substance misuse and 
disordered use are particularly burdensome for medical professionals, who treat the often-
serious medical conditions caused by deleterious use.  Health care expenditures for 
alcohol and illicit drug misuse and disordered use are estimated at $53 billion annually 
(NIDA, 2018), with medical costs ranking second only after specialty treatment (Sacks, 
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Gonzales, Bouchery, Tomedi, & Brewer, 2015).  People with alcohol and drug use 
problems overuse hospitalizations and emergency department visits, which are among the 
most expensive medical services (Bernardino et al., 2015; Cornett & Latimer, 2011; 
Hankin et al., 2013; Hoffman & Cronin, 2015).  They are overrepresented among 
emergency department patients, needing care for intensive conditions such as trauma, 
pain, and overdose (Bernardino et al., 2015; Hankin et al., 2013).  They are also more 
likely to be hospitalized.  Prolonged substance use is a major cause of chronic medical 
illness, which increases the frequency of hospital admissions and length of hospital stays 
(Friedman, Jiang, & Elixhauser, 2008).  According to a report from the National 
Academy of Medicine (Long et al., 2017), chronically ill patients require complex care 
and consume a disproportionate share of health system resources; they are “…more likely 
to be publicly insured (83 percent were insured under Medicare, Medicaid, or both), have 
fair to poor self-reported health, and have a behavioral or substance abuse condition” (p. 
20). 
Given the onus of substance misuse and disordered use on health systems, and 
because many people who need treatment for their substance use do not receive it, 
alternative approaches to detection and treatment in medical settings have become 
imperative.  Since most U.S. citizens see a physician at least once per year (Sacks et al., 
2016), an intervention technique was developed specifically for medical settings: 
Screening, Brief Intervention, and Referral to Treatment (SBIRT) (SAMHSA, 2013).  
SBIRT debuted over thirty years ago as a World Health Organization alcohol screening 
and intervention process (Babor, Del Boca, & Bray, 2017).  It is a “…public health model 
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designed to provide universal screening, secondary prevention (detecting substance 
misuse before the onset of disordered use), early intervention, and timely referral and 
treatment for people with [substance use disorders]” (SAMHSA, 2013).  A key benefit is 
its universal nature; SBIRT allows health professionals to detect hidden substance 
problems and to provide treatment even for patients not actively seeking help (SAMHSA, 
2013).  Patients of medical practices tend to view substance screening and counseling as 
part of their providers’ roles, so rarely object to these interventions (Sacks et al., 2016).  
With a growing evidence base, SBIRT is now operational or under implementation in 
over half of U.S. states (Agley et al., 2014) and is employed in outpatient, emergency 
department, and inpatient settings (Babor et al., 2017). 
SBIRT interventions by medical providers have been studied extensively relative 
to alcohol use and to a lesser degree for illicit drug use.  It has been found most effective 
in outpatient and emergency medical settings for helping people reduce alcohol misuse 
(SAMHSA, 2013).  However, SBIRT by medical providers has mixed outcomes for 
interventions in inpatient medical settings, for alcohol use disorders, or any level of illicit 
drug use (SAMHSA, 2017a).  Many possible causes for these disappointing results have 
been proposed, but one consistent finding is that medical providers are willing to screen 
for substance use but fail to conduct brief interventions or referrals to treatment when 
misuse or disordered use is detected (Agley et al., 2014; Chan et al., 2015; Glass, 
Bohnert, & Brown, 2016) 
Studies of SBIRT for alcohol misuse, defined as averaging more than one drink 
per day for women and older adults and two drinks for men but not meeting criteria for a 
 
 6 
disorder (National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2018), show 
consistently positive outcomes when conducted by medical personnel in outpatient clinics 
and emergency departments.  Jonas et al. (2012) performed a meta-analysis of 23 
randomized controlled trials (RCTs) where medical personnel provided SBIRT for 
primary care outpatients with alcohol misuse.  SBIRT was associated with significant 
reductions in number of drinks per week and in the number of heavy drinking episodes, 
as well as the likelihood of patients transitioning from misuse to low risk drinking.  
Schmidt et al. (2015) conducted a meta-analysis of 33 RCTs involving 14,456 ED 
patients who were misusing alcohol, with SBIRT performed by medical providers.  The 
researchers found small effects favoring reduction in alcohol misuse.  According to these 
researchers and others, though, SBIRT has not been found to be effective for outpatients 
or ED patients who use alcohol at disordered levels (Bray et al., 2007; SAMHSA, 2013; 
Schmidt et al., 2015).  SBIRT outcomes, then, appear to depend on alcohol substance use 
severity. 
SBIRT conducted by medical providers has also been explored with patients 
hospitalized for medical conditions (i.e., inpatients), with little to no results.  A meta-
analysis by Mdege and Watson (2013) reviewed 46 studies of SBIRT conducted by 
medical personnel in inpatient settings (n=17,231).  Study participants were a mixture of 
people who misused alcohol and those with alcohol disorders and were not stratified 
according to severity of use.  Across studies, SBIRT by medical providers was not 
effective with helping hospital inpatients reduce alcohol consumption. 
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Evidence for SBIRT’s effectiveness for illicit drug misuse and disordered use 
when conducted by medical providers is inconclusive, with research in this area in an 
early phase (SAMHSA, 2013).  A systematic review by Young et al. (2014) for drug-
related SBIRT uncovered only five studies, all in outpatient settings with interventions 
conducted by medical personnel.  The reported results were mixed but insufficient for 
comparison or meta-analysis.  An RCT for illicit drug use by Saitz et al. (2014) tested 
SBIRT (n=169 primary care outpatients) against a control group (n=175).  Nearly all 
patients were using drugs at severe levels.  SBIRT was provided by health educators with 
high school or bachelor’s degrees.  The researchers found no effects associating SBIRT 
and reduced drug use.  Consequently, the effectiveness of SBIRT by medical staff on 
reducing drug use is inconclusive and perhaps depends on severity of use.  According to 
the U.S. Preventative Services Task Force (USPSTF, 2017), although universal SBIRT 
for drug misuse and disordered use cannot be recommended based on current evidence, 
the USPSTF has developed a research plan for generating evidentiary support. 
An emerging innovation in medical practice structure offers potential for 
enhancing SBIRT’s effectiveness for people with disordered alcohol use, with misuse or 
disordered use of illicit drugs, or receiving care in inpatient hospital settings.  Under new 
structures known as integrated care practices, mental health professionals trained at the 
master’s level, such as counselors, social workers, and marriage and family therapists, 
work in cohesive medical/mental health groups, where they collaborate with medical 
providers to address substance-related problems along with other mental health concerns 
(Collaborative Family Health Association, 2017).  Integrated care is “…the systematic 
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coordination of general and behavioral healthcare” (SAMHSA, 2018).  In integrated 
care’s most evolved form, mental health and medical professionals are members of 
collaborative teams, sharing sites and systems, consulting with each other, and co-
creating treatment plans, as delineated in a seminal article by Doherty (1995).  For 
patients of integrated care practices, SBIRT is provided by mental health professionals, 
rather than the traditional model of SBIRT conducted by medical providers (e.g., 
physicians and nurses) (Collaborative Family Health Association, 2017). 
When a new form of practice is introduced to a field, such as SBIRT by mental 
health professionals in integrated medical settings, it should be considered against an 
existing theoretical framework to facilitate understanding.  A useful and relevant 
framework for the substance use treatment spectrum is the Addiction Recovery 
Management (ARM) model, advanced by White and Kelly (2011) and grounded in 
Bronfenbrenner’s Ecological Systems Theory (1992).  White and Kelly recognized that 
substance treatment was most often a series of acute, medicalized, disjointed incidents 
with judgmental moral overtones that were hindering recovery for most people.  They re-
conceptualized recovery from substance problems as a comprehensive staged process: 
pre-recovery identification and engagement, recovery initiation and stabilization, 
sustained recovery support, and long-term recovery maintenance.  The ARM model 
suggests processes that bring interventions directly to people in their communities rather 
than waiting for them to reach out for help, and surrounding people with 
multidisciplinary treatment teams. 
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Fornili (2016b) clarified how mental health clinicians conducting SBIRT in 
integrated care are part of the substance misuse/disordered use treatment continuum, 
using the four stages of ARM: 
Pre-recovery identification and engagement.  In integrated care, mental health 
clinicians use SBIRT to identify and engage early with patients who have substance 
problems. 
Recovery initiation and stabilization.  Integrated care clinicians initiate recovery 
by conducting brief interventions (BI) with patients who are misusing substances.  
Following the RT process of SBIRT, they refer people with more severe substance 
problems to clinical mental health clinicians in specialty treatment, who help clients 
stabilize and move into recovery. 
Sustained recovery support.  Sustained support is provided or arranged by both 
integrated care and specialty sites; it includes collaboration with families and peer 
organizations as well as coordination of services to help with employment, housing, child 
care, transportation, legal matters, and life skills 
Long-term recovery maintenance.  Integrated care clinicians use chronic care 
approaches to help patients learn self-care and self-management, provide checkups, and 
enable further connection to community resources. 
When considered against the ARM framework, SBIRT provided by mental health 
professionals in integrated care settings aligns with ARM closely, lending support for the 
appropriateness and potential efficacy of this model. 
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Early research in SBIRT provided by mental health professionals has shown 
promising results.  A recent study with 968 integrated care patients from inpatient, 
emergency, and outpatient settings involved SBIRT administered by counselors, social 
workers, psychologists and health educators, generally holding a master’s level or higher 
and with approximately half certified or licensed in addiction treatment (Barbosa et al., 
2017).  Substance use had decreased significantly at 6-month follow-up for drug and 
alcohol misuse and disordered use.  In an RCT conducted by Watkins et al. (2017), 
counselors and social workers conducted brief interventions in primary care settings for 
problem opioid and alcohol use.  The BI intervention arm included 187 patients while the 
control arm had 190. At 6-month follow-up, the intervention group was significantly 
more likely to have obtained specialty treatment and to have abstained from substance 
use.  These findings offer promise for having SBIRT interventions provided by mental 
health professionals in integrated care settings.  Patients with substance misuse or 
disordered use who are not otherwise seeking or accepting their need for treatment may 
be more likely to make changes when interacting with trained mental health 
professionals. 
Among all mental health professionals, SBIRT in integrated care seems especially 
well-suited to the training and skills of professional counselors, whose focus is on the 
therapeutic relationship and on wellness (Babor & Higgins-Biddle, 2001; CACREP, 
2015).  Counselor training and practice are allied with SBIRT practice, which may lead to 
improved outcomes.  SBIRT involves facilitative conditions and helping skills that 
counselors learn and routinely employ.  SBIRT guidelines recommend that providers be 
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empathetic and nonjudgmental, quickly build rapport and trust, recognize and manage 
resistance, conduct assessments and provide effective feedback, match interventions to 
readiness to change, set goals, and engage in patient advocacy (Babor & Higgins-Biddle, 
2001).  SBIRT often takes place with a patient’s family members or friends present; 
counselors are trained in family and group counseling methods (CACREP, 2015).  
Counselors are educated about trauma and psychiatric diagnoses (CACREP, 2015), 
conditions that frequently co-occur in substance misuse and disordered use (Patel et al., 
2016).  If counselors are conducting SBIRT in integrated care settings, more patients may 
be able to be receive treatment services immediately on-site, whereas medical 
professionals conducting SBIRT must refer higher-risk patients to specialty treatment 
(Babor & Higgins-Biddle, 2001), a process that has limited demonstrated efficacy (Glass 
et al., 2015).  Given how closely professional counseling is aligned with the SBIRT 
process, counselor-provided SBIRT may demonstrate significantly improved outcomes in 
inpatient settings, for alcohol use disorders, and for illicit drug misuse and disordered use.  
Research is essential for testing this promising intervention model, which has been 
implemented in at least one major health system. However, it appears that only one 
article involving counselor-provided SBIRT in integrated care has been published (Veach 
et al., 2018). 
Research involving a new and innovative technique like counselor-provided 
SBIRT benefits from following an established, evidence-based theoretical framework in 
the substance use treatment and/or SBIRT fields.  Such a framework from the treatment 
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field was offered by Simpson (2004), who developed the Texas Christian University 
Treatment Model (Figure 1). 
Figure 1.  Texas Christian University Treatment Model 
 
In the TCU Model, the four major components of treatment are client factors, 
program attributes, treatment processes, and post-treatment outcomes (Simpson, 2004).  
The model is adaptable to most clients, settings, and processes (Simpson, 2004).  Certain 
elements of the TCU Model can be employed as predictor variables for research in 
counselor-provided SBIRT in integrated care settings. For example, a client factor, 
substance use severity; the program attributes, collectively setting; and the treatment 
process, the SBIRT intervention, can all be predictor variables (Simpson, 2004).  The 
TCU Model does not address type of use (alcohol and/or illicit drugs), but the SBIRT 
literature strongly suggests substance use type is also an important predictor variable 
(Mdege & Watson, 2013; Saitz et al., 2014; Schmidt et al., 2015). 
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The fourth element of the TCU Model concerns post-intervention outcomes.  
Evaluating innovative treatment interventions, such as counselor-provided SBIRT, 
requires identifying critical outcomes.  For both the substance treatment and SBIRT 
fields, most researchers have focused on the traditional outcomes of interest to substance 
treatment programs, specifically participant reductions in substance use levels and/or 
abstinence (Jonas et al., 2012; Mdege & Watson, 2013; Schmidt et al., 2015).  This focus 
is consistent with “gold standard” RCT methodology, to which individual-level changes 
are central, but introduces potential bias due to underreporting (Glass et al., 2017). 
In medical settings such as integrated care, however, high-value outcomes for 
clinical programs are hospitalizations and emergency department visits (Bernardino et al., 
2015; Cornett & Latimer, 2011; Hankin et al., 2013; Hoffman & Cronin, 2015).  These 
outcomes are not often found in the treatment and SBIRT literature.  Bray et al. (2007) 
examined these organization-level effects as SBIRT outcomes; the researchers concluded 
that SBIRT delivered by medical providers for alcohol misuse did not predict reductions 
in hospital admissions or emergency department visits compared to no interventions.  A 
systematic review and meta-analysis of 29 publications by Bray, Cowell, and Hinde 
(2011) focused on health care utilization of inpatient, outpatient, and emergency services 
subsequent to SBIRT interventions by medical providers.  Only emergency department 
utilization demonstrated a small reduction.  Research studies involving counselor-
provided SBIRT may provide important new evidence about hospitalization and ED visit 
outcomes for health systems, given medical providers’ apparent reluctance to conduct the 
BI and RT components of SBIRT (Agley et al., 2014; Chan et al., 2015; Glass et al., 
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2016).  It may be that SBIRT performed by professional counselors will result in more 
positive outcomes than SBIRT performed by medical providers and even other mental 
health professionals, due to the alignment between effective counseling and effective 
SBIRT (Babor & Higgins-Biddle, 2001; CACREP, 2015). 
Research in counselor-provided SBIRT that demonstrates efficacy for reducing 
health utilization burdens may be welcomed by health system leaders and medical 
providers.  However, clinical outcomes alone may not be sufficient to convince health 
care decision-makers to invest in counselor-provided SBIRT programs.  The field of 
economics offers additional tools for these decision-makers that take into consideration 
the problems under review, the questions to be answered, and the decision-makers’ 
perspectives and needs for information (Drummond, Sculpher, Claxton, Stoddard, & 
Torrance, 2015; Link, 2018).  At the health system level, where decisions about 
alternative program investments are made, an appropriate tool is economic cost analysis.  
According to Drummond et al. (2015), cost analysis allows decision-makers to evaluate 
alternative programs within budget constraints.  The choice of elements to include in the 
analysis depend on the decision-maker’s perspective.  Employing cost analysis to analyze 
hospitalization and ED visit outcomes for counselor-provided SBIRT will add an 
important dimension to research in this area, as an informative analysis will provide 
health system leaders with needed data for making organizational investment decisions. 
Statement of the Problem 
The misuse and disordered use of alcohol and illicit drugs are pervasive, costly 
public health problems in the United States (NIDA, 2018; SAMHSA, 2017a).  The 
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consequences for people with substance use problems can be severe and sometimes fatal, 
and those problems extend to their families, communities, and workplaces.  Despite these 
serious outcomes, few people who need treatment for substance use receive it (Grant et 
al., 2015; Grant et al., 2016).  Barriers to treatment-seeking include stigma (Tai & 
Volkow, 2013) and lack of coordination between medical and mental health providers 
(Fornili, 2016a).  In the current fragmented system, people take years to recover 
successfully from substance problems (White & Kelly, 2011).  The costs to health care 
systems are substantial, as substance misuse and disordered use increases the likelihood 
of needing expensive medical services such as emergency departments and 
hospitalizations (Bernardino et al., 2015; Long et al., 2017). 
To reduce the treatment gap through early detection, treatment, and referral, 
substance-related interventions by medical providers are becoming common through the 
widespread adoption of SBIRT (Agley et al., 2014).  SBIRT by medical providers has 
demonstrated effectiveness for helping patients of outpatient clinics and emergency 
departments reduce alcohol misuse (Babor et al., 2017; Jonas et al., 2012; Schmidt et al., 
2015) but has mixed outcomes for alcohol use disorders, illicit drug misuse and 
disordered use, and in inpatient settings (Mdege & Watson, 2013; Schmidt et al., 2015).  
Higher severity of alcohol and illicit drug use has been associated with worse SBIRT 
outcomes (Mdege & Watson, 2013; SAMHSA, 2013; Schmidt et al., 2015). 
Integrated care, a recent trend involving medical and mental health care providers 
in collaborative teams, offers promise for improved outcomes when SBIRT is provided 
by mental health professionals (Barbosa et al., 2017; Watkins et al., 2017).  The practice 
 
 16 
of professional counseling, in particular, seems well-suited for brief interventions and 
treatment (Babor et al., 2017; CACREP, 2015); thus, counselor-provided SBIRT may 
have efficacy for helping people with substance problems other than alcohol misuse.  
Outcomes of high value to health systems – hospitalizations and emergency department 
visits – should be studied (Bray et al., 2007) when evaluating counselor-provided SBIRT 
in integrated care.  Economic analysis of these outcomes will provide important 
information to health system leaders for making programmatic investment decisions 
(Drummond et al., 2015). 
Purpose of the Study 
The purpose of this study is to determine whether counselor-provided SBIRT in 
inpatient integrated care settings is an effective treatment intervention for alcohol and 
illicit drug misuse and disordered use by evaluating the association between intervention 
and subsequent hospitalizations and emergency department visits.  Inpatient settings were 
selected for study given inconclusive results from prior research for this category of 
patient care location.  Because counselor-provided SBIRT’s effectiveness may depend on 
type (alcohol or illicit drugs), severity of substance use, and setting, this study also will 
examine the associations of these variables with post-intervention hospitalizations and 
emergency department visits.  In this study, severity is represented by substance use 
patterns as well as by frequency of hospitalizations and ED visits prior to SBIRT 
intervention.  Because of the substantial financial burden of substance misuse and 
disordered use on health care systems, this study also will evaluate whether counselor-
provided SBIRT interventions reduce economic costs from the health system perspective. 
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Need for the Study 
Research regarding counselor-provided SBIRT in inpatient integrated care 
settings may demonstrate its efficacy and economic benefit as a treatment model for 
substance misuse and disordered use.  If so, health system administrators, physicians, and 
community leaders may become more supportive of integrating professional counselors 
into inpatient units and other medical settings.  In addition, identifying treatments for 
substance misuse and disordered use that reduce hospital admissions and emergency 
department visits in a cost-effective way may lead to increased health system funding for 
SBIRT by professional counselors.  These changes may raise the likelihood that people 
who need help with their substance misuse or disordered use actually receive it. 
Research Questions 
Research Question 1.  For patients with alcohol or illicit drug misuse or 
disordered use, do patients in inpatient integrated care settings receiving counselor-
provided SBIRT experience fewer hospitalizations and emergency department visits 
compared to patients in the same settings not receiving interventions? 
Research Question 2.  Do hospitalization and emergency department visit 
outcomes for patients with alcohol or illicit drug misuse or disordered use differ by 
substance use type, substance use severity, or inpatient service location? 
Research Question 3.  Are counselor-provided SBIRT interventions associated 
with reduced economic costs from the health system perspective? 
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Operational Definitions 
Certain terms are employed throughout this report and are defined here for clarity: 
Alcohol misuse: for adult males aged 18-65, exceeding four drinks per day and/or 
14 per week and for adult females and males older than 65, three drinks per day and/or 
seven per week, but not meeting criteria for alcohol use disorder and/or being assigned 
International Compendium of Diseases-10 alcohol misuse coding following patient 
encounters with medical and/or mental health providers 
Binge drinking: for males, more than four drinks per occasion; for females, and 
males >65 years old, more than three per occasion 
Disordered alcohol or drug use: meeting Diagnostic and Statistical Manual-5 
criteria for the disorder of the substance being used and/or being assigned International 
Compendium of Diseases-10 disorder coding following patient encounters with medical 
and/or mental health providers  
Drug misuse: any use of an illegal drug or use of prescription drugs other than as 
prescribed, but not meeting criteria for a drug use disorder and/or being assigned 
International Compendium of Diseases-10 misuse coding following patient encounters 
with medical and/or mental health providers 
Emergency department visit: admission to the emergency department and receipt 
of medical care in the treatment area 
Hospitalization or inpatient: individual with a physician referral for hospital 
admission has undergone the admission process and occupies a hospital room 
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Illicit drug use: use of illegal drugs or of prescription drugs other than as 
prescribed 
Outpatient or clinic patient: individual receiving same-day services at a medical 
clinic 
Organization of the Study 
This chapter outlines the rationale and need for a research study.  In the second 
chapter, a review of relevant literature is presented, suggesting that counselor-provided 
SBIRT in integrated care settings is a promising, innovative intervention for people with 
misuse or disordered use of alcohol and/or illicit drugs and may help reduce health 
system burdens from treating the effects of harmful substance use.  In the third chapter, 
the research methodology for examining counselor-provided SBIRT in a specific 
integrated care setting and population is provided.  The research questions and 
hypotheses are stated.  The research design, consisting of the study setting, counseling 
program and intervention process, study population, data procedures, and measures, is 
explained.  The statistical analyses are described, and the pilot study design is proposed. 
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CHAPTER II 
LITERATURE REVIEW 
Introduction 
In chapter 1, the problems of substance misuse and disordered use were described, 
a promising new intervention presented – counselor-provided SBIRT in integrated care 
settings, and the basis for investigation established.  In this chapter, the literature 
supporting these topic areas will be explored, beginning with the mortality, morbidity, 
prevalence, and social and medical costs arising from alcohol and drug use.  The present 
state of intervention and treatment as well as barriers to treatment will be noted.  Two 
theoretical frameworks will be presented, the first, Addiction Recovery Management 
(White & Kelly, 2011), defining the substance use treatment continuum and the second, 
the Texas Christian University Treatment Model (Simpson, 2004), guiding research 
methodology.  Two major components of the treatment continuum, specialty substance 
use disorder treatment and an intervention common to medical settings, Screening, Brief 
Intervention, and Referral to Treatment (SBIRT) will be examined, along with relevant 
outcomes research.  The relatively new field of integrated care, with its provision of 
SBIRT by mental health professionals such as counselors, will be defined.  Counselor-
provided SBIRT in integrated care will be supported, and important outcomes 
highlighted, including economic evaluation.  Thematic findings of the literature review 
will be summarized.
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Substance Misuse and Disordered Use 
Misuse and disordered use of alcohol and illicit drugs are global public health 
risks, causing pervasive mortality and morbidity (United Nations Office on Drugs and 
Crime [UNODC], 2018; World Health Organization, 2018).  Alcohol use leads to three 
million deaths annually, or 5.3% of worldwide mortality, more than deaths from 
HIV/AIDS or diabetes (World Health Organization, 2018).  Disability arising from 
alcohol-related diseases, cognitive conditions, and accidents accounts for 5.1% of 
morbidity worldwide (World Health Organization, 2018).  Illicit drug use is less 
prevalent than alcohol use, but still takes the lives of 450,000 people each year; of these, 
one-third die from drug overdoses while most others contract drug-related infectious 
diseases (UNODC, 2018).  Three-fourths of overdoses are from opioids, enabled by a 
65% increase in global opium production from 2016 to 2017 (UNODC, 2018). 
In the United States, 88,000 people die from alcohol-related causes each year 
(SAMHSA, 2017a) with 39% succumbing to liver cirrhosis, 35% to cancer, another 16% 
to traffic fatalities, and the remainder to heart disease and infection (World Health 
Organization, 2018).  Binge drinking – defined as five or more drinks per day for men 
and four or more per women – is a hazardous monthly custom for more than 65 million 
U.S. residents (SAMHSA, 2017a).  Alcohol misuse and alcohol-related disorders affect 
14% of people older than 15 years (World Health Organization, 2018); of these, well over 
half use alcohol at disordered levels, consistently exceeding 14 drinks per week for men 
and seven for women and leading to serious life consequences (SAMHSA, 2017a). 
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In the U.S., approximately 29 million people misuse drugs illicitly.  Of these, one-
fourth are abusing drugs at disordered levels, with uncontrollable cravings, drug-seeking 
behaviors, and losses of relationships and livelihoods (SAMHSA, 2017a).  Drug overdose 
death rates have increased precipitously, now claiming 64,000 lives each year.  Opioids 
account for 49,000 of these deaths (NIDA, 2018).  Most people become addicted to 
opioids when they try to manage pain, a condition affecting 110 million U.S. citizens and 
costing $600 billion annually (Institute of Medicine, 2011); 14.4 million suffer from 
severe pain daily (Nahin, 2015).  Prescription opioids for pain management are associated 
with harm, including accidental overdose, illicit use, diversion to others (Chou et al., 
2015), and a high rate of conversion to heroin use (Dart et al., 2015).  Mortality from 
non-medical use of prescription painkillers rose from 1.4 deaths per 100,000 people in 
1999 to 7.0 in 2015, while heroin-related deaths rose from 0.7 to 4.1 (NCHS, 2017).  The 
recent widespread availability of the drug fentanyl, a synthetic opioid usually 
manufactured illicitly, is driving up fatalities (UNODC, 2018).  Fentanyl recently 
surpassed prescription painkillers as the leading cause of overdose deaths (Jones, 
Einstein, & Compton, 2018), most of which are thought to be unintentional (NIDA, 
2018).  Due to this distressing escalation in fatal overdoses, opioid use disorder has been 
identified as a national public health emergency (White House Office of the Press, 2017). 
Workplace, Governmental, and Health Care Costs 
Costs to the economy, governments, and health care providers from alcohol and 
illicit drug misuse and disordered use are at least $442 billion annually per federal 
government estimates, with alcohol accounting for $249 billion and illicit drugs $193 
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billion (Centers for Disease Control [CDC], 2018; National Drug Intelligence Center 
[NDIC], 2011).  While these estimates are the most recent available, it should be noted 
that they range from 8 (for alcohol) to 11 (for illicit drugs) years old (CDC, 2018; NDIC, 
2011); it’s probable that they are well short of current costs. 
Binge drinking accounts for most of the economic cost of alcohol at $192 billion, 
or about $2 in additional costs for every drink purchased (CDC, 2018).  Lost work 
productivity is associated with 72% of alcohol-related costs; another 11% arises from the 
cost of providing health care and rehabilitation; 10% is related to costs associated with 
law enforcement and criminal justice; 5% is associated with motor vehicle crashes, and 
2% is from other causes (CDC, 2018).  Ultimately, 40% of alcohol costs across these 
factors are borne by federal, state, and local governments and thus taxpayers (CDC, 
2018). 
For illicit drugs, the heaviest burden also is on workplace productivity, 
representing 62% of the total (NDIC, 2011).  The proportion attributable to costs 
associated with law enforcement and criminal justice is 32%, substantially larger than for 
alcohol, while health care and rehabilitation costs account for 6% of the total (NDIC, 
2011). 
Health Care Utilization 
The present study investigates the effects of substance misuse and disordered use 
on health care system outcomes, so further emphasis on health care utilization is 
warranted.  People with alcohol and/or drug misuse or disordered use are more likely to 
have severe physical health issues including chronic pain, comorbid mental health 
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diagnoses, and poor medical outcomes (SAMHSA, 2017a; Tai & Volkow, 2013).  They 
are less likely to seek preventive medical care, thus delaying treatment until problems are 
advanced (Ghitza & Tai, 2014), more likely to have low incomes and unable to afford 
care (Ghitza & Tai, 2014), and are more likely to receive lower-quality care that is not 
coordinated among providers (Saitz et al., 2013). 
Because people with alcohol and illicit drug misuse or disordered use tend to be 
sicker and lack consistent care, they are prone to excessive emergency department (ED) 
visits and hospitalizations, which are among the most expensive medical services 
(Cornett & Latimer, 2011; Hoffman & Cronin, 2015).  A three-year study at a large 
Northeastern U.S. hospital (n=6,432 adults) showed that ED patients used illicit drugs at 
more than double the national average for people 18-25 years old and by four times the 
average for those aged 26+, while alcohol use was 20% and 4% higher, respectively 
(Bernardino et al., 2015).  Researchers at a large Southeastern U.S. hospital (n=19,055 
adults) found that 28% of patients divulged alcohol or illicit drug use; of these, 20% of 
patients were using at disordered levels while experiencing poor health and extreme 
stress due to substance use (Hankin et al., 2013).  They were also frequent ED visitors, 
having sought care an average of 1.7 times in the prior 30 days (Hankin et al., 2013).  
In addition to ED utilization, substance misuse and disordered use are associated 
with more frequent hospitalizations.  In one of the few studies to compare chronic illicit 
drug use with inpatient, ED, and outpatient health services utilization and with the cost of 
medical care, people with chronic drug use were compared to people who did not use 
drugs (n=1,480 adults) (French, McGeary, Chitwood, & McCoy, 2000).  People using 
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drugs were more likely to visit EDs and to be admitted to hospitals, and they were less 
likely to seek clinic-based outpatient care such as primary and preventive visits.  The 
excess costs associated with their health service utilization exceeded $1,000 per person 
(not adjusted for inflation). 
According to a report from the National Academy of Medicine (Long et al., 
2017), substance-related conditions are prevalent in patients who have high medical 
needs.  High-needs patients account for 50% of our nation’s health care expenditures, 
despite representing only 5% of the patient population (Long et al., 2017).  In a study of 
2011 and 2012 Medicare insurance claims (n=6,112,450 older adults), the majority of 
costs were for hospitalizations and post-hospital care.  Patients who were in the top decile 
for costs were 1.75 times more likely to have an alcohol or drug diagnosis compared to 
patients in lower deciles (Joynt et al., 2017).  Long et al. (2017) argued that medical 
treatment alone was insufficient for improving outcomes and reducing hospitalizations 
and other medical costs for these patients; rather, a full spectrum of care that addressed 
medical, social, and mental health needs was imperative.   
Substance use disorders are key concerns for patients hospitalized with chronic 
illnesses, a subset of the high-needs patient population.  In a study of hospital discharges 
occurring in 2002 across six states (California, Nevada, New York, Pennsylvania, 
Tennessee, and Utah), substance-related disorders were identified in 13% of patients with 
one chronic illness, 16% of those with three chronic illnesses, and 14% of patients with 
five chronic illnesses (Friedman et al., 2008).  In the same population, other mental health 
disorders were factors in 15% of patients with one chronic illness, 22% of patients with 
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three and 27% of those with five (Friedman et al., 2008).  Taken together, substance and 
other mental health disorders were among the top four conditions in patients with chronic 
disease(s), rivaling hypertension, cardiovascular disease, and diabetes (Friedman et al., 
2008).  Given that personality and mood disorders are predictive of substance use 
disorders (Sarvet & Hasin, 2016), addressing substance misuse and disordered use is 
critical in treating hospitalized patients who have chronic diseases.  Even small 
reductions in hospitalizations could yield significant cost savings, particularly if there are 
reductions in readmissions of patients discharged less than 30 days prior (Hoffman & 
Cronin, 2015). 
Intervention and Treatment 
Despite the life-threatening and expensive consequences of substance misuse and 
disordered use, most people do not receive the interventions or treatments they need, and 
many who do receive treatment still struggle to reduce their use or abstain.  Only about 
6.3% of people with alcohol use disorders enter treatment each year (Grant et al., 2015), 
while 13.4% of those with drug use disorders are treated (Grant et al., 2016).  Nearly two-
thirds of people entering treatment have done so before, and 40% of people entering 
treatment have been treated more than three times (White & Kelly, 2011).  From the time 
an individual first seeks help for alcohol use, it takes an average of four-to-five years to 
recover; for the use of heroin and other opioids, the timeframe is even longer (White & 
Kelly, 2011).  Over their lifetimes, almost half of people using alcohol or drugs at 
disordered levels are unable to recover (White & Kelly, 2011).  People whose substance 
misuse is potentially harmful but not yet disordered are unlikely to be identified for 
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intervention or offered help, as treatment programs target alcohol and drug disorders only 
(SAMHSA, 2017b). 
Barriers to Intervention and Treatment 
The barriers to intervention and treatment are multifaceted and interwoven, 
incorporating personal and systemic factors (Tai & Volkow, 2013).  People may be 
unaware that they need treatment, may deny their need for treatment, may attempt to self-
manage their substance problems, or fear the stigma of being judged by others if they 
seek treatment (Office of the Surgeon General, 2016; SAMHSA, 2015; White & Kelly, 
2011).  Results from a large study of adult health center patients (n=3,949 low-income 
adults) showed that 93% of patients with serious substance-related problems were 
unwilling to accept treatment when it was directly offered (Lebrun-Harris et al., 2014).  
Other reasons are structural; people lack health insurance or transportation, do not know 
where to find treatment, or cannot afford to leave their jobs (Office of the Surgeon 
General, 2016).  Problematic substance use can be missed when communities lack 
adequate detection and intervention activities (Office of the Surgeon General, 2016).  
Consequently, many people enter treatment only under familial or justice system coercion 
at late stages of disordered use (White & Kelly, 2011). 
Although substance problems tend to be pervasive and chronic, intervention and 
treatment are usually short-term, confined to special facilities, and engaged in response to 
crisis (Tai & Volkow, 2013).  Managed care “carve-outs” for behavioral health (Tai & 
Volkow, 2013), along with historical medical provider beliefs that substance problems 
are moral failings, not chronic diseases (French et al., 2000), have divided medical care 
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from substance-related treatment, and separated out insurance reimbursement 
accordingly.  Medical facilities have difficulty getting paid for providing substance 
misuse or disorder treatment, while specialty treatment programs face obstacles to 
reimbursement for medical care (Tai & Volkow, 2013).  Consequently, medical facilities 
typically manage physical problems when patients become ill from substance use, while 
specialty facilities provide mental health care but only for advanced substance disorders 
(SAMHSA, 2017b).  People who misuse alcohol or drugs and would benefit from early 
detection and treatment are missed (Tai & Volkow, 2013).  This body-mind separation of 
care, along with strict federal privacy laws surrounding substance treatment that forestall 
open communication among providers, creates fragmentation of services and failure to 
coordinate treatment plans (Fornili, 2016a).  Not surprisingly, the dearth of coordination 
and communication pre- and post-treatment limits access to supportive, continuous care 
and contributes to high relapse rates (Tai & Volkow, 2013). 
Theoretical Frameworks 
Prior to formulating and testing novel solutions to overcoming personal and 
systemic barriers to treatment and recovery, applying a relevant theoretical framework 
will help guide understanding and design.  A framework organizes structures and 
processes and properly situates research findings regarding interventions and outcomes.  
A framework appropriate for this study must include both the specialty substance use 
disorder treatment field and the medical field, aligning two interdependent helping 
professions that have been artificially separated to the detriment of individuals, their 
families, communities, health care providers, and our nation and world.  Unfortunately, 
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no existing framework is comprehensive enough to incorporate both mental health and 
medical care structure, processes, research, and outcomes relative to substance misuse 
and disordered use.  Instead, two frameworks have been identified that together cover the 
full spectrum of these fields.  The first, to position structure and process, is the Addiction 
Recovery Management (ARM) Model (White & Kelly, 2011).  The second, to guide 
research, evaluation, and design, is the Texas Christian University (TCU) Treatment 
Model (Simpson, 2004). 
Addiction Recovery Management Model 
White and Kelly (2011) recognized that substance misuse and disordered use 
were chronic, pervasive, systemic conditions that were being treated ineffectively by 
mental health and medical professionals with uncoordinated, episodic, short-term 
solutions.  They developed the Addiction Recovery Management (ARM) Model from 
Bronfenbrenner’s Ecological Systems Theory (1992), firmly grounding substance misuse 
and disordered use in the surrounding familial, community, economic, and cultural 
systems (White & Kelly, 2011).  Within ARM, a chronic disease approach is applied to 
substance problems to guide intervention and treatment (White & Kelly, 2011).  Chronic 
diseases have genetic and environmental risk factors, following prolonged courses that 
vary widely among people, and can be effectively treated but have no known cures 
(White & Kelly, 2011).  They can be identified via broadly accepted screening tools and 
diagnostic checklists (White & Kelly, 2011).  Health behaviors can worsen or improve 
chronic disease severity, which is associated with increased disability and elevated risks 
for premature death (White & Kelly, 2011). 
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Effective treatment for substance misuse and disordered use requires long-term 
engagement with provider teams; a multidisciplinary approach to addressing 
biopsychosocial concerns; full use of information technology for tracking, treatment 
planning, and telehealth; and teaching patients and families the skills needed for disease 
management (Tai & Volkow, 2013).  Post-treatment support is essential, involving peer 
recovery groups, advocacy organizations, frequent check-ups, recovery coaching, and 
early detection of relapse (White & Kelly, 2011).  Moving beyond the patient to 
population health, the ARM model incorporates public education, universal screening, 
and early intervention (White & Kelly, 2011).  Recovery from substance use is 
conceptualized as a four-stage process called “recovery management,” from pre-recovery 
identification and engagement, to recovery initiation and stabilization, to sustained 
recovery support, and to long-term recovery maintenance (White & Kelly, 2011). 
White and Kelly (2011) described eight interconnected “performance arenas” to 
effectively design and organize evidence-based treatment and recovery support services, 
as follows (all assertions, qualitative and quantitative, were drawn from White and Kelly, 
2011): 
Attraction and access to treatment.  Because only about one in ten people who 
need treatment receive it, the ARM model offers multipronged strategies for reaching 
people at the early to middle stages of risk and for making treatment widely available.  
These tactics can be employed by both medical and mental health organizations.  
Attraction strategies include public education, messaging that lessens stigma, 
identification of and outreach to people needing help, and connection to community 
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support services.  Access strategies focus on making intervention and treatment as easy 
and inviting as possible, with night and weekend hours, telephone availability, warm 
welcoming, and electronic guides and reminders. 
Assessment and level of care placement.  In the ARM model, medical and mental 
health practitioners perform comprehensive biopsychosocial assessment of people with 
substance issues and also their families and communities.  Assessment is strengths-
focused and continuous.  Decisions about care placement, including inpatient vs. 
outpatient and intensive vs. episodic, are made in conjunction with individuals, their 
families, and their family advisors, in consideration of interconnected needs. 
Composition of the service team.  Currently, specialty substance use disorder 
treatment by mental health clinicians rarely includes input from family physicians or 
other primary care providers.  Treatment sites also lack meaningful interaction with 
psychiatrists and psychologists, let alone spiritual mentors, community healers, and peer 
sponsors.  With ARM, these shortcomings are counteracted by engaging primary care 
providers in early detection, monitoring, and recovery check-ups at their sites; increasing 
specialty treatment facility access to psychiatrists and psychologists; emphasizing peer 
support; and including indigenous healers in treatment.  
Service relationships and roles.  Under ARM, therapeutic relationships are 
humanistic – collaborative, empowered, consultative – rather than directive, caretaking, 
and expertise-driven.  Recovery is client- or patient-directed, given that active 
engagement by people in their own treatment planning and goals is predictive of positive 
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outcomes, such as spending more time in treatment and reducing or abstaining from 
substance use after treatment. 
Service dose, scope, and duration.  Because increasing “doses” of treatment 
predict improved recovery outcomes, the ARM model emphasizes adequate treatment 
periods of at least 90 days for most substances and one year for opioid replacement 
medications.  The model includes wraparound services before and after treatment, such as 
early detection and intervention, resolution of barriers to entering treatment, monitoring 
and support during the waiting period, continuing care immediately post-treatment 
through careful discharge planning and community resourcing, and long-term follow-up 
with check-ins.  These actions should be carried out both by mental health providers and 
medical providers, with communication to ensure the wraparound services are 
appropriately applied and are effective. 
Locus of service delivery.  Rather than intervention and treatment taking place 
only in professional offices and facilities, the ARM model recommends robust outreach 
programs by professionals into communities, in-reach programs that bring community 
resources such as peer supporters into professional settings, and resource innovation and 
development to match individual and community needs. 
Linkages to communities of recovery.  Recovery communities are an essential 
component of the treatment continuum, providing support, connection, reinforcement, 
and early detection of potential relapse to people who are considering reducing their 
substance use or abstaining, as well as people in recovery.  Under the ARM model, 
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medical and mental health providers are assertive in linking people with substance 
problems to these communities. 
Posttreatment monitoring, support, and early reintervention.  More than 50% of 
people who complete specialty substance use treatment restart active use within a year of 
discharge, and most within 90 days.  Up to one-third of all people completing treatment 
will be readmitted to treatment within a year, and half within five years.  Despite this 
recidivism, only one in five people receive any form of continuing professional care after 
discharge.  Under the ARM model, recovery check-ups and support by medical and/or 
mental health professionals are critical services following treatment discharge, when 
people are trying to establish themselves in new environments and with new ways of 
being. 
In summary, the ARM model emphasizes structures and processes supporting 
early detection and sustained recovery in addition to episodic treatment.  The model 
assumes a systems perspective, engaging families and communities, and expanding the 
care team beyond traditional providers.  The focus is on extensive, effective services that 
create optimum conditions for people with substance use problems to be found, to get 
help and then to reduce or abstain from use over the long term. 
Texas Christian University (TCU) Model 
The Texas Christian University (TCU) Treatment Model is a theoretical 
framework linking patient, program, and process factors to post-treatment outcomes 
(Simpson, 2004).  The model was developed from studies of specialty community-based 
treatment for illegal drug use but was designed to apply to all substance types and 
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treatment settings (Simpson, 2004).  Similar to the ARM model, the TCU model follows 
the perspective that treatment outcomes are influenced not only by personal factors but 
also by systemic influences like relationships with family and friends and cultural norms 
(Simpson, 2004).  According to the model, examples of treatment factors predicting 
outcomes are patient readiness to change, substance use severity, duration and intensity 
of treatment, and successful transitions out of treatment (Simpson, 2004). 
Patient factors.  The TCU model identifies readiness to change and substance use 
severity as the patient factors most predictive of outcomes, such as retention (staying in 
the program) and harm reduction (reducing use or abstaining) (Simpson, 2004).  
Readiness to change is based on the ‘stages of change’ work of Prochaska and 
DiClemente (1983) and the motivational strategies work of Miller (1985).  The global 
readiness to change construct has been defined and measured in various ways, but 
however described, it has been associated consistently with therapeutic engagement, 
retention, and harm reduction (Simpson, 2004).   
Substance use severity incorporates factors such as misusing/abusing more than 
one substance, levels of criminal activity, poor psychosocial adjustment, and dual 
psychiatric diagnoses, with greater severity predicting worse outcomes for retention and 
harm reduction (Simpson, 2004).  However, when severity has been matched with 
increasing intensity of services provided, such as longer times in treatment and more 
frequent counseling, outcomes tend to improve (Simpson, 2004). 
Program attributes.  Most specialty substance treatment takes place in 
community-based residential and outpatient facilities; in general, patients with greater 
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problem severity have had better outcomes in residential treatment (Simpson, 2004).  
Examples of other program attributes are available resources, organizational climate, staff 
characteristics, and use of information technology; however, research is lacking, as these 
attributes have rarely been tested vis-a-vis treatment outcomes (Simpson, 2004). 
Treatment process.  In the TCU model, the treatment process has three stages: 
early engagement, which means participating in programs and forming therapeutic 
relationships with counselors; early recovery, which involves cognitive shifts and new 
ways of behaving; and retention and transition, which means staying through program 
completion and successfully transitioning out of the program (Simpson, 2004).  Keys to 
successful early engagement are frequent session attendance and a solid therapeutic 
relationship (Simpson, 2004).  Goals in early recovery include reductions in or abstinence 
from substance use, engaging loved ones in recovery efforts, and strengthening social 
support (Simpson, 2004).  Staying in one’s program to the end, the goal of retention, is 
strongly associated with harm reduction (Simpson, 2004).  Successful early engagement 
predicts early recovery which predicts retention and transition, which ultimately predicts 
harm reduction and sustained recovery (Simpson, 2004). 
In summary, the TCU Treatment Model is an evidence-based theoretical 
framework that identifies several patient, program, and process factors that are associated 
with treatment outcomes and that can help frame and guide future research.  Most 
prominent among these are readiness to change, substance use severity, and the patient-
counselor therapeutic alliance, all of which predict program engagement and retention 
and post-treatment harm reduction.   
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The ARM Model and the TCU Treatment Model theoretical frameworks aid in 
understanding and evaluating specialty substance use disorder treatment and relevant 
outcomes research, as well as medical interventions and treatment and outcomes 
research.  These models, particularly the TCU model, will guide development of research 
methodology for evaluating substance use interventions in medical settings. 
Specialty Substance Use Disorder Treatment 
Both the ARM and TCU frameworks incorporate specialty substance use disorder 
treatment as essential to the recovery process.  Designed for people at the severe end of 
the substance use spectrum, specialty treatment takes place in facilities such as 
community clinics, residential campuses, and hospitals. According to SAMHSA (2017b), 
there are more than 16,000 such facilities in the U.S. treating 1.15 million clients per day.  
Half are operated by private nonprofit organizations, one-third by private for-profit 
companies, and the rest by government entities (mostly local governments) (SAMHSA, 
2017b).  All sites offer detoxification services, as withdrawal from alcohol or drugs can 
be deadly.  Nine out of ten clients participate in outpatient programs such as medication-
assisted therapy, intensive outpatient therapy, and partial hospitalization.  About 8% of 
clients attend short-term (30 days or less) or long-term residential treatment, and 1% are 
admitted to hospital inpatient treatment programs (SAMHSA, 2017b). 
Per SAMHSA (2017b), most programs are staffed by trained substance use 
counselors such as professional counselors, licensed addiction specialists, and social 
workers. They offer many different interventions, chief among them motivational 
interviewing, cognitive-behavioral therapy, relapse prevention, brief intervention, trauma 
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counseling, 12-step facilitation, and anger management.  These interventions are 
provided in individual, group, family and couples counseling formats.  In addition, 
substance use professionals perform screening and assessment, diagnose substance and 
other mental health disorders, provide psychoeducation, plan for discharge and post-
treatment programs, and conduct case management.  More than 30% of facilities offer 
specialized programs for people with co-occurring disorders, males, females, trauma 
survivors, criminal justice clients, and young adults. 
People who need help enter specialty treatment via many pathways.  They may 
choose treatment on their own or because of family pressure; be mandated to attend 
treatment after entering the criminal justice system; or be referred by police, emergency 
services, medical clinics or hospitals, intimate partner violence programs, family service 
agencies, homelessness advocacy groups, or other entities that frequently encounter 
people with substance problems (Office of the Surgeon General, 2016).  The majority of 
treatment facilities conduct outreach to their local communities to find people needing 
help (SAMHSA, 2017b).  Augmenting these referral sources to enhance detection and 
intervention has become a critical priority for governments, communities, and helping 
organizations (Office of the Surgeon General, 2016).  Investing in referral processes may 
attract more people to treatment and improve access, both goals that are aligned with 
ARM model principles for the treatment continuum (White & Kelly, 2011). 
Patients who stay engaged in treatment and complete programs work with their 
treatment teams to develop post-discharge plans (SAMHSA, 2017b).  Depending on 
patient severity of use, prior experiences with treatment and relapse, program 
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experiences, and other relevant factors, discharge plans may include transitions to less 
intensive treatment programs or be limited to follow-up calls and/or support groups 
(Office of the Surgeon General, 2016).  Rarely are patients’ medical teams involved in 
these aftercare processes, which is a key missing linkage according to the ARM model 
(White & Kelly, 2011). 
Outcomes Research 
In specialty treatment for substance use disorders, research has focused on 
predictors of three primary outcomes: people staying in treatment programs (retention), 
achieving low-risk substance use or abstinence after program completion (harm 
reduction), and maintaining harm reduction (relapse prevention).  The predictors most 
often associated with these outcomes are the counselor-client working alliance, substance 
use severity, and readiness to change, each of which is emphasized in the TCU model. 
Counselor-client working alliance.  The counselor-client working alliance is 
characterized by agreement on goals and tasks and the strength of the interpersonal bond 
(Bordin, 1979).  Study outcomes associated with alliance have been largely positive, 
predicting greater retention and harm reduction (Barber et al., 2001; Crits-Christoph et 
al., 2013; Van Horn et al., 2015; Watts et al., 2018). 
In research involving residential treatment for clients with substance use disorders 
and child maltreatment histories (n=113 adults), trust predicted the working alliance, 
which in turn strongly predicted treatment engagement and retention (Watts et al., 2018).  
In a study of intentional re-engagement and alliance-building with clients who had 
relapsed after they had dropped out of outpatient treatment, researchers personally 
 
 39 
contacted clients and offered re-entry to any of the available treatment programs (Van 
Horn et al., 2015).  All clients reachable by phone (n=96 adults) chose to return to 
various forms of treatment.  Of these, over half attended at least one session per week to 
program completion.  A randomized clinical trial of cocaine-dependent clients (n=308 
adults) enrolled in three types of outpatient counseling – group supportive-expressive 
therapy, group cognitive therapy, and individual drug counseling – demonstrated that 
client ratings of working alliance increased with additional sessions for all modalities 
(Barber et al., 2001).  In this particular study, alliance in both supportive-expressive 
therapy and individual counseling were predictive of increased retention.  In cognitive 
therapy, however, it predicted decreased retention.  The researchers noted that previous 
studies of cognitive therapy and cocaine dependence had found no relationship between 
working alliance and outcome, so this result may be specific to type of therapy and drug.  
In another analysis of the same clinical trial (n=440), positive working alliances with 
group counseling facilitators predicted harm reduction, with fewer overall days of drug 
use and reduced likelihood of drug use between sessions (Crits-Christoph et al., 2013).  
The findings from these studies signify that the counselor-client alliance is a consistent 
predictor of positive substance use treatment outcomes. 
Substance use severity.  Substance use severity – the frequency of use and 
quantities consumed, along with the extent to which life roles are affected – and its 
associations with retention, harm reduction, and relapse prevention have been a focus of 
numerous studies.  The most common finding (Allen & Olson, 2016; Siqueland et al., 
2002) is that greater severity is associated with worse retention, failure to reduce harm, 
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and/or increased likelihood of relapse.  However, this finding is not universal.  A study of 
patients with co-occurring substance use and other mental health disorders (n=360 adults) 
found these patients more likely to stay in treatment compared to a control group (Griffin 
et al., 2014).  The researchers postulated that the study medications given for substance 
problems also may have improved psychiatric conditions to some extent, leading to better 
outcomes.  In another study involving 36 outpatient and residential treatment centers 
(n=1,939 adults), researchers investigated aspects of client satisfaction and substance use 
severity (Hser, Evans, Huang, & Anglin, 2004).  They found that satisfaction with 
counselors and programs – also an indicator of working alliance – and the intentional 
matching of service intensity (number, type, and length of sessions) to substance use 
severity improved retention, harm reduction and relapse prevention. 
Readiness to change.  The readiness to change construct is comprised of both 
motivation and intention (DiClemente, Schlundt, & Gemmell, 2004).  Motivation 
represents a person’s willingness to change and reasons for changing substance use 
patterns, while intent represents his or her goals and plans to change (DiClemente et al., 
2004).  In a study of treatment retention for veterans with alcohol use disorders, readiness 
to change was assessed, with higher readiness scores associated with completing 
treatment (Edens & Willoughby, 2000).  In another study of hospitalized patients with 
alcohol use disorders, participants (n=267 adults) were assessed for readiness to change, 
for awareness of problems with alcohol, and for specific actions being taken to reduce 
drinking (Bertholet, Cheng, Palfai, Samet, & Saitz, 2009).  Participants were followed up 
at three months for self-report of alcohol use.  Those in the highest one-third of readiness 
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were 57% more likely than the lowest one-third to be consuming fewer drinks.  Those 
taking action had 42% likelihood of reducing alcohol use.  However, people in the 
highest quartile of problem awareness had 164% likelihood of increased use.  The 
researchers noted that problem awareness can be a proxy for substance use severity, and 
severity may be associated with worse outcomes. 
A randomized controlled trial of both alcohol use disorders and methamphetamine 
drug use disorders was conducted in three South Africa emergency departments (Myers, 
van der Westhuizen, Naledi, Stein, & Sorsdahl, 2016).  Readiness to change predicted 
reductions in alcohol use, but not in drug use, at three-month follow-up.  The researchers 
noted that methamphetamine use was a complex syndrome that had been associated 
previously with high ambivalence to change; they suggested counseling strategies 
focused on ambivalence. Another study of disordered alcohol and drug use and harm 
reduction recruited people using both alcohol and opioid drugs (n=55) (Hesse, 2006).  
Readiness to change was associated with reductions in self-reported drug and alcohol use 
at 18-month follow-up. 
Summary of research.  With few exceptions, the counselor-client working alliance 
has been consistently predictive of improved harm reduction and treatment retention 
outcomes for people struggling with substance use.  Given mixed findings for the 
association of retention and harm reduction with substance use severity, more research is 
needed to confirm or disconfirm results.  For alcohol use, readiness to change generally 
has predicted outcomes of retention and harm reduction.  For illicit drug use, the findings 
for readiness to change are inconclusive, and further research is warranted.  It appears 
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that few studies have followed participants long enough to determine relapse outcomes or 
sustainability of harm reduction; this is an additional area for research. 
Medical Setting Intervention and Treatment 
The substantial barriers to intervention and treatment, along with the shortage of 
treatment options for people who haven’t yet developed substance use disorders, have 
resulted in a ‘treatment gap’ for people who misuse alcohol and illicit drugs (Office of 
the Surgeon General, 2016).  Given that substance misuse and disordered use are costly 
medical conditions, and that most people in the U.S. see a doctor at least once a year, 
medical settings have moved to the forefront of public health efforts to expand early 
detection, intervention, and treatment (Sacks et al., 2016).  The leading model in use, 
developed specifically for medical settings, is Screening and Brief Intervention (SBI) 
(Office of the Surgeon General, 2016).  SBI can be implemented with its Referral to 
Treatment component as SBIRT, the acronym most commonly found in the literature 
(SAMHSA, 2013).  SBIRT helps close the ‘treatment gap’ by bridging prevention and 
treatment with screening and brief intervention; it can be implemented in any type of 
medical setting (SAMHSA, 2013). 
SBIRT History 
SBIRT was introduced over thirty years ago as a World Health Organization 
alcohol screening and intervention process (Babor et al., 2017).  Its broad expansion in 
the U.S. was enabled by SAMSHA; in 2003, the agency initiated cooperative agreements 
for widespread SBIRT adoption in medical, college, and other settings (Babor et al., 
2017).  By 2017, 32 grants had been awarded to states, territories, and tribal organizations 
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(Bray, Del Boca, McRee, Hayashi, & Babor, 2017).  With a growing evidence base, 
SBIRT is now operational or under implementation in over half of U.S. states (Agley et 
al., 2014) and is employed in outpatient, emergency department, and inpatient settings. 
SBIRT Model 
According to SAMHSA (2013), the SBIRT model has six key features.  First, it is 
a brief process thus suitable for medical settings.  Second, screening is applied 
universally to all patients of a medical practice, permitting detection of hidden substance 
problems even for patients not actively seeking help.  Third, specific behaviors that are 
precursors to substance use disorders are targeted for screening and intervention.  Fourth, 
SBIRT is flexible and can be conducted in many types of settings, not only medical.  
Fifth, SBIRT is a comprehensive approach that for many people may be sufficient to help 
them transition to reduced use and prevent disease progression to disordered use.  Finally, 
SBIRT is supported by substantial research evidence for alcohol misuse while showing 
promise for other types and levels of substance misuse and disordered use. 
SBIRT Process 
The preferred application of the SBIRT model begins with screening (Babor & 
Higgins-Biddle, 2001).  To screen, medical care providers can rely on medical test 
results, observation, or dialogues with patients and family, and/or they may choose 
among several free, reliable, valid screening tools in widespread use, such as the Alcohol 
Use Disorders Identification Test and the Drug Abuse Screening Test (Office of the 
Surgeon General, 2016).  Tools may be used as self-reports or as the basis for patient 
interviews (Office of the Surgeon General, 2016).  Screening creates pathways for 
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discussing substance use with patients, who tend to view substance screening and advice 
as part of their providers’ roles (Sacks et al., 2016).  Through screening, patients can be 
identified at low, moderate, high, or severe levels of health risk given their substance use 
patterns (SAMHSA, 2013).   
The next steps in SBIRT depend on risk level.  Patients at low risk should be 
reinforced for healthy behavior and may be offered educational materials or other 
preventive measures (SAMHSA, 2013).  Interventions are recommended for moderate, 
high, and severe risk levels, either as a standalone treatment or a segue to more intensive 
care (SAMHSA, 2013).  For moderate risk, Brief Interventions (BI) are appropriate, 
consisting of one or more short sessions to help patients gain insight and knowledge 
about their substance use, increase motivation, and encourage behavior change 
(SAMHSA, 2013).  For high risk, the recommended intervention is Brief Treatment (BT), 
two to twelve sessions of one hour or less wherein a member of the medical team 
determines patients’ interest in and readiness to change, discovers and fills gaps in patient 
knowledge about health risks, explores patient ambivalence about substance use, and co-
creates goals with patients around behavior modification (Del Boca, McRee, Vendetti, & 
Damon, 2017).  Patients at high health risk and at severe risk should be referred to 
specialty substance use disorder treatment (Referral to Treatment, RT) and followed by 
the medical team until treatment entry (SAMHSA, 2013). 
Several SBIRT formats have been developed from therapeutic modalities used in 
psychology and counseling.  Motivational interviewing (MI) may be the most common 
(Del Boca et al., 2017), given MI’s utility for addressing the ambivalence and resistance 
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to change often found with substance use (Miller, 1985).  MI is based in the holistic, non-
judgmental, self-actualizing tenets of humanistic counseling (Miller, 1985).  A more 
structured form of MI in widespread use is Feedback, Responsibility, Advice, Menu of 
options, Empathy, and Self-efficacy, or FRAMES (Del Boca et al., 2017).  A format 
arising from the psychology field is cognitive-behavioral therapy, a process for 
transforming the maladaptive thoughts and behaviors driving excess substance use into 
realistic and healthy alternatives (Bray et al., 2017).  Unique to this study and Veach et al. 
(2018) is the person-centered SBIRT process, which borrows unconditional positive 
regard, empathy, and therapist congruence from the person-centered counseling theory 
developed by Rogers (1961). 
Impediments to the application of SBIRT are many.  Physicians, nurses, and other 
medical staff have expressed concerns about SBIRT, ranging from discomfort with 
talking to patients about substance use, to anxiety about learning and incorporating a new 
process into medical operations, to reluctance to expend valuable practice time for brief 
interventions (SAMHSA, 2013).  Historically, the medical professions have considered 
substance misuse and disordered use to be moral failings and not in the purview of 
medical care (Tai & Volkow, 2013), although views of substance problems as diseases 
and behavioral disorders have gained widespread acceptance (Babor et al., 2017).  
Medical providers may be unwilling to document substance misuse and disordered use 
formally in medical records for fear of stigmatizing patients with their insurers and other 
providers and/or from uneasiness with assigning mental health diagnoses (SAMHSA, 
2013).  Medical practices often lack linkages to treatment programs (SAMHSA, 2013).  
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For these reasons, medical practices benefit from having one or more SBIRT champions 
to change culture and to devote careful consideration to training, implementation, and 
continuous program evaluation (Agley et al., 2014).  In addition, SBIRT was designed to 
be highly flexible and can be modified as providers see fit, as even simple and very brief 
interactions can help patients initiate changes in substance use (SAMHSA, 2013). 
Outcomes Research 
SBIRT interventions by medical providers have been studied comprehensively 
relative to alcohol use and to a lesser degree for illicit drug use.  SBIRT has been found 
most effective in outpatient and emergency medical settings for helping people reduce 
alcohol misuse (Glass et al., 2017).  Alcohol misuse is defined as averaging more than 
one drink per day for women and older adults and two drinks for men, but not meeting 
criteria for an alcohol use disorder (NIAAA, 2018).  However, SBIRT has mixed 
outcomes for interventions in inpatient medical settings, for alcohol use disorders, or for 
any type of illicit drug use (SAMHSA, 2017a; USPSTF, 2017).  It has also not been 
shown as effective for referring people to specialty treatment (Glass et al., 2015). 
Alcohol.  Studies of SBIRT for alcohol misuse show consistently positive 
outcomes when conducted by medical providers in outpatient clinics and emergency 
departments.  Researchers conducted a systematic review and meta-analysis of the Brief 
Intervention component with primary care outpatients, locating 23 randomized controlled 
trials (RCT) of at least six months’ duration, with some studies lasting four years (Jonas 
et al., 2012).  Most RCTs excluded people with alcohol use disorders.  The researchers 
found that Brief Intervention following screening was associated with reductions in 
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number of drinks per week (n=4,332), the number of binge drinking episodes (consuming 
five drinks or more for men, or four for women, on one occasion [NIAAA, 2018]), 
(,n=2,737), and in the likelihood of patients transitioning from misuse to low risk 
drinking (n=5,937).  The researchers identified potential limitations.  First, the act of 
assessing for alcohol use may have been an intervention itself, leading to drinking 
reductions in control groups and biasing results towards the null hypothesis of no 
difference between control and intervention groups.  Second, the exclusion of people with 
alcohol use disorders limited the applicability of results to that population.  Third, basing 
outcomes on self-report may have biased the results if participants under-reported use. 
A systematic review of SBIRT for alcohol misuse when conducted by emergency 
department staff resulted in 33 RCTs (n=14,456 adults) with 3 to 12-month follow-up 
periods (Schmidt et al., 2015).  SBIRT is of high interest to EDs given that one-third of 
alcohol-attributable deaths involve traumatic injury, and one in seven ED patients are at 
moderate, high, or severe risk of harm from their drinking (Schmidt et al., 2015).  After 
meta-analysis, the researchers found small effects favoring subsequent reductions in 
drinks per week per month, average number of drinks per occasion, and binge drinking 
episodes.  Five moderating variables were tested – intervention type, length, and medical 
provider; control type; and study quality – but were not associated with outcomes.  The 
study’s metanalytic methodology required imputation of certain parameters was required, 
a limitation which may have introduced bias.  Because effect sizes were small, the 
researchers recommended additional research in ED-based SBIRT to confirm or 
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disconfirm findings.  They also suggested economic analysis to aid health care leaders in 
making SBIRT resource decisions. 
Brief interventions for alcohol misuse and disordered use among medically 
hospitalized adults (age 16+) were studied to determine effects on consumption levels 
and mortality (McQueen, Howe, Allan, Mains, & Hardy, 2011).  The researchers 
conducted a systematic review and meta-analysis, finding 14 controlled trials (n=4,041, 
>80% male), of which eight excluded people with alcohol use disorders, with follow-up 
periods from three months to three years.  Although reductions in consumption levels 
were evident up to six months after hospital discharge, by one year there were no 
differences between the intervention and control groups across studies.  The researchers 
suggested that the inclusion of people with alcohol disorders in several studies may have 
contributed to the non-significant findings, as previous research had indicated brief 
intervention might not be effective with this population.  However, at one year the 
intervention group had experienced fewer deaths than the control group, perhaps due to 
less drinking during the six months following discharge.  The limitations identified by the 
researchers were the overrepresentation of men in the participant group, which affected 
generalizability, and potential upward bias in outcomes due to subjective self-reported 
usage.  The researchers recommended future investigations regarding SBIRT for 
hospitalized patients to confirm or disconfirm findings. 
Researchers were interested in comparing alcohol brief interventions between 
primary care outpatient clinic settings and hospital settings, with hospital settings 
including EDs, trauma units, medical inpatient units, and hospital-based outpatient clinics 
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(Mdege & Watson, 2013).  They sought to determine whether differences in predictive 
factors explained previous findings that hospital-based SBIRT was less effective than 
SBIRT in primary care, although in this study ‘hospital’ was defined differently and more 
broadly compared to others by including EDs and outpatient clinics.  A systematic review 
resulted in 30 controlled trials from primary care settings and 46 from hospital settings 
(n=17,231 adults).  Significant differences in predictors between settings were number of 
sessions, with more sessions occurring in primary care; the inclusion of people with 
alcohol use disorders in most hospital-based trials, but not in primary care; and shorter 
follow-up periods for hospital studies (9.3 months vs. 13.5 months for primary care).  The 
researchers surmised that prior evidence showing SBIRT as not effective for people with 
disordered use contributed to differences in outcomes between settings, as most hospital 
studies including people with disordered use.  A limitation they identified was their 
inclusion of disparate settings in the hospital category, although secondary analysis did 
not reveal differences among those settings.  Future research focusing on number of 
sessions and substance use severity was suggested. 
The Referral to Treatment (RT) component of SBIRT has received less attention 
from researchers than other components (SAMHSA, 2013).  The researchers of an 
alcohol-focused systematic review and meta-analysis located 15 randomized controlled 
trials (total n=1,930) with an RT process (Glass et al., 2015).  Settings included 
emergency, outpatient, inpatient, and trauma settings, with three- to 18-month follow-up 
periods.  Meta-analysis of RCTs resulted in non-significant findings, indicating that RT 
was not a predictor of post-intervention specialty treatment.  The study was limited by 
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vagueness in how referral to treatment processes were defined which hindered 
comparability, and low power across studies.  The researchers suggested future research 
focused on the referral to treatment component of SBIRT. 
Illicit drug.  Evidence for SBIRT’s effectiveness for illicit drug misuse and 
disordered use is inconclusive, with research in this area in an early phase (SAMHSA, 
2013).  A systematic review of drug-related SBIRT yielded only five studies (n=2,369), 
all in outpatient settings with interventions conducted by medical providers (Young et al., 
2014).  The researchers noted that there were no previously published systematic reviews 
or meta-analyses for SBIRT and illicit drug use.  Their reported results were mixed but 
insufficient for comparison or meta-analysis, with quality of evidence rated low or very 
low for all outcomes.  However, the researchers noted that 16 new trials of SBIRT and 
illicit drugs were underway, some with large sample sizes, that might provide improved 
data compared to the trials in their review. 
An RCT for illicit drug use tested an SBIRT intervention group against a control 
group (n=344 adults), with 63% of participants using marijuana, 19% cocaine, and 17% 
opioids at varying levels of consumption and health risk (Saitz et al., 2014).  Brief 
interventions were provided by health educators with high school or bachelor’s degrees.  
The researchers found no differences between the intervention and control groups for 
drug use at six-month follow-up overall or when stratified by substance use severity or 
type of drug used.  They identified several aspects of the RCT, such as videotaping brief 
interventions, compensating participants and a short follow-up period, that limited 
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generalizability to real-world settings.  For future research, they recommended focusing 
on drug subgroups, such as cocaine or opioids. 
Despite these non-significant findings, the rapidly increasing mortality from drug 
use continues to generate interest in SBIRT as a treatment modality.  According to the 
U.S. Preventative Services Task Force (USPSTF, 2017), although universal SBIRT for 
drug misuse and abuse cannot be recommended based on current evidence, the USPSTF 
has proposed a research plan to encourage generation of evidentiary support. 
SBIRT in practice.  A troubling finding regarding SBIRT efficacy is that although 
screening is common in the general U.S. population, brief intervention is not.  A 
secondary data analysis of the 2013 National Survey on Drug Use and Health was 
performed for people who visited outpatient clinics but had not sought hospitalization or 
emergency services in the prior year (n=17,266 adults) (Glass et al., 2016).  The 
researchers discovered that 71% had received an alcohol assessment, but only 4.4% of 
people who were binge drinking monthly (n=4,367) were advised to reduce their 
drinking.  Of people reporting disordered use levels, only 7% were provided with 
treatment information.  Although the prevalence of SBIRT interventions in outpatient 
settings is rising, implementation of the full SBIRT model may be limited by cultural and 
operational barriers (Agley et al., 2014).  The researchers identified reliance on self-
reported usage as a limitation, as its validity is unknown. 
A similar study involved a retroactive comparison of screening and follow-up for 
substance use in rural versus urban primary care clinics (Chan et al., 2015).  Participants 
were from a statewide mental health program for people receiving state financial 
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assistance.  Those included in the study had been identified by their primary care 
providers as needing treatment for mental health disorders, primarily depression and 
anxiety (n=15,843 from 133 clinics).  Of these, 74% had been screened for potential 
substance use problems, a screening rate similar to the general U.S. population.  
However, only two out of five patients screening positive were asked about substance use 
at subsequent appointments.  Of patients from small and isolated rural clinics (n=636), 
only 14% were monitored for substance use at later appointments, whereas 40% of 
patients of large rural clinics (n=863) and 42% of patients of urban clinics (n=14,344) 
were asked about their substance use at follow-up appointments.  This variability was not 
explained by patient demographic or clinical factors but was partially explained by 
patient travel time, which was over twice as far for small rural clinics (20 miles on 
average) versus other clinics (9 miles).  The researchers noted that rural clinics had 
shortages of case managers, possibly due to travel time, that might explain the low 
monitoring rate.  They suggested that without case managers onsite, physicians and other 
medical staff may have been reluctant to engage patients with co-occurring disorders 
about problematic substance use.  Among their recommendations for future research was 
to address systemic and provider barriers to intervening with substance use problems. 
Summary of research.  Consistently across studies, the outcomes of interest to 
SBIRT researchers have been changes in self-reported consumption of alcohol or illicit 
drugs.  This was identified by several researchers as a limitation due to potential under-
reporting at follow-up.  For alcohol misuse, SBIRT has been associated with decreased 
use; for alcohol use disorders and any level of illicit drug use, SBIRT has not been 
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associated with decreased use.  SBIRT has efficacy for people misusing alcohol who see 
providers in outpatient clinics and emergency departments, but efficacy for hospitalized 
patients who misuse alcohol has not been shown.  Some researchers identified varied 
inclusion or exclusion of participants with alcohol use disorders as a limitation across 
settings.  For illicit drug use, some trials appear to suffer from low-quality data and/or 
limited follow-up periods.  New clinical trials are underway, and the U.S. Preventative 
Services Task Force is encouraging the generation of new evidence for SBIRT and illicit 
drugs.  When SBIRT is conducted in ‘real-world’ settings, only the screening component 
has been adopted broadly.  Brief interventions, brief treatments, and referrals to treatment 
appear to be exceptional events in actual medical settings. 
Suggestions for future research included studies to confirm or disconfirm 
inconclusive findings, in subpopulations of substance use type and severity, to analyze 
economic factors, and to address barriers to SBIRT implementation. The International 
Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA) has suggested 
other directions for future research, given that the demonstrated efficacy for SBIRT is 
limited to alcohol misuse and that SBIRT’s adoption in medical settings has been 
suboptimal (Agley et al., 2014; Glass et al., 2017).  Potential areas of focus include 
pinpointing how SBIRT should be used within the continuum of treatment, analyzing 
outcomes for multiple vs. single interventions, investigating efficacy for severe substance 
use and illicit drug use, improving rates of referral to specialty treatment, predicting 
health outcomes other than self-reported consumption levels, and disseminating best 
practices for operational implementation in medical settings. 
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What has not been considered as a research focus is the profession and training of 
the SBIRT provider.  Of note is that most studies to date involve SBIRT conducted by 
medical providers who may have been ambivalent about SBIRT and substance use in 
general.  The disappointing outcomes for alcohol disorders and illicit drug use may be 
improved if the SBIRT provider is a trained interventionist with skills in building 
therapeutic alliances.  An emerging model in outpatient and hospital sites is the provision 
of SBIRT by mental health clinicians who are part of integrated medical and mental 
health teams. 
SBIRT in Integrated Care 
The historical division of physical from mental health care, while culturally and 
operationally still the norm for the U.S. healthcare system, has begun to shift towards 
integrated medical and mental health structures (Sacks et al., 2016).  These structures, 
known as integrated care practices, offer potential for enhancing SBIRT’s effectiveness 
with populations for which research demonstrates mixed or inconclusive outcomes: 
people with alcohol use disorders, people who use illicit drugs, and/or people who are 
hospitalized for medical reasons.  For patients of integrated care practices, SBIRT is most 
often provided by mental health professionals, rather than the traditional model of SBIRT 
conducted by medical staff (e.g., physicians and nurses) (Sacks et al., 2016).  The training 
and professional practices of mental health clinicians may introduce greater 
understanding of and skill with the SBIRT process, thus improving outcomes. 
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Integrated Care 
In integrated care, mental health professionals such as counselors, psychologists, 
social workers, psychiatrists, and marriage and family therapists operate on teams with 
medical staff, collaborating to address substance-related problems along with other 
mental health concerns (Collaborative Family Health Association, 2017).  In its most 
evolved form, as delineated in a seminal article by Doherty (1995), mental health and 
medical professionals share sites and systems, consult with each other frequently, and co-
create treatment plans.  At times, integration occurs in specialty treatment settings by co-
locating primary care teams with specialty mental health treatment teams but more often, 
mental health care is integrated into medical settings, a model that is rapidly expanding 
(Sacks et al., 2016). 
DeGruy and Etz (2010) argued for incorporating mental health care, substance-
related care, and health behavior change into “medical homes,” primary care practices 
responsible for the full coordination of their patients’ care with specialty physicians, 
hospitals, substance use treatment centers, ancillary services, and the like.  The 
researchers described the indivisibility of physical and psychological symptoms and 
noted that one-third of primary care patients meet criteria for at least one mental health 
disorder.  The co-occurrence of chronic diseases (e.g., diabetes and heart disease) with 
psychiatric diagnoses adds costs, medical complications, and disease management effort.  
Overall outcomes improve when patients engage in positive health behavior change, 
which is best guided by mental health clinicians.  In fact, adults served by integrated care 
practices tend to receive more preventive services, use hospital and emergency services 
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less, and have lower health system costs (Reiss-Brennan et al., 2016).  However, DeGruy 
and Etz (2010) noted, the obstacles to integration are pervasive and daunting: behavioral 
health carveouts in managed care contracts, barriers to sharing clinical information, 
differing practice styles, and provider ambivalence regarding the extra time required to 
address mental health issues.  They supported continued vigorous efforts to overcome 
these obstacles, viewing integration as the only feasible pathway.  Dickinson and Miller 
(2010) concurred, adding that continuity of care, which signifies long-term relationships 
with patients and multi-specialty care teams, improves outcomes and lowers healthcare 
costs.  Notably, these principles of integrated care, medical homes, care coordination, and 
care continuity are central to the ARM model (White & Kelly, 2011). 
Patients have expressed appreciation for integrated care practices as well.  At a 
large medical center in a major Northeast U.S. city, people with substance misuse and 
disordered use who were infected with or at high risk for HIV participated in a qualitative 
study (Drainoni et al., 2014).  Participants in focus groups (n=40) or providing survey 
text responses (n=212) noted their preferences for the convenience and efficiency of co-
located medical and substance use care; supported team-based, collaborative care; 
recognized the importance of counseling and education to their care; and felt their overall 
well-being and quality of life had improved.  One participant described integrated care as 
a “circle of help that doesn’t stop” (p. 75).  Patients receiving medication-assisted therapy 
for opioid use disorders were particularly supportive of integration. 
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Application of ARM Model 
When mental health clinicians such as professional counselors conduct SBIRT in 
integrated care settings, enhanced intervention and treatment can occur within medical 
practices rather than being referred elsewhere or not performed.  Fornili (2016b) clarified 
how mental health clinicians conducting SBIRT in integrated care are central to the 
substance use treatment continuum, using the four stages of the ARM model in a 
combined model entitled SBIRT+RM (Figure 2). 
Figure 2.  SBIRT + RM Model 
 
Pre-recovery identification and engagement.  Pre-recovery identification and 
engagement aids in the early detection of substance misuse prior to development of 
disorders.  Establishing therapeutic alliances between clients and mental health clinicians 
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is also a goal.  In integrated care, mental health clinicians use the SBIRT process to 
identify and engage with patients who have substance misuse or disordered use and offer 
preventive care for patients at low risk for substance problems.  People in mental health 
are also trained to create client-counselor working alliances. 
Recovery initiation and stabilization.  Recovery is initiated when a person with 
substance problems accesses and enters a treatment process.  Stabilization will vary 
according to a person’s situation and occurs when chaos and unpredictability engendered 
by substance misuse or disordered use has largely subsided and recovery is well 
underway.  In integrated care, clinicians initiate recovery by conducting brief 
interventions (BI) with patients who are misusing substances or have disorders.  Patients 
may be able to stabilize with intervention alone.  If not, mental health professionals can 
follow the BT and/or RT processes of SBIRT, providing more intensive on-site 
interventions or referring people with more severe or recalcitrant substance problems to 
specialty treatment, where substance use counselors can help clients stabilize and move 
into recovery. 
Sustained recovery support.  Helping patients sustain recovery requires the 
engagement and support of the people and organizations surrounding the patient – 
families and friends, medical care providers, mental health clinicians, community 
services, and the like.  It involves collaboration with families and peer organizations as 
well as coordination of services to help with employment, housing, child care, 
transportation, legal matters, and life skills.  Sustained support can be arranged by both 
integrated care and specialty sites. 
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Long-term recovery maintenance.  Long-term recovery support is currently the 
weakest link in the substance treatment continuum (White & Kelly, 2011).  Ideally, the 
locus of help shifts from the provider’s setting to the patient’s environment.  In integrated 
care, mental health clinicians use chronic care approaches to help patients learn self-care 
and self-management, to provide checkups, and to enable further connection to 
community resources.  They collaborate with specialty treatment counselors if patients 
return to specialty treatment. 
Outcomes Research 
Initial research regarding SBIRT provided by mental health clinicians in 
integrated care settings has shown positive results.  The studies presented here are 
segregated by type of substance. 
Alcohol.  In an RCT involving professional counselors on a hospital integrated 
care team, hospitalized trauma patients with alcohol misuse or disordered use (n=333) 
were randomized to receive either a qualitative and quantitative SBIRT intervention 
(Veach et al., 2018).  Participants were predominantly white males and African-American 
males (58% and 18%, respectively).  Patients were screened prior to intervention using 
the Alcohol Use Disorders Identification Test (AUDIT) and were followed up at six 
months for reassessment; however, almost half of participants were lost to follow-up, 
although there were no significant differences in demographic factors for this group from 
the remaining participants.  No difference was found between the two interventions, but 
average AUDIT scores decreased by 64% in the quantitative group and 69% in the 
qualitative group, with both groups shifting from high risk to low risk drinking levels on 
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average.  Limitations of this study included the use of self-reported data; a low response 
rate at follow-up, which may have biased the results upward if non-respondents had more 
severe substance use; and a high percentage of male participants, which reduced 
generalizability of results.  The researchers suggested future research to compare 
counselor-provided SBIRT to SBIRT provided by medical professionals and to follow up 
with participants for longer periods. 
An RCT compared SBIRT provided in Veterans Affairs (VA) primary care clinics 
to non-VA specialty substance use treatment for veterans with alcohol use disorders 
(n=242) (Oslin et al., 2013).  SBIRT was conducted by behavioral health providers, a 
commonly used title for mental health clinicians in integrated care who are trained at the 
master’s level or above, such as social workers, professional counselors, psychologists, or 
marriage and family therapists.  The format was Brief Treatment, a more intensive 
version of Brief Intervention; Brief Treatment is suggested by SAMHSA for higher risk 
and disordered use (SAMHSA, 2013).  Patients were scheduled to be in contact with 
behavioral providers weekly for 30 minutes, in person or by telephone, for three months.  
After three months, they were to meet twice per month until recovery was well-
established.  If indicated, medication for alcohol recovery was provided.  At six-month 
follow-up, the intervention group (primary care) was 2.2 times more likely to refrain 
from heavy drinking than the control group (specialty treatment).  The intervention group 
also self-rated as more motivated and as having fewer alcohol-related problems.  The 
researchers concluded that treatment for high risk to severe risk disorders in a primary 
care setting was more effective than specialty treatment for this population.  However, 
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they noted that results may not generalize beyond the VA system, which has committed 
substantial resources to integrating care.  Other limitations were self-reported usage and a 
short follow-up period.  Suggestions for future research included longer follow-up 
periods and a focus on economic factors. 
Another RCT involving veterans 65+ years old analyzed health care expenditures 
from all available sources (e.g., outpatient, inpatient, ED, nursing home, pharmacy) for 
an SBIRT model in VA facilities vs. a specialty treatment referral model in non-VA 
facilities for depression, anxiety, and/or at-risk drinking (n=1,177) (Domino et al., 2008).  
The study took place at nine sites, consisting of 30 primary care clinics and 19 specialty 
treatment facilities, with SBIRT provided by behavioral health professionals.  The 
researchers found no difference in all-source costs between the two models, indicating 
that SBIRT in primary care is budget neutral compared to non-VA specialty treatment.  
This finding refuted assumptions held by some that integrated care is costlier than 
specialty care.  The study was limited in generalizability due to the VA setting and a 
predominance of males among participants (69%), and because one-fourth of costs had to 
be imputed due to missing data.   
Illicit drug.  To assess SBIRT brief interventions in primary care for illicit drug 
use, an RCT was conducted at five urban community health centers serving patients of 
lower socioeconomic status (Gelberg et al., 2015).  Patients screening positive for illicit 
drug misuse were randomized to intervention and control groups (n=334).  Patients with 
disordered use were excluded.  The intervention consisted of scripted brief advice from a 
medical provider, a 2-minute physician video reinforcing the advice, and a health 
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education booklet.  It was followed by 20-30-minute counseling phone calls at two and 
six weeks with a trained health educator overseen by an addiction psychologist.  Control 
group participants only viewed the video and received the booklet.  At three-month 
follow-up, patients in the intervention group reported illicit drug use of 2.21 fewer days 
in the prior month compared to patients in the control group, with mean drug use 41% 
lower for the intervention group.  Urine drug screen tests were performed at follow-up to 
verify self-reported use, with low rates of under-reporting detected; however, participants 
may have altered use knowing they would undergo urine drug screens.  The study was 
limited because 18% of patients declined the initial screening for substance use, and 10% 
of eligible participants declined enrollment.  The characteristics of these populations are 
unknown, but their absence may have biased the final results positively.  The researchers 
suggested future RCTs with longer follow-up periods that included economic analyses 
and that addressed sustainability of SBIRT in clinical operations. 
Alcohol and/or illicit drug.  The SAMHSA SBIRT grant program, which has 
funded 32 large state, territorial, and tribal SBIRT initiatives since 2003 (Bray et al., 
2017), was the basis for the following two studies.  The SAMHSA grants encourage 
SBIRT to be administered by trained substance use professionals such as counselors, 
social workers, psychologists and/or health educators, generally holding a master’s level 
or higher. 
A retrospective analysis of New Mexico SBIRT grant data examined the 
relationship between substance use outcomes at baseline and six-month follow-up to the 
type of SBIRT intervention delivered: brief intervention (71%) or brief treatment with or 
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without referral to treatment (29%) (Gryczynski et al., 2011).  The data used in the study 
were collected naturalistically in the course of operations at community health centers or 
Indian Health Service clinic sites.  The majority of people included in the study (n=1,208) 
were white (82%) and male (61%).  At six months, both interventions were associated 
with reductions in patient self-reported alcohol and illicit drug use.  Analysis of 
additional data collected for alcohol use showed greater reductions in frequency of 
drinking and intoxication after receiving BT/RT interventions, while increasing the 
number of BI sessions also predicted reduced drinking frequency and intoxication.  Study 
limitations were reliance on self-reported usage and the over-representation of male 
participants.  For future investigations, the researchers suggested RCTs and cost-
effectiveness studies focusing on the components of SBIRT. 
A large retrospective analysis of six SAMHSA state grants (states not identified) 
investigated outcomes for patients who screened positive for illicit drug misuse or 
disordered use, with some also screening positive for alcohol misuse or disordered use, 
who received BI, BT, or RT interventions (n=104,505) (Madras et al., 2009).  The patient 
population was notable for its diversity, with Alaska Natives, American Indians, African-
Americans, Caucasians, and Hispanics (categories used by SAMHSA).  The clinical sites 
were varied and representative of the health care spectrum, with inpatient hospitals, 
emergency departments, trauma centers, primary care clinics, specialty care clinics, and 
community health clinics.  Most patients received BI (70%), while BT and RT rates were 
nearly equal (14% vs. 16%).  A random sample of 10% of participants receiving 
interventions was selected for six-month follow-up.  Based on self-reported consumption, 
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illicit drug use had decreased 67.7%, while alcohol use for the same participants had 
decreased 38.6%, on average, with comparable findings across all demographic factors.  
People who received BT or RT self-reported significantly improved general health, 
mental health, employment, housing status, and criminal behavior.  Study limitations 
included the reliance on self-reported usage as outcomes, as under-reporting may have 
occurred, and a short follow-up period.  The researchers suggested future RCTs with 
SBIRT and illicit drug use, particularly opioid drugs, focusing on confounding factors 
and specific at-risk populations, such as people with co-morbid psychiatric diagnoses or 
poor social determinants of health. 
An RCT for opioid and alcohol use disorders was conducted at two community 
health centers serving patients of lower socioeconomic status, the majority of Hispanic 
origin (n=377) (Watkins et al., 2017).  The intervention group was treated under a 
collaborative care model, a form of integrated care that emphasizes case management and 
involving primary care physicians, advanced practice providers (e.g., physician assistants, 
nurse practitioners), psychiatrists, case managers, and mental health clinicians.  The 
control group received a list of community treatment resources.  The outcome of interest 
was whether patients in collaborative care would freely seek brief treatment from the in-
house counselors or social workers and/or seek medication therapy.  At 6-month follow-
up, the intervention group was significantly more likely to have accessed treatment (39% 
vs. 17%) and to have self-reported abstinence from substance use (33% vs. 22%).  A 
study limitation was the reliance on self-reported usage, as under-reporting was a 
concern. 
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Summary of research.  Investigations into SBIRT provided by mental health 
professionals for people with alcohol, illicit drug, or co-occurring alcohol and drug 
misuse and disordered use have demonstrated consistently positive outcomes for harm 
reduction across outpatient, emergency department, and inpatient settings, and for diverse 
populations.  Many of these investigations were randomized controlled trials, enhancing 
validity.  Most studies, however, relied on self-reported usage as outcomes, a limitation 
that can bias results upward if participants intentionally under-report usage.  Short 
follow-up periods were also limitations in several studies, along with the use of 
distinctive settings and populations that reduced generalizability.  Suggestions for future 
research included comparing outcomes for mental health vs. medical providers of SBIRT 
interventions, investigating the components of SBIRT, following up with participants for 
longer periods, controlled trials for illicit drug use, and economic analysis of findings. 
SBIRT and Professional Counselors in Integrated Care 
Research investigations of SBIRT by mental health professionals on integrated 
care teams have shown promising outcomes, especially for settings and populations that 
have not responded well to SBIRT provided by medical professionals.  Among mental 
health professionals, the training and skills of counselors may be most closely aligned 
with the SBIRT process, as well as the ARM and TCU models supporting it. 
Alignment of SBIRT and Counseling 
SBIRT involves facilitative conditions and helping skills that professional 
counselors learn and routinely employ.  Counseling programs offer specialty training in 
the foundations, context, and practice of substance use counseling (CACREP, 2015). 
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Relationships with patients.  According to SBIRT guidelines, providers should be 
empathetic and nonjudgmental, working to quickly build rapport and trust (Babor & 
Higgins-Biddle, 2001).  Similarly, the ARM model suggests relationships that are 
collaborative and empowering (White & Kelly, 2011).  Central to the counseling 
relationship are unconditional positive regard and empathy, which facilitate rapport and 
trust (Rogers, 1961).  A primary goal of counseling is to strengthen the counselor-client 
working alliance (Bordin, 1979), which in turn is predictive of treatment retention and 
harm reduction per the TCU model (Simpson, 2004) and according to research findings 
(Barber et al., 2001; Crits-Christoph et al., 2013; Van Horn et al., 2015; Watts et al., 
2018). 
Working with resistance.  According to guidelines, SBIRT providers should 
recognize and manage resistance in the relationship, and should match interventions with 
readiness to change, a significant predictor of outcomes according to the TCU model 
(Simpson, 2004).  Counseling incorporates psychodynamic, Gestalt, and motivational 
interviewing techniques for working with resistance and identifying client readiness to 
change (Gehart, 2016). 
Working with groups.  SBIRT interventions may take place with patients’ family 
members or friends present and engaged with the SBIRT process along with the patient 
(Babor & Higgins-Biddle, 2001).  Counselors are trained in effective group-level 
counseling, which is one of the profession’s eight core curriculum areas, and in working 
with families (CACREP, 2015). 
 
 67 
Assessment and diagnosis.  SBIRT involves conducting substance use 
assessments and providing effective feedback, while comprehensive biopsychosocial 
assessment is foundational to the ARM model (Babor & Higgins-Biddle, 2001; White & 
Kelly, 2011).  Counselors receive thorough training in assessment/testing, also one of the 
eight common core areas of the counseling curriculum (CACREP, 2015).  In addition, 
counselors are educated about and trained to work with people who have mental health 
diagnoses, including trauma, depression, and anxiety (CACREP, 2015), conditions that 
frequently co-occur in substance misuse and abuse (Office of the Surgeon General, 
2016). 
Advocacy.  Patient advocacy is a principal value both of the SBIRT process and of 
the ARM model (Babor & Higgins-Biddle, 2001; White & Kelly, 2011).  Advocacy is 
also fundamental to the counseling professional identity, as counselors are called to 
overcome institutional and societal barriers to client access, equity, and success 
(CACREP, 2015).  As members of integrated care teams, counselors have the opportunity 
to advocate with medical providers for the needs of patients and for the profession of 
counseling. 
Research Investigation 
Given the alignment of professional counseling with the SBIRT process and the 
ARM and TCU models, counselor-provided SBIRT may be associated with improved 
outcomes compared to SBIRT conducted by medically-trained providers, and comparable 
to or even more positive than outcomes for other mental health professionals.  To date, 
however, only one study has explored the association of SBIRT counseling interventions 
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with outcomes (Veach et al., 2018), with positive results for reduced consumption of 
alcohol. 
Without a research canon, it is important to examine research gaps and limitations 
identified in similar fields and to build on suggestions from those fields.  For counselor-
provided SBIRT, researchers in specialty substance use disorder treatment and of SBIRT 
interventions by medical and mental health providers have offered directions for research 
investigation.  Populations suggested for future study are those most frequently 
associated with mixed or non-significant results for SBIRT: people with disordered use of 
alcohol, people with illicit drug misuse and disordered use, and people hospitalized in 
inpatient units.  Substance use severity, a related construct, is also associated with mixed 
and sometimes opposite results.  To address limitations in previous designs, researchers 
have suggested selecting outcomes other than self-reported consumption, extending 
follow-up periods beyond six months, and increasing statistical power.  Suggested 
alternative outcomes for investigation are barriers to real-world implementation of 
SBIRT, effects of multiple vs. single interventions, and focusing on individual 
components of SBIRT e.g. BI, BT, RT.  A final suggestion for several researchers was to 
conduct economic evaluations, with a goal to ensure SBIRT funding and sustainability.  
This review has explored the research literature regarding populations, constructs, 
limitations and outcomes, with the exception of economic evaluation. 
Economic Evaluation 
Economists have developed widely-used evaluative tools for informing decision-
makers, which are selected after careful consideration of the problems under review, the 
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questions to be answered, and the decision-makers’ perspectives and needs for 
information (Drummond et al., 2015; Link, 2018).  Among these tools are cost-
effectiveness analysis, its variant cost-utility analysis, cost-benefit analysis and its 
reduced form, cost analysis. 
According to Drummond et al. (2015), cost-effectiveness analysis (CEA) allows 
decision-makers to rank and compare alternative programs that have a common identified 
outcome, using monetary and non-monetary costs and benefits.  The choice of elements 
to include in the CEA depend on the decision-maker’s perspective; for example, a 
societal perspective might include lost wages and accidents, whereas an organizational or 
health care provider perspective may focus more on revenues, expenses, and facility costs 
(Drummond et al., 2015).  CEAs can help clarify investment options by identifying 
programs that are both more effective and less costly than alternatives using a preference 
process called ‘dominance’ (Drummond et al., 2015).  Cost utility analysis (CUA) is a 
ratio used in health care decision-making, with the difference between costs and benefits 
as the numerator, and a standardized measure of life quality with a health condition 
(Quality-Adjusted Life Years, or QALYs), or life years lost to a condition (Years Life 
Lost, of YLL), or disability from a condition (Disability-Adjusted Life Years, or DALYs) 
as a common denominator (Drummond et al., 2015). 
In cost-benefit analysis (CBA), relevant costs and benefits are valued monetarily, 
then costs are netted against benefits, thus allowing comparison of programs with 
disparate outcomes (Drummond et al., 2015).  If costs and/or benefits will occur in the 
future, they may be discounted to a net present value (NPV) using an agreed-upon 
 
 70 
discount rate, generally a federal treasury rate or bank prime rate (Drummond et al., 
2015).  A program with a positive CBA or NPV can be considered on its own for 
investment or compared with other programs, with the highest net value program(s) 
selected for investment within the decision-maker’s financial constraints (Drummond et 
al., 2015).  Using information from the cost-benefit analysis, a benefit cost ratio can be 
calculated as discounted benefits divided by discounted costs, with ratios greater than 1.0 
worthy of investment (Link, 2018). In cost analysis, only costs are considered, with 
programs of differing costs compared to each other (Drummond et al., 2015). 
Economists and others have used these tools to evaluate SBIRT programs.  A 
systematic review included 23 studies that applied CEA, CUA, CBA, and/or variants of 
these to SBIRT programs (Angus, Latimer, Preston, Li, & Purshouse, 2014).  Of note, 
nearly all SBIRT interventions in Angus et al. (2014) were performed by medical 
personal such as general practitioners and nurses.  Overall, the researchers found that 
most studies, regardless of evaluation type, reported SBIRT as a beneficial investment.  
Nearly half of studies utilized CUA with a common denominator of QALYs or DALYs.  
Five studies reported using CEA, three CBA, and three other cost-based analyses. There 
were substantial methodological differences among studies that used similar evaluation 
tools, perhaps due to different intended audiences.  For example, some CUA studies 
included only intervention costs, while other studies also included societal costs.  
However, because researchers did not identify the decision-making audience for each 
study, comparison of analyses was challenging.  
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Four recent SBIRT economic evaluation studies were not included in Angus et al. 
(2014). An alcohol SBIRT program in Wales was compared to minimal intervention 
using CUA (Drummond et al., 2009).  SBIRT interventions were provided by trained 
nurses and alcohol substance use counselors, and the target decision-makers were health 
policy-makers.  Included in the numerator were staff time valued using salaries and 
benefits, educational and training materials, facilities, and overhead.  Societal costs were 
estimated from health services and social program utilization, accidents, and criminal 
activity.  The denominator was QALYs.  The SBIRT program interventions were cost-
effective compared to minimal intervention. 
A randomized controlled trial investigating four-session SBIRT interventions for 
alcohol misuse in India was evaluated using 12-month follow-up results (Nadkarni et al., 
2017).  The interventions were conducted by trained non-professional staff.  Two types of 
decision-makers were targeted – health care system leaders and policy-makers. Costs 
were valued similarly to Drummond et al. (2009) but also included staff time and travel 
for a home-based component of the study, while the denominator for comparison was 
QALYs.  Costs were offset by reductions in health utilization at the health system level 
for the SBIRT group.  The societal perspective added labor productivity for patients and 
their family members.  The CUA results indicated that the SBIRT intervention program 
dominated usual care and was therefore the preferred economic investment.  For SBIRT, 
total costs were less than total benefits due to health utilization reductions and the 
avoidance of most societal costs, so the brief intervention resulted in a net benefit per 
QALY. 
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SBIRT interventions for alcohol misuse performed in emergency departments 
(ED) were compared to SBIRT interventions in outpatient settings (Barbosa, Cowell, 
Bray, & Aldridge, 2015) using data from a SAMHSA SBIRT grant recipient.  The target 
decision-makers were health care providers and policy-makers.  Program costs were 
developed in a similar manner to Drummond et al. (2009).  Societal costs – health care 
utilization, criminal activity, automobile accidents, and lost income – were collected from 
a subset of patients for six months before and after interventions then valued using peer-
reviewed literature and patient wage self-reporting. The researchers found that SBIRT in 
EDs was less costly and more effective than SBIRT in outpatient settings.  Because this 
was due in part to fewer interventions per patient in EDs, a sensitivity analysis was 
developed assuming the maximum recommended interventions for both settings; the ED 
setting still dominated. 
Based on data from another SAMHSA SBIRT grant recipient, SBIRT brief 
intervention (1-4 sessions) was compared to brief treatment (5-12 sessions) for alcohol 
and drug misuse and disordered use across six outcome conditions (Barbosa et al., 2017).  
The target decision-makers were treatment providers; therefore, program costs were 
included but societal costs were not.  Brief treatment was more cost-effective than brief 
intervention for one condition, probability of alcohol use, but brief intervention was more 
cost-effective for the other five conditions (days of alcohol use, probability of using 
alcohol to intoxication, days using alcohol to intoxication, probability of using drugs, 
days using drugs). 
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Based on economic theory and prior research, evaluating counselor-provided 
SBIRT requires identifying the relevant target audience.  For the present study, the stated 
target audience is health system leaders who must choose among disparate programs for 
investment and balance many priorities in a budget-constrained environment; therefore, 
cost analysis was selected, with health system costs included but not societal costs. 
Summary and Conclusions 
Substance misuse and disordered use are prevalent throughout the world, 
implicated in death and disability and with widespread effects on families, communities, 
economies, and societies.  The costs to workplaces, local governments, and health care 
providers are immense.  Yet most people struggling with alcohol and drug use are not 
identified as needing help and do not receive help in the form of interventions or 
specialty treatment.  The reasons are many, but include stigma, denial or minimization of 
problems, difficult finding help, lack of coordination between mental health and medical 
treatment, and shortages of intervention and treatment services.  The Addiction Recovery 
Management (ARM) Model delineates these challenges and proposes systematic changes 
to address them, thus making recovery from substance misuse and disordered use more 
likely.  The Texas Christian University Treatment Model connects system components 
with outcomes, identifying predictive variables such as readiness to change, substance 
use severity, and counselor-client alliance. 
Specialty substance use disorder treatment is designed for more severe levels of 
substance use, with research generally supporting its efficacy for reducing alcohol and 
drug intake.  For people who need help but aren’t receiving it, interventions in medical 
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settings have been on the rise in the form of Screening, Brief Intervention, and Referral to 
Treatment (SBIRT).  SBIRT extends intervention and treatment as recommended by the 
ARM model.  When conducted by medical professionals, SBIRT has been shown 
effective for alcohol misuse in outpatient and emergency department settings, but not 
drug use or alcohol use disorders, or for hospital inpatients.  A newer medical practice 
model, integrated care, offers promise for improving outcomes overall.  In integrated 
care, SBIRT is provided most often by mental health professionals who are trained to 
work with mental health problems such as substance misuse and disordered use.  Early 
research results have shown that SBIRT by mental health professionals is associated with 
reductions in alcohol and drug use regardless of severity level or setting. 
An intriguing innovation is the provision of SBIRT by professional counselors, a 
subset of mental health professionals.  The training and professional identity of 
professional counselors is closely aligned with SBIRT guidelines as well as the ARM and 
TCU models, and counselors have been part of multi-specialty mental health provider 
teams from prior studies.  However, only one study has investigated counselor-provided 
SBIRT, with promising results.  Additional investigation is needed, with designs that can 
incorporate recommendations by prior researchers, such as testing outcomes other than 
self-reported consumption; associating outcomes with severity, type of substance used, 
and setting; incorporating follow-up periods longer than six months; and conducting 
economic evaluation of findings. 
Accordingly, the present study is designed to associate counselor-provided SBIRT 
with outcomes important to the health care systems that bear significant costs from 
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treating patients with substance misuse and disordered use, specifically hospitalizations 
and emergency department visits.  Because investigations regarding SBIRT for hospital 
inpatients have been inconclusive, this setting has been selected for the present study.  
The effects of severity and type of substance used will be estimated, and an economic 
evaluation of outcomes performed.  Positive outcomes may lead to additional investment 
in counselor-provided SBIRT, bringing needed intervention and treatment to people who 
need it the most. 
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CHAPTER III 
METHODOLOGY 
The rationale and need for a research study presented in Chapter 1, along with the 
review of relevant literature in Chapter 2, suggest that counselor-provided SBIRT in 
integrated care settings is a promising, innovative intervention for people with alcohol or 
illicit drug misuse or disordered use.  In this chapter, the research methodology for 
examining counselor-provided SBIRT in a specific integrated care setting and population 
is provided.  The research questions and hypotheses are stated.  The research design, 
consisting of the study setting, counseling program and intervention process, study 
population, data procedures, and measures, is explained.  The statistical analyses and the 
pilot study are described. 
Research Questions and Hypotheses 
Research Question 1.  For patients with alcohol or illicit drug misuse or 
disordered use, do patients in inpatient integrated care settings receiving counselor-
provided SBIRT experience fewer hospitalizations and emergency department visits 
compared to patients in the same settings not receiving interventions? 
Research Hypothesis 1.  Patients with alcohol or illicit drug misuse or disordered 
use and receiving counselor-provided SBIRT in integrated care settings experience fewer 
hospitalizations and emergency department visits compared to patients not receiving 
interventions.
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Research Question 2.  Do hospitalization and emergency department visit 
outcomes for patients with alcohol or illicit drug misuse or disordered use differ by 
substance use type, substance use severity, or inpatient service location? 
Research Hypothesis 2.  Hospitalization and emergency department visit 
outcomes for patients with alcohol or illicit drug misuse or disordered use differ by 
substance use type, substance use severity, and/or inpatient service location. 
Research Question 3.  Are counselor-provided SBIRT interventions associated 
with reduced economic costs from the health system perspective? 
Research Hypothesis 3.  Counselor-provided SBIRT interventions are associated 
with reduced economic costs from the health system perspective. 
Research Design 
The study was a retrospective analysis of data to determine whether counselor-
provided SBIRT treatment interventions for adults with substance misuse or disordered 
use who were hospitalized on integrated care services predicted reductions in 
hospitalizations and ED visit outcomes when compared to no intervention, and whether 
these outcomes differed significantly by substance use type, substance use severity, or 
inpatient service location.  This study was also an evaluation of whether counselor-
provided SBIRT was associated with economic cost reductions for health care systems. 
Study Setting 
The setting for this study was the primary teaching hospital of a large academic 
health system in the southeastern U.S. comprised of a medical school, several hospitals 
and clinics, allied health organizations, and foundations.  The hospital admits 50,000 
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inpatients per year to its 885 licensed inpatient beds and observation units, while 111,000 
patients visit the Emergency Department annually (Wake Forest Baptist Medical Center 
[WFBMC], 2018b).  The health system offers primary, specialty, trauma, and intensive 
care to patients, most of whom live in the surrounding 24 counties (WFBMC, 2018b).  
The health system’s budget exceeds $2.6 billion, with 2,000 faculty and resident 
physicians and a total workforce of 15,000 people (WFBMC, 2018b). 
Counseling Program and Intervention Process 
The study population was drawn from patients receiving SBIRT interventions 
from the counselors and counselor trainees of an inpatient substance use counseling 
program.  This program operates on the hospital’s integrated care medical services 
(Trauma, Burn, and General Medicine) and has been active for more than a decade.  The 
program’s founder/director is a faculty member who is a licensed professional counselor 
and licensed substance use counselor.  The program employs licensed professional 
counselors at the master’s and doctoral levels.  It serves as a training site for master’s- 
and doctoral-level counseling students during their practicum and internship experiences.  
The program has established procedures, both verbal and written, that are followed by the 
director and staff counselors and are taught to each trainee; program procedures are 
documented in Veach et al. (2018).  These procedures are the basis for the patient 
selection and counseling intervention narratives that follow. 
Program patient selection for SBIRT intervention.  In the course of daily program 
operations, counselors and/or trainees (hereinafter referred to collectively as ‘counselor’ 
or ‘counselors’) first review electronic medical records and/or consult with medical 
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providers to identify patients with known or potential substance misuse or disordered use.  
The electronic medical record (EMR) system is the repository for data collected during 
patient admission to the hospital and medical care.  Aspects of the EMR reviewed by 
counselors are the following: 
• Demographics, specifically language(s) spoken.  Patients identified for 
intervention are limited to English-speaking adults, with English denoted as 
the patient’s primary language in the EMR.  Due to limited hospital resources, 
translators are not readily available to the counseling program. 
• Medical problem list.  The problem list contains all active and historical 
medical issues of patients, including specific substance use disorders.  
Problems are recorded by physicians during patient encounters with the health 
system. 
• Alcohol and drug screening questions.  During hospital admission procedures, 
nursing staff are prompted by the EMR to ask patients about their alcohol and 
illicit drug use.  If patients respond positively about use, nurses are expected 
to obtain weekly frequencies and/or quantities as well as the type(s) of alcohol 
and/or drug(s) consumed.  In practice, depending on the patient’s condition 
(e.g., incoherent or unresponsive) or nursing error, the screening questions 
may be left unanswered until the patient or an accompanying person is able to 
respond. 
• Laboratory test results.  Physicians routinely order blood alcohol levels 
(BAL) for Trauma patients.  BALs are sometimes ordered for Burn and 
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General Medicine patients if alcohol use is concerning based on patient 
clinical presentation or histories provided by patients or persons 
accompanying them to the hospital.  Urine drug screens (UDS) are ordered for 
Trauma, Burn, and General Medicine patients if drug misuse and/or 
disordered use are clinical concerns. 
• History and physical reports (H&Ps).  Prepared by admitting physicians, 
H&Ps are text-based documents in the EMR that include data such as 
thorough patient histories; results of physical exams; interpretations of 
diagnostic laboratory, radiology, and similar tests; and treatment plans. 
Counselors also consult collaboratively with physician and/or nursing staff about 
patients, usually during daily medical rounds or nursing multi-disciplinary morning 
meetings.  They sometimes learn about substance misuse or disordered use concerns that 
have not yet been recorded in the EMR and arise from medical provider interactions with 
patients and/or the persons accompanying them. 
A patient is selected for an SBIRT counseling intervention if he or she is English-
speaking and any of the following conditions are met: 
• Patient has active or historical substance use disorders appearing on the 
medical problem list, such as alcohol use disorder or opioid use disorder 
• Patient either answers the nurse screening questions with responses indicating 
potential misuse or disordered use of alcohol and/or illicit drugs, or the 
screening question are blank in the EMR 
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• Patient has a positive blood alcohol level, represented in the EMR laboratory 
results by a score of 10 or greater.  When divided by 1000, the score 
represents the actual blood alcohol concentration at the time of testing (e.g., 
100/1000 = .10 blood alcohol concentration) 
• Patient has a positive urine drug screen for any of six substances 
(amphetamines, barbiturates, benzodiazepines, cannabis, cocaine, and 
opiates), provided there is no prior medical explanation for the positive screen 
(e.g., drug appears in the patient medication list in the EMR or drug was 
provided at the hospital) 
• Patient has written indications of substance misuse or disordered use in the 
physician H&P 
• Physicians, nurses, or care coordinators share verbal concerns with counselors 
about the patient’s known or potential substance misuse or disordered use 
(according to program procedures, recording these concerns in program 
documentation is not required) 
Procedures for SBIRT counseling interventions.  For newly admitted patients 
selected for SBIRT intervention, counselors enter patient names, medical record 
numbers, demographic information, screening question responses, laboratory test results, 
and other related clinical data to spreadsheets stored on secure program servers.  The 
same data are recorded on paper intake documents.  Counselors review the status of 
patients previously admitted and selected for intervention; some of these patients already 
would have been seen for SBIRT while others would not.  Newly available data, such as 
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test results (e.g., BAL, UDS), are entered on spreadsheets and intake documents for these 
patients.  Counselors then attend physician rounds and/or multi-disciplinary meetings 
where patient conditions and treatment plans are discussed, and where they may receive 
additional input from medical providers about patient substance use. 
Once a complete list of patients selected for intervention is established for the 
day, the counselors conduct SBIRT interventions for as many patients as possible and 
make return visits to patients previously seen.  Following each intervention or attempted 
intervention, the patient intake form is completed for the encounter, documenting such 
factors as components of SBIRT performed, length of time in session, and assessment 
scores.  These results are transferred to spreadsheets, which are accumulated by month 
for each integrated care service. 
During the first (and sometimes only) session with a patient, the counselor 
adheres to program procedures by making a brief introduction, discussing confidentiality, 
obtaining verbal consent for counseling, then, upon consent, spending 10-20 minutes 
developing a therapeutic relationship.  The counselor then follows World Health 
Organization (WHO) guidelines for the SBIRT process (Babor & Higgins-Biddle, 2001).  
The counselor will seek the patient’s verbal consent to administer the Alcohol Use 
Disorders Identification Test (AUDIT) (Babor, Higgins-Biddle, Saunders, & Monteiro, 
2001) and/or the CAGE Questionnaire (Dhalla & Kopec, 2007).  If a screening test 
and/or patient declaration indicates no substance use, the session will conclude.  At times, 
patients will self-disclose substance use issues early in the session; when this occurs, the 
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counselor may decide to bypass the screening tests and proceed directly to brief 
intervention. 
For patients who misuse alcohol and/or illicit drugs or have disordered use, 
SBIRT guidelines recommend an intervention of at least 15 minutes (Babor & Higgins-
Biddle, 2001).  If, per the screening test or patient disclosure, low risk use is present, the 
counselor will provide psychoeducation and materials intended to prevent progression to 
misuse or disordered use (Babor & Higgins-Biddle, 2001).  If misuse or disordered use is 
detected, brief interventions will be attempted to help patients identify deleterious 
consequences from using substances, fortify desires to reduce harm or abstain, create a 
harm reduction plan, work on relapse prevention skills, and/or discuss post-discharge 
treatment options (Babor & Higgins-Biddle, 2001). 
Patients who are hospitalized for several days or weeks may have multiple brief 
interventions.  They may also be visited by a different counselor or trainee for some or 
most of these visits, depending on the service schedule.  If patients are hospitalized more 
than once during the study period, they may have more than one hospitalization with an 
intervention. 
Study Population 
The study population consisted of English-speaking adults aged 18 years and 
older who were admitted to the integrated care inpatient services of the hospital between 
January 2014 and December 2017, were selected for SBIRT intervention, and met criteria 
for study inclusion.  The patients included in the study population were those admitted to 
the hospital and identified by or referred to the Trauma and Burn integrated counseling 
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services beginning in January 2014 and those admitted to the hospital and identified by or 
referred to the General Medicine integrated counseling service beginning in September 
2015 (the month this service was first integrated). 
The start date of January 2014 was based on electronic health record data 
availability.  The health system installed new, comprehensive health record software in 
September 2012 (WFBMC, 2018a).  Medical records data prior to the implementation 
month were not readily accessible.  The study design included a one-year lookback 
period (see Data Procedures), so the first full calendar year of health data available for the 
lookback period began in January 2013.  Therefore, the start date for including patients 
selected for SBIRT interventions in the study population was January 2014. 
Study inclusion criteria.  Patients identified for SBIRT counseling interventions 
during the time period of interest (January 2014 – December 2017) were considered for 
inclusion in the study population.  The intervention group was comprised of patients who 
received one or more SBIRT counseling interventions during a single hospitalization.  
The total intervention time met or exceeded the recommended guideline for SBIRT brief 
interventions of at least 15 minutes (Babor & Higgins-Biddle, 2001).  For patients who 
received interventions during more than one hospitalization, the first hospitalization 
involving an intervention became the target hospitalization for inclusion in the 
intervention group, to avoid potential confounding effects from increasing “doses” of 
counseling. 
The comparison group included patients who were identified for SBIRT 
intervention but did not receive them due to timing issues, such as being absent from the 
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hospital room or being discharged prior to counselor availability for intervention.  
Patients might not have received interventions for several other reasons, including 
temporary or permanent cognitive deficits, active psychotic symptoms, refusal of 
intervention, or departure from the hospital against medical advice (AMA).  As patients 
with these cognitive, psychiatric, and behavioral factors were likely to be qualitatively 
different from the intervention group, only patients who did not receive interventions for 
timing were included in the comparison group. 
Study exclusion criteria.  Patients with direct contact time with counselors, but not 
exceeding 14 minutes for any hospitalization during the study period, were excluded 
from the study population as not meeting the minimum time recommendation for brief 
interventions.  Patients with cognitive deficits, with psychotic symptoms, refusing 
intervention, and leaving the hospital AMA were unable to participate in counseling 
interventions by condition or by choice and were excluded from the study population.  
Figure 3 provides a flowchart summarizing the study population selection process. 
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Figure 3.  Study Population Selection 
 
Data Procedures 
Institutional Review Board (IRB) approvals were obtained for the study from both 
Wake Forest Baptist Medical Center and The University of North Carolina at 
Greensboro.  A patient dataset was created from 120 individual monthly spreadsheet tabs 
for all patients meeting inclusion criteria during the investigation time period (January 
2014–December 2017).  Extracted from the spreadsheets were patient names and medical 
record numbers, inpatient service, age, gender, and ethnicity/race.  Also extracted was 
total intervention time for patients receiving SBIRT interventions greater than 15 
minutes. 
All patients 
admitted to 
integrated care 
services
• Burn
• General 
Medicine
• Trauma
Patients with 
known or 
suspected 
substance 
misuse/abuse
• Active disorder on problem list
• Screening questions indicate substance misuse/abuse
• Positive BAL and/or UDS
• Medical provider EMR documentation (H&P)
• Medical provider verbal concerns
• English-speaking
Patients able to 
participate in 
counseling 
• Excludes patients with cognitive impairment, psychotic 
symptoms, discharged against medical advice, or 
refusing counseling
• Excludes patients with 1-14 minutes intervention time
Treatment 
Group
• Intervention time 
>= 15 minutes
Comparison 
Group
• No intervention due to 
timing issues
Counselor-Provided SBIRT Interventions:  Study Population Selection
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Using medical record numbers along with admission and discharge dates for 
intervention and comparison hospitalizations, dates of all hospitalizations and ED visits 
one year prior to admission and one year subsequent to discharge for these 
hospitalizations, thus occurring sometime between January 2013 and December 2018, 
were obtained from the data analytics warehouse.  Other data extracted were clinical 
disease coding, measures of illness severity and risk of mortality, physician clinical 
service overseeing the patient’s care, room location at time of discharge, and payers 
(entities responsible for bill payment such as insurance companies or patients).  Patient-
specific costs for each encounter were obtained to test economic outcomes.  Marital 
status was acquired as an additional demographic variable. 
Clinical disease coding data was extracted from the data warehouse to determine 
whether substance use was noted as a concern by a physician(s) for a given 
hospitalization or visit.  While coding cannot be assigned for undetected substance use or 
use that is not thought to be a problem for a patient, coding is assigned if the substance 
use was managed, evaluated, assessed, or treated in any way during the patient encounter 
(M. Matthews, personal communication, September 11, 2018).  Using disease coding for 
this study may underestimate substance use in the study sample, although from the health 
system’s perspective it is the active substance use effects on medical care and treatment 
that is of highest priority, and these effects are most like to by captured by the coding (M. 
Matthews, personal communication, September 11, 2018). 
Disease coding was used to assign substance use severity and type for the 
intervention and comparison groups.  Coding was also used to identify hospitalizations 
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and ED visits during the study period that involved substance use, misuse and/or use 
disorders.  Counts of hospitalizations and ED visits and economic costs were summarized 
separately by encounters with substance use coding and encounters without coding, as 
well as in total, then added to the patient dataset. 
Disease coding from the World Health Organization’s International Compendium 
of Diseases, Clinical Modification (ICD-CM), Ninth Version (1999) was in effect from 
January 2013 through September 2015.  Disease coding from the World Health 
Organization’s ICD-CM, Tenth Version (2016) has been in effect since October 2015.  
To ensure consistency between versions when using disease coding in this study, the 
Classification of Mental and Behavioural Disorders: Conversion Tables Between ICD-8, 
ICD-9 and ICD-10, Rev. 1 (World Health Organization, Division of Mental Health, 
1994) was followed.  See Appendix A for substance use disease coding for both the ninth 
and tenth versions. 
Measures 
To guide research in this emerging area, the Texas Christian University (TCU) 
Treatment Model provides an evidence-based theoretical framework (Simpson, 2004).  
The TCU Model delineates the factors most predictive of treatment outcomes in 
substance misuse.  Aligning the TCU Model with counseling program and available 
health record data reveals several variables of common interest: patient-level factors such 
as substance use severity and time spent in treatment, plus program-level factors such as 
staff and climate (Simpson, 2004).  These factors are also critical to the SBIRT process, 
along with substance use type (Sacks et al., 2016). 
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Accordingly, the predictor variables included in this study were counselor-
provided SBIRT interventions; substance use type; substance use severity; and inpatient 
location, representing program staff and climate.  The outcome variables were prior and 
subsequent hospitalizations and ED visit counts and per-patient encounter costs.   
Counselor-provided SBIRT interventions.  The intervention was coded in two 
ways.  First, a dichotomous predictor variable was coded as ‘1’ for intervention or ‘0’ for 
no intervention.  This variable was an indicator of whether a patient was in the 
intervention group (‘1’) or the comparison group (‘0’).  The intervention variable was 
dichotomous to allow for propensity scoring techniques in data analysis.  Assignment of 
this variable was as follows: 
• A ‘1’ specified that a patient received at least 15 minutes of counselor-
provided SBIRT during one hospitalization of the study period.  The 15-
minute floor represents the time duration recommended by the WHO for a 
brief intervention (Babor & Higgins-Biddle, 2001).  The first 
hospitalization experienced by a patient that included at least 15 total 
minutes of counseling time was labeled as the index hospitalization.  
Provided the patient met other inclusion criteria, this hospitalization 
entered the patient into the intervention group.  Future hospitalizations 
were excluded from intervention or comparison groups to avoid double 
counting of prior and subsequent hospitalizations. 
• A ‘0’ specified that a patient did not receive any minutes of counselor-
provided SBIRT or other professional counseling interventions at any time 
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during the study period.  Provided the patient met other inclusion criteria, 
the patient’s first hospitalization was labeled as an index hospitalization, 
and the patient was entered into the comparison group.  Future 
hospitalizations were excluded from intervention or comparison groups to 
avoid double counting of prior and subsequent hospitalizations. 
Second, a categorical variable was created based on length of time spent 
counseling.  This variable was inspected for natural groupings then stratified into 
quintiles.  The reference group of ‘0’ for no intervention was added to this categorical 
variable, resulting in six levels, coded as follows: 
• A ‘0’ specified that no intervention occurred, using the criteria from the 
comparison group of the dichotomous intervention variable 
• Using the criteria for the intervention group of the dichotomous variable, 
the following levels were assigned to divide the distribution of session 
times into five roughly equal parts: 
o ‘1’ for sessions between 15 and 25 minutes 
o ‘2’ for session between 26-30 minutes 
o ‘3’ for sessions between 31-45 minutes 
o ‘4’ for sessions between 46-60 minutes 
o ‘5’ for sessions exceeding 60 minutes 
Prior and subsequent hospitalizations.  Studies comparing SBIRT interventions 
with hospitalization and ED visit outcomes used frequency counts to measure these 
variables (Bray et al., 2007; Freeborn, Polen, Hollis, & Senft, 2000), as did studies of 
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integrated care practice outcomes using these outcomes (Driscoll et al., 2013; Reiss-
Brennan et al., 2016; Yoon, Chow, & Rubenstein, 2016).  Therefore, hospitalizations 
were a count variable, with count representing the number occurring during each one-
year period of interest.  The one-year periods are consistent with studies involving 
hospital and ED utilization for hospitalized patients (Bray et al., 2007; Saitz et al., 2014) 
and in other studies of substance misuse outcomes (Bloor, Neale, Weir, Robertson, & 
McKeganey, 2008; Glass et al., 2015; Jonas et al., 2012).  For both the intervention and 
comparison groups, the date one year prior to the admitting date became the beginning of 
the one-year period prior to hospitalization.  The date of patient discharge was the 
starting point for the one-year period following hospitalization.  Counts from both one-
year periods were outcome variables.  For the intervention group, the count period 
followed the first hospitalization during the study period wherein a patient received a 
counselor-provided SBIRT intervention(s) of at least 15 minutes.  For the comparison 
group, the count followed the first hospitalization wherein the patient was identified for 
intervention but not counseled. 
Prior or subsequent hospitalizations with clinical disease coding for substance 
misuse or disordered use were counted separately from those without substance codes, 
then were added together to obtain another count level.  Patients can experience other 
conditions leading to frequent hospitalizations that are not directly associated with 
substance use (e.g., congestive heart failure or uncontrolled diabetes); however, because 
past or current substance use can interact with chronic conditions to deleterious effect, 
both types of encounters were included as outcome variables along with their totals. 
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Prior and subsequent emergency department visits.  ED visits were a count 
variable, with count representing the number of visits during each period of interest.  The 
counts were derived according to the process described for hospitalizations and were used 
as outcome variables.  Prior and subsequent visits with and without clinical disease 
coding for substance misuse or disordered use were included in the counts separately and 
in total.  Other health conditions that can cause frequent medical emergencies may be 
exacerbated by past or current substance use.  ED visits from which patients were 
subsequently admitted to the hospital were not counted as ED visits because of how 
patients are classified in the electronic health record.  ED visits resulting in 
hospitalizations are designated as hospitalizations, whereas ED visits without 
hospitalizations (“treat and release”) are designated as ED visits. 
Cost estimates.  For each patient hospitalization or ED visit included in the study, 
proprietary patient cost estimates were extracted from the health system’s data analytics 
warehouse to use as separate outcome variables.  Costs were managed similarly to 
counts.  In the proprietary patient costing system, a cost accounting process is used to 
fully allocate all health system costs to patient encounters, including hospitalizations and 
ED visits (WFBMC, 2017; G. Carter, personal communication, February 7, 2019).  Costs 
and metrics to allocate costs are obtained from several financial sources, including the 
accounting system and the payroll system.   
In the cost accounting process, departments are categorized as “direct,” meaning 
people in those departments provide direct billable services to patients such as surgical 
services, or as “indirect,” for departments not billing patients for services, such as 
 
 93 
executive leadership.  Indirect departments are only those associated with the clinical 
mission of the health system, so that research, teaching, and related administrative 
activities are not allocated to clinical costs.  Direct department costs are allocated to the 
patient charges billed by direct departments using bases such as “relative value units” 
(RVU) or “diagnostic related groups” (DRG).  Both mechanisms are foundational to 
health care billing and payment.  Indirect department costs are allocated across all direct 
departments reasonably associated with their activities using various metrics or other 
allocation methodologies. 
A categorization between “variable,” or activity that varies with patient volumes, 
and “fixed,” activity that does not vary with patient volumes, is applied to each job code 
in the health system.  For example, a nurse would be in a variable job code category 
whereas a marketing manager would be in a fixed job code category.  Costs associated 
with variable job codes are allocated to the patient charges (again, RVUs, DRGs, or other 
basis) associated with those job codes, while fixed job codes are allocated across patient 
charges using metrics or other allocation methods. 
Both direct/indirect and fixed/variable add up to the same total costs.  Total costs 
for each inpatient hospitalization and ED visit were extracted from the data warehouse 
for use in this study as economic outcomes. 
The combinations of counts, costs, hospitalizations, ED visits, and 
presence/absence of substance use coding resulted in 24 possible outcome variables for 
consideration in the analysis, as described in Table 1. 
 
 94 
Table 1.  Planned Outcome Variables 
Outcome Type Variable Description 
Count Pre-intervention hospitalizations with substance use coding 
Count Pre-intervention emergency visits with substance use coding 
Count Pre-intervention hospitalizations without substance use coding 
Count Pre-intervention emergency visits without substance use coding 
Count Pre-intervention hospitalizations, all 
Count Pre-intervention emergency visits, all 
Count Post-intervention hospitalizations with substance use coding 
Count Post-intervention ED visits with substance use coding 
Count Post-intervention hospitalizations without substance use coding 
Count Post-intervention ED visits without substance use coding 
Count Post-intervention hospitalizations, all 
Count Post-intervention ED visits, all 
Costs Pre-intervention hospitalizations with substance use coding 
Costs Pre-intervention emergency visits with substance use coding 
Costs Pre-intervention hospitalizations without substance use coding 
Costs Pre-intervention emergency visits without substance use coding 
Costs Pre-intervention hospitalizations, all 
Costs Pre-intervention emergency visits, all 
Costs Post-intervention hospitalizations with substance use coding 
Costs Post-intervention ED visits with substance use coding 
Costs Post-intervention hospitalizations without substance use coding 
Costs Post-intervention ED visits without substance use coding 
Costs Post-intervention hospitalizations, all 
Costs Post-intervention ED visits, all 
Substance use type.  Substance use type was a categorical predictor variable with 
four levels and codes: ‘0’ absence of substance use; ‘1’ alcohol use; ‘2’ illicit drug use; 
and ‘3’ use of both alcohol and illicit drugs.  The purpose of these categories was to 
associate outcome variables with type of use, given that SBIRT has demonstrated 
consistent effectiveness only for alcohol misuse.  Clinical disease coding for substance 
use was stratified according to type for both ICD-CM9 and ICD-CM10 codes.  Using 
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lookup and pivot table functions in spreadsheet software, patients were assigned one of 
these categories based on coding from their index hospitalizations.  Patients without 
substance use codes defaulted to the category of absence of substance use. 
Substance use severity.  Substance use severity was a categorical predictor 
variable with four levels and codes, using the terminology of clinical disease coding: ‘0’ 
absence of substance use; ‘1’ substance use (detection of use); ‘2’ substance abuse 
(equivalent to substance misuse); and ‘3’ substance use disorders (equivalent to substance 
use dependence in the codes).  The purpose of these categories was to associate outcomes 
with severity of use, given that SBIRT may not be effective for more severe levels of 
alcohol use, or for any level of drug use.  Clinical disease coding for substance use was 
stratified according to severity for both ICD-CM9 and ICD-CM10.  Using lookup and 
pivot table functions in spreadsheet software, patients were assigned to one of these 
categories based on coding from their index hospitalizations.  Patients without substance 
use codes defaulted to the category of absence of substance use. 
Inpatient location.  Inpatient service location was a categorical predictor variable 
with six levels and codes: ‘0’ Burns patients hospitalized in the Burns unit; ‘1’ Burns 
patients hospitalized elsewhere in the hospital; ‘2’ Medicine on-unit; ‘3’ Medicine off-
unit; ‘4’ Trauma on-unit; and ‘5’ Trauma off-unit.  These categories represented the three 
hospital services that have integrated medical and mental health care for patients with 
substance use issues, separated by patients who stayed on the three physical units that are 
the main locations for these services, and patients assigned to the physician service teams 
but, due to lack of available beds, stayed elsewhere.  The off-service categories also 
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include occasional patients referred to the Trauma, Burn, or General Medicine counseling 
teams by physicians elsewhere in the hospital.  The purpose of this variable was to 
associate outcomes with inpatient location, as the inpatients who are admitted to these 
three hospital services are cared for by physicians of differing specialties and treatment 
approaches and have different medical conditions. 
Table 2 summarizes the constructs measured, the research questions (RQs) and 
research hypotheses (RHs), the variables, and the data sources in the preceding 
narratives. 
Table 2.  Constructs Tested, Research Questions and Hypotheses, and Variables 
Construct(s) 
Tested 
Research Questions and Hypotheses Relevant Variables and 
Sources 
Counselor-
provided 
SBIRT 
intervention 
Research Question 1.  For patients 
with alcohol or illicit drug misuse or 
disordered use, do patients in 
inpatient integrated care settings 
receiving counselor-provided 
SBIRT experience fewer 
hospitalizations and emergency 
department visits compared to 
patients in the same settings not 
receiving interventions? 
Research Hypothesis 1.  Patients 
with alcohol or illicit drug misuse or 
disordered use and receiving 
counselor-provided SBIRT in 
integrated care settings experience 
fewer hospitalizations and 
emergency department visits 
compared to patients not receiving 
interventions. 
• Intervention(s) from 
program documentation 
(spreadsheets, intake 
forms), defined as 
counselor contact of 15 
minutes or more per World 
Health Organization 
guidelines for SBIRT 
• Hospitalizations and ED 
visits with and without 
substance use ICD-CM 
coding, one year prior to 
initial intervention, from 
data warehouse 
• Hospitalizations and ED 
visits with and without 
substance use ICD-CM 
coding, one year 
subsequent to initial 
intervention, from data 
warehouse 
Type of 
substance use 
Research Question 2.  Do 
hospitalization and emergency 
• Hospitalizations and ED 
visits with and without 
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Severity of 
substance use 
 
Type of 
clinical 
service 
department visit outcomes for 
patients with alcohol or illicit drug 
misuse or disordered use differ by 
substance use type, substance use 
severity, or inpatient service 
location? 
Research Hypothesis 2.  
Hospitalization and emergency 
department visit outcomes for 
patients with alcohol or illicit drug 
misuse or disordered use differ by 
substance use type, substance use 
severity, and/or inpatient service 
location. 
substance use ICD-CM 
coding, one year prior to 
initial intervention, from 
data warehouse 
• Hospitalizations and ED 
visits with and without 
substance use ICD-CM 
coding, one year 
subsequent to initial 
intervention, from data 
warehouse 
• Substance use type of 
alcohol, illicit drug, both, 
or none from ICD-CM 
clinical disease coding 
• Substance use severity of 
disordered use, misuse, use 
or absence of use from 
ICD-CM clinical disease 
coding 
• Inpatient service location 
from program 
documentation 
(spreadsheets) – Trauma, 
Burn, General Medicine 
and data warehouse 
Economic 
cost reduction 
Research Question 3.  Are 
counselor-provided SBIRT 
interventions associated with 
reduced economic costs from the 
health system perspective? 
Research Hypothesis 3.  Counselor-
provided SBIRT interventions are 
associated with reduced economic 
costs from the health system 
perspective. 
• Patient costs per 
hospitalization or ED visit 
from data warehouse 
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Data Analysis 
Prior to analysis, the dataset was checked, verified, and modified using 
recommended data cleaning processes from Cody (2008).  Data cleaning was performed 
in Microsoft Excel and Stata statistical software using data validation tools, filtering, and 
sorting and by validating the dataset against the data warehouse.  The spreadsheet data 
was visually inspected for unexpected data and trends using filtering and sorting, with 
unusual results and outliers reviewed and, if erroneous, repaired.  Data validity checks 
were performed for invalid values such as character entries in numerical data; errors were 
manually corrected by group if possible or individually.  Checks for duplicate records 
were performed and duplications removed.  Both numerical and character data were 
checked for missing values, with hand-searching of electronic health records and paper 
records to complete the dataset. 
Propensity scores.  In this study, the intervention and comparison groups were not 
randomly assigned.  Without randomization, group differences in observed covariates can 
create selection bias, in that certain covariates may make it more or less likely that 
patients will receive counselor-provided SBIRT interventions.  Selection bias is a 
confounder that can threaten a study’s internal validity, that is, whether its conclusions 
about associations between predictor and outcome variables are valid (Heppner, 
Wampold, Owen, Thompson, & Wang, 2016). 
For this study, observed demographic covariates included a continuous variable, 
age, and three categorical variables: gender (‘0’ male, ‘1’ female); ethnicity/race (‘0’ 
White, ‘1’ African-American/Black, and ‘2’ other [American Indian, Asian, Hispanic or 
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Latino/a, other]); and marital status (‘0’ single, ‘1’ married, and ‘2’ other [divorced, 
separated, widowed, unknown]).  Other observed covariates were also categorical 
variables.  Severity of illness and risk of mortality are standardized measures of patient 
clinical status that were obtained from the data warehouse, each stratified by four levels: 
‘0’ minor, ‘1’ moderate, ‘2’ major, and ‘3’ extreme.  Payer, also obtained from the data 
warehouse, was a covariate proxy for observed differences in economic circumstances 
among patients.  Health care payers include government (provided through Medicare for 
older adults and Medicaid for poorer adults) and commercial (provided by employers or 
commercial markets).  Patients without insurance are classified as “self-pay.”  Payer was 
a categorical variable with five levels: ‘0’ managed care, ‘1’ Medicaid, ‘2’ Medicare, ‘3’ 
all other insurances, and ‘4’ self-pay.  Finally, to capture potential seasonality of 
treatment, the calendar quarter of the index hospitalization was calculated from the 
admission date, with ‘1’ January – March, ‘2’ April – June, ‘3’ July – September, and ‘4’ 
October - December.  The availability of counselors for interventions somewhat followed 
educational scheduling, as many of the counselors were counselor trainees from academic 
institutions.  Seasonality helped balance counselor availability and other seasonal factors, 
such as holidays and weather, between groups. 
Propensity scores (Austin, 2011; D'Agostino & Rubin, 2000) were calculated 
using logistic regression with these covariates as predictors and the dichotomous 
intervention variable as the outcome.  Propensity scores represent the conditional 
probability of receiving interventions given the covariates (D'Agostino & Rubin, 2000).  
With observational data, propensity scores are more likely to reduce selection bias than 
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traditional covariate analysis (Austin, 2011; D'Agostino & Rubin, 2000).  The scores 
were used as additional predictor variables of all outcome variables. 
Power.  Per G*Power analysis (Faul, Erdfelder, Buchner, & Lang, 2009), a 
sample size of 366 was needed for the planned analysis using an a priori one-tailed Z-test 
at alpha of 0.05 for Poisson distributions (b1=1.2, [1-b]=0.80, b0=0.5, R2 other than X = 
0.5). The moderate power level of 0.80 was selected based on Balkin and Sheperis 
(2011).  The remaining components represent G*Power default values for Poisson 
distributions. 
Regression.  The overarching model was a differences-in-differences (DID) 
approach to assess the effects of an intervention.  According to Crown (2014), the DID 
model is a quasi-experimental research design intended to control for unobserved 
covariates that remain stable over time.  It has widespread use in program evaluation.  
DID is appropriate when two or more periods of data are available for both intervention 
and comparison groups: a baseline period where neither group receives the intervention, 
and a following period(s) where one group receives the intervention and the other does 
not (Crown, 2014).  For this study, the year prior to the index hospitalization was the 
baseline period, with the intervention occurring at the beginning of the following period, 
then the year after the hospitalization completing the following period. 
Regression analysis was performed using generalized linear models.  Because the 
outcome variables of hospitalizations and ED visits were counts, generalized linear 
regression models were recommended (Hilbe, 2014).  Given an excess number of zeros 
in the count outcome data (over-dispersion), negative binomial regression models were 
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used with the count data (Cameron & Trivedi, 2009).  Generalized linear models were 
used with the cost data, employing the gamma distribution and log link options to 
account for excess zeros which positively skewed the data (McCue et al., 2008).   
The predictor variables for a first set of regression models for the count and cost 
outcomes were counselor-provided SBIRT intervention (dichotomous), substance use 
type (categorical), substance use severity (categorical), and clinical service (categorical).  
A time variable was included for DID and interacted with the intervention variable.  The 
intervention/time interaction demonstrates whether an intervention during the second 
time period of the DID model changes the outcomes for the intervention group.  For a 
second set of models, the same predictors and DID model were used, except counselor-
provided SBIRT was measured as session time quintiles, a categorical variable. 
Interpretation of results.  Wald’s test statistic and McFadden’s Psuedo R2, the 
proportion of variance explained by the model, were examined to assess negative 
binomial model fit to the data.  Akaike’s Information Criterion (AIC) and Bayesian 
Information Criterion (BIC) test statistics were used to assess generalized linear model 
fit.  Given acceptable fit, significance of the random coefficients and variance 
components were compared to an alpha level of 0.05 to test the research hypotheses.  
Significant coefficients for interventions provide support for the hypothesis that 
counselor-provided SBIRT in inpatient integrated care settings is an effective treatment 
intervention for reducing patient hospitalizations and emergency department visits as well 
as economic costs.  Coefficients for substance use type, substance use severity, and 
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clinical service that are significant support the hypothesis that hospitalization and/or 
emergency department visit outcomes differ by these predictors. 
Pilot Project 
The purpose of the pilot project for this research study was to determine the 
feasibility of transforming operational, pragmatic counseling data into a usable, testable 
dataset and to estimate the size of the study sample.  The research questions associated 
with this purpose were the following: 
Is it possible to assemble a complex multi-year dataset from retrospective 
operational counseling data and if so, what are the procedural considerations in doing so? 
Can the inclusion and exclusion criteria outlined in the research methodology be 
applied to the data, and if so, what is the estimated number of participants in each group, 
by clinical service? 
Methods 
The counseling data was collected and stored in 120 separate Microsoft Excel 
spreadsheets from the integrated care services for the period January 2014 through 
December 2017, with 48 spreadsheets from Burn, 48 from Trauma, and 24 from General 
Medicine (the service that was integrated two years into the study period).  The 
spreadsheet format differed among the services and across the years for a given service, 
although the basic data elements needed for this research study were present in all 
spreadsheets in some form – patient names, medical record numbers, admission dates, 
demographic information, and, if counseling intervention(s) were performed, the 
intervention dates and durations.  An Excel workbook per service per year was created 
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from individual spreadsheets, representing two years of Burn data, one year of Medicine, 
and one year of Trauma.  The following categories by service assigned to each patient 
after applying inclusion/exclusion criteria, and categories separated by worksheets: 
On-service intervention group.  The on-service counseling intervention groups 
consist of patients receiving counseling interventions who stayed on the hospital unit(s) 
operated by the integrated care clinical service.  At WFBMC, each clinical service is 
assigned to one or more physical units (building floors) with a fixed number of inpatient 
rooms and dedicated allied health professionals such as nurses and physical therapists.  
The Trauma and Burn services have one integrated care unit each, while the General 
Medicine service has two units. 
Off-service intervention group.  The off-service counseling intervention groups 
include two types of patients: those assigned to the service who stayed on other units due 
to rooms not being available on the primary unit, and those referred to the counseling 
service from other hospital units.  At times, physicians who had worked on integrated 
care teams with counselors and then rotated to other hospital units would ask the 
counseling team to treat one of the patients on their unit.  The off-service intervention 
group is segregated because these patients were not on an integrated care unit but did 
receive counseling interventions, so are of interest. 
On-service comparison group.  The on-service comparison groups consist of 
patients on the clinical service identified for intervention but not receiving them. 
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Off-service comparison group.  The off-service comparison groups are patients 
staying off the clinical service but assigned to it, and patients referred by physicians on 
other units, identified for interventions but not receiving them. 
Excluded for intervention time.  These patients are excluded because interventions 
were between 1-14 minutes and so did not meet the 15-minute intervention threshold. 
Excluded for other causes.  These patients are excluded for cognitive deficits, 
leaving the hospital against medical advice, refusing counseling, seen at physician 
request for a mental health concern other than substance use (e.g. PTSD, depression, 
anxiety, anorexia, delusions/hallucinations), dying while in the hospital, and other causes, 
with reason for exclusion noted. 
To estimate the study sample, data from all 120 spreadsheets were reviewed and 
patients classified into two groups, Intervention and No Intervention, totaled by service 
by year.  The groups were obtained from the spreadsheets without applying 
inclusion/exclusion criteria and without separating patients into on-service and off-
service groups.  Classifying patient into Intervention and No Intervention groups was a 
simpler process than the laborious application of criteria and location to each patient.  
Once the Intervention and No Intervention totals were created, an estimation process was 
followed to separate each Intervention group into SBIRT intervention group (included in 
study) and mental health interventions (excluded from study), and to separate the No 
Intervention group into the comparison group (included in study) and the exclusion 
group.  The estimation process employed group proportions derived from the partial 
creation of the dataset.  Detailed estimation of rule-out causes, on-service vs. off-service 
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locations, and similar granularity was not performed for the pilot project but were 
performed for the full study. 
Results 
Creation of a multi-year dataset from pragmatic counseling data is feasible, and 
the inclusion/exclusion criteria can be applied to each patient.  The entire dataset is 
estimated at 4,790 patients, of which 2,635 patients are in the intervention group and 834 
patients in the comparison group.  The patients excluded from the study are estimated at 
1,321.  Details of these estimates are provided in Table 3. 
Table 3.  Pilot Study Estimation of Study Sample 
 Intervention Comparison Excluded/ 1-14 Min Total 
Burn Service     
2014 59 33 48 140 
2015 85 48 73 206 
2016 86 48 5 209 
2017 110 63 96 269 
Subtotal 340 192 292 824 
General Medicine Service    
2014     
2015 64 10 25 99 
2016 143 37 81 261 
2017 466 12 71 549 
Subtotal 673 59 177 909 
Trauma Service    
2014 319 139 285 743 
2015 280 132 268 680 
2016 438 134 155 727 
2017 585 178 144  907  
Subtotal 1,622 583 852  3,057  
Total All Services    
2014 378 172 333 883 
2015 429 190 366 985 
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 Intervention Comparison Excluded/ 1-14 Min Total 
2016 667 219 311 1,197 
2017 1,161 253 311 1,725 
Total 2,635 834 1,321 4,790 
Discussion 
Procedural obstacles were considerable.  The allocation of patients to these groups 
required time-intensive patient-by-patient review.  There were no grouping techniques 
that could be employed due to the complexity of the inclusion/exclusion criteria and the 
disparate formats of the spreadsheets.  Often, to distinguish between whether a patient 
received a substance use intervention or was seen for other mental health concerns at a 
physician’s request required reviewing individual patient data and reading text-based 
notes entered by counselors. 
Various errors were encountered during this pilot project.  Data entry errors were 
common, such as incorrect medical record numbers, incorrect names, and data elements 
entered into wrong columns on the spreadsheets.  Missing values were also discovered 
such as missing medical record numbers or names and missing values for other columns 
(e.g., admission dates, ethnicity, gender).   At times, accessing EMR records was required 
to fill in forgotten data points such as intervention session lengths.  Missing data seemed 
to be more of concern for the earlier years in the study period, 2014 and 2015. 
Differences in recording methods among services added to the complexity of this 
process.  For example, the Burn service recorded the length of time for intervention 
sessions using text; these had to be converted one-by-one to numbers to be suitable for 
analysis.  For several months during one study year, the Burn data was commingled with 
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the Trauma data.  The Trauma and Medicine services used color-coding to identify 
different types of patients (e.g. intervention completed, intervention not done, other 
mental health counseling only) but the Burn service did not. 
Implications for Full Study 
The sample size appeared to be sufficient power for analysis.  The full dataset 
could be created by completing the application of inclusion and exclusion criteria to all 
patients and allocating patients to the groups identified in the pilot project.  Paper records 
had to be accessed to complete missing data, and data errors noted and repaired.  All data 
accumulation procedures and decisions were documented, and limitations arising from 
these procedures identified. 
Summary 
Innovative, accessible, and effective treatment interventions are imperative for 
people who misuse alcohol or illicit drugs, or struggle with alcohol or drug disorders, as 
most are failing to access the treatment they need.  Counselor-provided SBIRT in 
integrated care settings holds substantial promise as an intervention but suffers from a 
lack of research investigation.  The purpose of this study was to determine the 
effectiveness of this intervention for helping people reduce their use of hospitalizations 
and emergency care and to assess the economic costs of this intervention.  In this chapter, 
the research methodology for examining counselor-provided SBIRT in a specific 
integrated care setting and population was provided.  The research questions and 
hypotheses were stated.  The research design, consisting of the study setting, counseling 
program and intervention process, study population, data procedures, and measures, was 
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explained.  The statistical analyses were described, and the pilot study rationale, methods, 
results, and implications were presented.
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CHAPTER IV 
RESULTS 
The purpose of this study was to determine the effectiveness of counselor-
provided Screening, Brief Intervention, and Referral to Treatment for helping people 
reduce their use of hospitalizations and emergency care and to assess the economic costs 
of this intervention.  Specifically, this study examined three research questions and 
associated hypotheses: 
Research Question 1.  For patients with alcohol or illicit drug misuse or 
disordered use, do patients in inpatient integrated care settings receiving counselor-
provided SBIRT experience fewer hospitalizations and emergency department visits 
compared to patients in the same settings not receiving interventions? 
Research Hypothesis 1.  Patients with alcohol or illicit drug misuse or disordered 
use and receiving counselor-provided SBIRT in integrated care settings experience fewer 
hospitalizations and emergency department visits compared to patients not receiving 
interventions. 
Research Question 2.  Do hospitalization and emergency department visit 
outcomes for patients with alcohol or illicit drug misuse or disordered use and receiving 
counselor-provided SBIRT differ by substance use type, substance use severity, or 
inpatient service location?
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Research Hypothesis 2.  Hospitalization and emergency department visit 
outcomes for patients with alcohol or illicit drug misuse or disordered use and receiving 
counselor-provided SBIRT differ by substance use type, substance use severity, and/or 
inpatient service location. 
Research Question 3.  Are counselor-provided SBIRT interventions associated 
with reduced economic costs from the health system perspective? 
Research Hypothesis 3.  Counselor-provided SBIRT interventions are associated 
with reduced economic costs from the health system perspective. 
The first section of the chapter is a descriptive report of the study sample.  The 
second section describes the data procedures for dataset creation.  The third section 
presents the model selection and statistical analyses conducted to test the research 
hypotheses.  The chapter concludes with a summary. 
Study Sample 
The study sample consisted of English-speaking adults aged 18 years and older 
who were admitted to the integrated care inpatient services of Wake Forest Baptist 
Medical Center between January 2014 and December 2017, were selected for SBIRT 
intervention, and met criteria for study inclusion.  The final sample size was 2,195, with 
1,577 patients in the intervention group and 618 in the comparison group, exceeding the a 
priori power calculation of 366 patients. 
The mean age of the overall sample was 44.73; the youngest patient was 18 and 
the oldest was 93 at date of hospitalization.  Males comprised 74% of the sample, 
consistent with findings that men use alcohol, binge drink, and drink heavily at 
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appreciably higher rates than women (McHugh, Votaw, Sugarman, & Greenfield, 2015).  
Persons identifying as White represented 73% of the total, with 22% identifying as 
Black/African-American and the remaining 5% identifying as American Indian, Asian, 
Latino/Hispanic and other.  In comparison, the racial/ethnic distribution in the urban 
county containing the medical center, from which one-third of hospitalizations and two-
thirds of emergency visits arise, is 59% White, 26% Black/African-American, 13% 
Hispanic or Latino, and 2% Asian.  Of these county residents, 14% speak a language 
other than English at home (City of Winston-Salem, 2019).  Because language translators 
are not available to the counselors, non-English speaking patients, who were more likely 
to be Hispanic, Latino, or Asian, were excluded from the study, which skewed the study 
sample towards other ethnic origins. 
Almost half of the sample patients self-identified as single, 29% as married 
(which could include domestic partnerships and marriages between persons of the same 
gender), and the remainder of other status, such as having a significant other, being 
divorced or being widowed.  The average hospital patient in the sample was seriously ill, 
at the 69th percentile on a four-point severity scale from minor to extreme.  The mean 
risk of patient mortality, in contrast, was at the 27th percentile.  So, most patients were 
quite ill but unlikely to die.  On the substance use continuum between no use and 
disordered use, the study sample was at the 60th percentile or between misuse and 
disordered use, based on clinical disease coding.  The percent of patients identified as 
using alcohol only was 13%, using illicit drugs only was 33%, and using both was 28%.  
This distribution of substance use type is within a few percentage points of the 
 
 112 
distribution in the North Carolina substance use treatment population (SAMHSA, 2017b).  
In the study sample, 26% of patient cases lacked clinical disease coding for substance use 
and thus were assigned to the “absence of use” level. 
Patients in the study sample were admitted evenly across the four quarters of the 
year.  Two-thirds of patients were admitted to the Trauma service, almost a quarter to the 
Medicine services, and the remainder to the Burns service.  Approximately seven out of 
ten patients in the sample received counselor-provided SBIRT, with a median 
intervention time of 40 minutes and average time of 51 minutes.  This positive skew is 
attributable to the tendency of certain patients to be hospitalized for weeks or months, 
with 6.5% of the sample receiving two or more total hours of SBIRT and related 
counseling interventions.  Table 4 provides the full complement of descriptive statistics 
by study variable. 
Table 4.  Description of Study Sample and Associated Variables 
Variable Code Count % Mean SD Min Max 
Age 44.73 16.15 18 93 
Age 
 
2,195 100% 
    
Gender 0.26  0.44 0 1 
Male* 0 1,622 74% 
    
Female 1 573 26% 
    
Ethnicity/ Race 0.33 0.58 0 2 
White* 0 1,594 73% 
    
Black/African-American 1 480 22% 
    
Other 2 121 5% 
    
Marital Status 0.72 0.79 0 2 
Single* 0 1,077 49% 
    
Married 1 647 29% 
    
Other 2 471 21% 
    
Severity of Illness 1.75 0.83 0 3 
Minor* 0 158 7% 
    
Moderate 1 627 29% 
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Variable Code Count % Mean SD Min Max 
Major 2 1,011 46% 
    
Extreme 3 399 18% 
    
Risk of Mortality 1.06 0.95 0 3 
Minor* 0 741 34% 
    
Moderate 1 775 35% 
    
Major 2 485 22% 
    
Extreme 3 194 9% 
    
Substance Use Severity 1.41 1.07 0 3 
Absence of use* 0 578 26% 
    
Use 1 548 25% 
    
Misuse (abuse) 2 647 29% 
    
Disordered Use (dependence) 3 421 19% 
    
Substance Use Type 1.62 1.15 0 3 
Absence of use* 0 579 26% 
    
Alcohol 1 282 13% 
    
Illicit Drugs 2 726 33% 
    
Alcohol and Illicit Drugs 3 608 28% 
    
Calendar Quarter of Admission 2.54 1.11 1 4 
Jan-Mar* 1 506 23% 
    
Apr-Jun 2 554 25% 
    
Jul-Sep 3 570 26% 
    
Oct-Mar 4 565 26% 
    
Clinical Service and Location 3.40 1.53 0 6 
Burns on unit* 0 223 10% 
    
Burns off unit 1 25 1% 
    
Medicine on unit 2 367 17% 
    
Medicine off unit 3 127 6% 
    
Trauma on unit 4 941 43% 
    
Trauma off unit 5 512 23% 
    
Intervention 0.72 0.45 0 1 
No* 0 618 28% 
    
Yes 1 1,577 72% 
    
Intervention Time 2.15 1.8 0 6 
0 Minutes* 0 618 28% 
    
15-25 Minutes 1 315 14% 
    
26-30 Minutes 2 297 14% 
    
31-45 Minutes 3 359 16% 
    
46-60 Minutes 4 291 13% 
    
60+ Minutes 5 315 14% 
    
* reference level for binary or categorical variables 
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Data Procedures 
The patient dataset was created from 120 individual monthly spreadsheet tabs for 
all patients meeting inclusion criteria during the investigation time period (January 2014–
December 2017).  Each monthly spreadsheet was specific to a service and contained 
patient names and medical record numbers for patients hospitalized and identified for 
intervention during that month.  Also recorded were demographics, clinical data, and 
detailed records of counselor-assigned categories and counselor activities. 
Approximately 4,300 patient cases from the inpatient services were considered for 
the study.  Hand-vetting of each individual patient was needed in order to apply inclusion 
and exclusion criteria, requiring review of counselor notes and other counselor 
documentation.  Hospitalizations qualifying for study inclusion served as index 
hospitalizations.  About 60 patients had two index hospitalizations eligible for inclusion 
during the study period.  These hospitalizations were handled according to the study plan, 
with any hospitalization subsequent to another index hospitalization dropped from the 
dataset.  For all patients meeting inclusion criteria, patient names and medical record 
numbers, admission dates, inpatient clinical service overseeing patient evaluation and 
management, age, gender, and ethnicity/race were extracted from the spreadsheets.  The 
total intervention time for patients receiving SBIRT interventions greater than 15 minutes 
also was extracted. 
Using medical record numbers and admission dates for the index hospitalizations, 
additional data were obtained from the data analytics warehouse, a medical center 
information structure that accumulates data from patient health records along with 
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economic data from the system’s financial records.  In the data warehouse, each patient 
encounter with the health system is identified by a unique ‘hospital account record’ 
(HAR) number, and all activity associated with that encounter, such as physician, place 
of service, dates, charges, and payments, is connected to the HAR.  Dates and HARs for 
hospitalizations and ED visits one year prior to admission and one year subsequent to 
discharge for the index hospitalization, thus occurring sometime between January 2013 
and December 2018, were obtained.  For all hospitalizations and ED visits, including the 
index hospitalizations, clinical disease coding and total costs were extracted.  For index 
hospitalizations, patient marital status, measures of illness severity and risk of mortality, 
physician clinical service overseeing the medical care, room location at time of discharge, 
calendar quarter of discharge, and payers (entities responsible for bill payment such as 
insurance companies or patients) were acquired. 
Disease coding was used to assign substance use severity and type for the index 
hospitalization (see Appendix A for substance use disease coding and classifications of 
severity and type).  Coding was also used to identify hospitalizations and ED visits 
during the study period that involved substance use, misuse and/or use disorders.  Counts 
of hospitalizations and ED visits and economic costs were summarized separately by 
encounters with substance use coding and encounters without coding, as well as in total, 
then added to the patient dataset. 
Data validation was performed in Microsoft Excel spreadsheet software and Stata 
statistical software using data cleaning tools as appropriate.  The spreadsheet data was 
visually inspected for unexpected values and trends using filtering and sorting, with 
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unusual results reviewed and, if erroneous, repaired.  Often, errors were systematic, 
requiring groups of records to be research and corrected.  Data validity checks were 
performed for invalid values such as character entries in numerical data; errors were 
manually corrected by group if possible or individually.  Checks for duplicate records 
were performed and duplications were removed.  Both numerical and character data were 
checked for missing values, with hand-searching of electronic health records and paper 
records used to complete the dataset.  This process was iterated once warehouse data 
were added to the dataset, with new discrepancies in the data resolved. 
Per estimation, over half of counselor spreadsheet cases were missing one or more 
data elements used as variables in this study, contained improperly formatted data, e.g. 
text entries where values were needed for the study, or had erroneous data, requiring 
retrieval of missed and corrected data from individual patient electronic health records 
and paper documentation or proper formatting.  For example, when medical record 
numbers from the counselor spreadsheets were validated against medical record numbers 
in the data analytics warehouse, two hundred and twenty-five discrepancies were 
discovered and repaired, the majority related to the Trauma service.  If injured Trauma 
patients are brought to the emergency department and are unable to be identified 
immediately, they are assigned temporary medical record numbers.  When their identities 
are known, those with existing medical record numbers are reassigned the correct 
numbers.  This reassignment may not occur until several days after the patients are 
hospitalized, or even after they are discharged.  Counselors often recorded only the 
temporary numbers, but the data warehouse contains only the reassigned numbers.  Each 
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of these discrepancies had to be resolved by hand-searching the electronic health record 
system.  As another example, data validation revealed that about 5% of the spreadsheet-
sourced counseling dates of admission were incorrect, as the dates did not match those in 
the data warehouse.  These errors appeared to be clerical and were repaired via individual 
electronic record searches.  The only data missing from the data warehouse extraction 
were a few room locations, which were resolved by hand-searching the electronic 
records. 
Following data cleaning, all records included in the dataset were 100% complete 
without missing data and thus without the need for data imputation.  No outliers were 
removed.  A small number of records were excluded from the dataset for one of two 
reasons: either outcome variables could not be obtained from the data warehouse due to 
unresolvable medical record number, admission date, or patient name discrepancies; or a 
key predictor variable, length of counseling session, was not captured by the counselors.  
Data imputation is not recommended in either circumstance (Long, 2009).  Another set of 
records, estimated at about 165 cases, was expected to be in the Trauma counselor 
spreadsheets but instead was not tracked for about 18 months.  These patients were 
identified for counseling intervention with unknown or low-risk alcohol use.  The 
Trauma counselors made a procedural decision to stop tracking these patients in January 
2016, then reversed it in July 2017.  These three types of cases represent study limitations 
and will be discussed in the final chapter. 
Table 5 describes the findings from reviewing cases and applying inclusion and 
exclusion criteria, resulting in deletion of approximately 2,100 patient cases. 
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Table 5.  Case Review for Inclusion and Exclusion Criteria 
Cases Disposition Rationale 
64 Exclusion from 
intervention 
SBIRT conducted but lasting 1-14 minutes 
97 Exclusion from 
intervention 
SBIRT conducted but patient younger than 18 years 
of age 
302 Exclusion from 
intervention 
Counseling provided but SBIRT not conducted 
73 Exclusion from 
intervention 
Sessions conducted by peer support specialists 
(people in recovery certified to provide peer 
support) but mixed in with counseling data 
81 Exclusion from 
comparison 
Declined counseling or left the hospital against 
medical advice 
392 Exclusion from 
comparison 
Ruled out for cognitive issues, medical issues that 
prevented counseling (e.g. inability to speak), 
and/or active psychiatric diagnoses; also included 
non-English-speaking patients 
325 Exclusion from 
intervention or 
comparison 
Classified by counselors as inpatients but classified 
in hospital medical record as another category, such 
as “observation patient” or “outpatient in a bed” 
57 Exclusion from 
intervention or 
comparison 
Hospitalizations for patients receiving SBIRT in a 
prior hospitalization, or comparison hospitalization 
following another comparison hospitalization by 
less than one year 
425 
(estimated) 
Duplicate cases Duplicate hospitalizations in monthly program 
spreadsheets for patients in hospital across two or 
more months 
86 Missing key 
predictor of 
interest* 
Time length of counseling interventions(s) not 
recorded; also affected application of 
inclusion/exclusion criteria 
31 Missing key 
outcome 
variables* 
Cases unable to be matched with data warehouse 
using medical record numbers 
165 
(estimated) 
Missing cases 
from comparison 
group* 
Identified for SBIRT intervention, not counseled, 
and not recorded in counseling spreadsheets due to 
a temporary 18-month change in Trauma tracking 
procedures 
*represents study limitations to be addressed in discussion section 
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Model Selection and Hypothesis Tests 
To select appropriate statistical models to test the research hypotheses for this 
study, the distributions of the targeted outcome cost and count variables were examined.  
Most values were zero, meaning that most patients did not have hospitalizations or ED 
visits either prior to or subsequent to their index hospitalizations.  The percent of zero 
values ranged from 63% to 96% for the different types of outcome variables (e.g. with 
and without substance abuse coding, hospitalization vs. ED visit).  This finding was not 
entirely surprising, given the medical center’s place in the health care continuum as a 
regional trauma center and provider of complex tertiary and quaternary care.  Some 
patients might not return to the medical center for lower-complexity care, which could be 
found closer to their communities. 
To increase usability and relevance of the data by decreasing the prevalence of 
zero values, the outcome variables were reduced to four outcome measures for combined 
hospitalization and ED visit encounters: (1) summary count of pre-index encounters, (2) 
total costs of pre-index encounters, (3) summary count of post-index encounters, and (4) 
total costs of post-index encounters.  The following graphs, Figures 4 and 5, illustrate that 
zero values were still predominant in the outcome variables and that these variables were 
widely dispersed from zero to disproportionately high values. 
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Figure 4.  Summative Pre and Post Index Hospitalization Counts 
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Figure 5.  Summative Pre and Post Index Hospitalization Costs 
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(Raudenbush & Bryk, 2002).  Because the cost data was extremely positively skewed, 
generalized linear model options specified were the gamma distribution, which is a 
positively skewed distribution, and a log link to smooth the distribution (McCue et al., 
2008).  Due to the violations of linear regression assumptions in the data, both models 
were at risk of underestimating standard errors, overestimating statistical significance, 
and therefore increasing the possibility of rejecting null hypotheses when they were true 
(Type I error) (Long & Freese, 2014).  The robust standard errors option mitigates this 
risk (Long & Freese, 2014), so this option was employed with both models. 
As described in the research plan for this study, a differences-in-differences 
design was applied to demonstrate the association of counselor-provided SBIRT 
interventions, using both binary and categorical forms, with hospitalization and ED visit 
counts and costs.  This design minimized the effects of unobserved covariates that were 
stable over time.  A binary time period variable, with the pre-index hospitalization year as 
the first time period and the post-index hospitalization year as the second time period, 
was added to the predictor variables along with a time-intervention interaction.  As 
delineated in the research plan, propensity scores were created to balance the intervention 
and comparison groups on observed covariates.  The models were as follows: 
Propensity Score Model 
Purpose: create propensity scores for balancing intervention and comparison groups; the 
scores are added to the hypothesis-testing models as a covariate 
Model: Logistic regression 
Equation: 
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ln(P/(1-P)) of intervention = β0 + β1 (age-18) + β2 (gender) + β3 (ethnicity) + β4 (marital 
status) + β5 (risk of mortality) + β6 (severity of illness) + β7 (insurer) + β8 (calendar 
quarter) 
Count Outcomes Model 
Purpose: to test Hypothesis 1 that patients receiving counselor-provided SBIRT in 
integrated care settings experience fewer hospitalizations and emergency department 
visits compared to patients not receiving interventions and Hypothesis 2 that 
hospitalization and emergency department visit outcomes differ by substance use type, 
substance use severity, and/or inpatient service location. 
Model: Negative Binomial Regression with robust standard errors 
Equations: 
1. ln(count) = β0 + β1 (intervention as binary) + β2 (time) + β3 (intervention x time) + 
β4 (substance use type) + β5 (substance use severity) + β6 (clinical service) + β7 
(propensity score) + r 
2. ln(count) = β0 + β1 (intervention as categorical) + β2 (time) + β3 (intervention x 
time) + β4 (substance use type) + β5 (substance use severity) + β6 (clinical service) 
+ β7 (propensity score) + r 
Cost Outcomes Model 
Purpose: to test Hypothesis 3 that counselor-provided SBIRT interventions reduce 
economic costs from the health system perspective 
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Model: Generalized Linear Model with gamma distribution, log link, and robust standard 
errors 
Equations: 
1.  ln(cost) = β0 + β1 (intervention as binary) + β2 (time) + β3 (intervention x time) + 
β4 (substance use type) + β5 (substance use severity) + β6 (clinical service) + β7 
(propensity score) + r 
2. ln(cost) = β0 + β1 (intervention as categorical) + β2 (time) + β3 (intervention x 
time) + β4 (substance use type) + β5 (substance use severity) + β6 (clinical service) 
+ β7 (propensity score) + r 
Propensity Scores 
To assess balance, the intervention and comparison groups were tested against the 
null hypothesis of no difference between groups on observed covariates.  Groups were 
compared on the continuous variable Age with a t-test and on the categorical variables 
using Chi-square tests.  As shown in Table 6, the groups were not significantly different 
except for payer and calendar quarter, evidence that the groups were well-balanced on 
most covariates.  However, to be conservative about the two significant differences, 
propensity scores were calculated and used as model covariates.  The scores were 
approximately normally distributed, as shown in Figure 6.  They were centered around 
0.7, equivalent to the portion of the study sample receiving counselor-provided SBIRT 
interventions. 
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Table 6.  Test of Propensity Score Covariates 
Covariate Description Mean Difference p-value 
Age Continuous (0.40) 0.461  
    
Covariate Description df Pearson Chi-square p-value 
Gender 0=Male 1=Female 1 1.0396 0.308 
Ethnicity/ Race 
0=White 
1=Black/AA 
2=Other 
2 0.4001 0.819 
Marital Status 
0=Single 
1=Married 
2=Other 
2 5.4367 0.066 
Severity of Illness 
0=Minor 
1=Moderate 
2=Major 
3=Extreme 
3 4.7827 0.188 
Risk of Mortality 
0=Minor 
1=Moderate 
2=Major 
3=Extreme 
3 2.3172 0.509 
Payer 
0=Managed Care 
1=Medicaid 
2=Medicare 
3=All Other 
4=Self-Pay 
4 22.0519 0.000* 
Calendar Quarter 
of Admission 
1=Jan-Mar 
2=Apr-Jun 
3=Jul-Sep 
4=Oct-Dec 
3 41.9479 0.000* 
*significant at α=.05     
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Figure 6.  Propensity Score Distribution 
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used in the study, with its excess zero values, widely dispersed observed and predicted 
outcomes, and heteroskedastic error terms (Long & Freese, 2014). 
Collinearity 
In all models testing the intervention, perfect collinearity was detected by the 
Stata software, with exclusion of the substance use type level denoting both alcohol and 
illicit drugs from the estimation process.  Correlation tables and a cross-tabulation of 
substance use type against substance use severity suggested that this collinearity was with 
the disordered level of substance use severity.  This suspicion was confirmed by changing 
the order of covariates in the model.  When the type variable was listed before the 
severity level, the highest level of substance use severity was dropped from the models. 
Correlation matrices from the models revealed negative correlations ranging from 
.5 to .8 between the use and disordered use levels of substance use severity and the illicit 
drug level of substance use type, suggesting collinearity and thus potential instability in 
the models.  Positive intercorrelation among certain clinical service levels and severity 
levels was also present.  Comparing full and restricted models is a way to determine 
whether adding potentially collinear variables still improves the model (another way is to 
examine coefficient patterns for stability; see sections for tests of hypotheses) (Long & 
Freese, 2014).  Post-estimation tests were performed to determine whether the individual 
covariates should be excluded from the model (see Post-Estimation Tests section); based 
on test results, all covariates reduced variability in the model and were therefore not 
excluded. 
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Logarithmic Transformations 
In the statistical output, all outcomes for the models were logs of the predicted 
outcomes, which are challenging to interpret unless transformations are applied to the 
coefficients.  The coefficients were transformed into meaningful numbers in two ways.  
For the tests of Hypothesis 1 and Hypothesis 3, coefficients were exponentiated, with the 
coefficient as the exponent and the natural log e as the base.  Subtracting the integer one 
from the result provides the percentage change in the predicted outcome attributable to a 
one-unit change in counts (events) or costs (dollars) compared to the reference levels for 
the intervention variables.  For the covariate tests of Hypotheses 2, the incident rate ratio 
(IRR) option in Stata was employed to obtain predicted changes in counts of 
hospitalizations and ED visits.  All IRR coefficients are positive, with significant IRR 
coefficients between zero and one predicting reductions in counts compared to the 
reference level of each covariate. 
Tests of Hypotheses 1 and 3 
The key variables of interest in the differences-in-differences models for 
Hypothesis 1, the prediction that counselor-provided SBIRT interventions were 
associated with reduced post-intervention hospitalization and ED counts, were the 
interactions of the time binary variable with the intervention binary and categorical 
variables.  The estimation procedures resulted in non-significant but negative coefficients 
and confidence intervals, indicating that the coefficients were trending in the predicted 
direction; the results are shown in Table 7.  The interaction term containing the binary 
SBIRT intervention variable (intervention vs. no intervention) predicted an average 
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reduction of 22.4% (p = .126, 95% CI (44%), 7.5%).  The coefficients for the terms with 
categorical intervention levels (SBIRT interventions stratified into equivalent quintiles by 
time) were negative.  The coefficient for 60+ minutes predicted an average 36.4% 
reduction in the outcomes (p = .06, 95% CI (60.3%), 1.9%). 
The key variables for Hypothesis 3 regarding reductions in post-intervention 
economic costs were, again, the interactions of the time binary variable with the 
intervention binary and categorical variables.  The results are shown in Table 7.  The 
estimation procedures resulted in one significant finding supporting Hypothesis 3.  The 
interaction containing the binary SBIRT intervention variable (intervention vs. no 
intervention) was not significant, with a wide confidence interval (p = .338, 95% CI 
(65.8%), 44.6%).  The interaction of time period and the categorical intervention variable 
was significant for counselor interventions of 60+ minutes, predicting 62.3% reductions 
in the cost outcome variables, on average (p = .031, 95% CI (84.4%), (8.7%)). 
However, coefficients and confidence intervals for the intervention levels of 26-
30 minutes and 31-45 minutes were not stable in the models.  The confidence intervals 
for the cost outcomes were extremely wide and averaging positive (95% CI (57.2%), 
252.9% and (48.7%), 195.6% respectively) yet for the corresponding count outcomes for 
26-30 minutes and 31-45 minutes were narrower and more negative (95% CI (41.8%), 
38.4% and (57.6%), 33.6% respectively).  The strength of the negative coefficients for 
the remaining intervention levels, 15-25 minutes and 46-60 minutes, varied across 
models.  For the cost outcome, interventions of 15-25 minute predicted average 
reductions of 54.7%, while for the count outcome this prediction was half the size, at 
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27.5%.  The results for 46-60 minutes were similar, predicting 56.4% reductions for the 
cost outcome yet only 5.4% for the count outcome.  The inconsistency in these results is 
cautionary for interpreting significance at the 60+ minute level.  Further analysis is 
needed to determine the cause of model instability. 
Table 7.  Results for Hypotheses 1 and 3 
Outcome Variable Type 
Intervention 
Level 
Predicted 
Change 
p-
value 
95% Confidence 
Interval 
Min Max 
Count Binary Intervention (22.4%) .126 (44.0%) 7.5% 
Count Categorical 15-25 minutes (27.5%) .163 (53.9%) 13.9% 
Count Categorical 26-30 minutes (10.3%) .622 (41.8%) 38.4% 
Count Categorical 31-45 minutes (24.8%) .332 (57.6%) 33.6% 
Count Categorical 46-60 minutes (5.4%) .815 (40.5%) 50.4% 
Count Categorical 60+ minutes (36.4%) .060 (60.3%) 1.9% 
       
Cost Binary Intervention (29.7%) .338 (65.8%) 44.6% 
Cost Categorical 15-25 minutes (54.7%) .220 (87.2%) 60.5% 
Cost Categorical 26-30 minutes 22.9% .701 (57.2%) 252.9% 
Cost Categorical 31-45 minutes 23.1% .641 (48.7%) 195.6% 
Cost Categorical 46-60 minutes (55.6%) .118 (84.0%) 23.0% 
Cost Categorical 60+ minutes (62.3%) .031* (84.4%) (8.7%) 
*significant at α=.05 
Given these results, Hypothesis 1 that patients receiving counselor-provided 
SBIRT in integrated care settings experience fewer hospitalizations and emergency 
department visits compared to patients not receiving interventions, is not supported when 
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evaluated according to coefficient significance.  However, the consistent negativity of the 
coefficients and confidence intervals are promising trends. 
Also given these results, Hypothesis 3 that counselor-provided SBIRT 
interventions reduce economic costs from the health system perspective is supported by 
significance testing for interventions exceeding 60 minutes but results must be interpreted 
with caution due to instability in the remaining coefficients. 
Tests of Hypothesis 2 
The key variables of interest for Hypothesis 2, that hospitalization and emergency 
department visit outcomes differ by substance use type, substance use severity, or 
inpatient service location, were the interactions of severity, type, and clinical service 
individually with the time variable and interactions of these covariates individually with 
the time variable and the intervention variables.  The interaction of the covariates across 
time tested whether the covariates predicted differences in counts of hospitalizations and 
ED visits following the index hospitalization.  The three-way interaction of covariates, 
time, and intervention tested whether the intervention was a predictor of these covariate 
differences over time. 
The reference categories for severity and type, coded as 0, were the absence of 
use.  For severity, the remaining categories were coded as 1 for the detection of use, 2 for 
misuse (equivalent to abuse in clinical disease coding), and 3 for disordered use 
(equivalent to dependence).  For type, the coding was 1 for alcohol, 2 for illicit drugs, and 
3 for use of both substances.  The reference category for clinical service, coded as 0, was 
patients hospitalized on the Burn unit, chosen simply by alphabetical order.  The 
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remaining categories were coded as 1 for Burns off-unit patients, 2 for Medicine on-unit, 
3 for Medicine off-unit, 4 for Trauma on-unit, and 5 for Trauma off-unit. 
Because the outcomes of interest were counts, the negative binomial models were 
used, with incidence rate ratios as coefficients and confidence intervals to allow 
interpretability of the outcomes, which were in log form.  The results of estimation are in 
Table 8.  The estimation results for the count models were interpretable for every level of 
these categorical variables except for the Burns off-unit service category.  Only 25 
patients were in this category, which may explain this exception.  The process underlying 
the negative binomial model is maximum likelihood estimation, with sample sizes 
exceeding 100 preferred for accurate estimation (Cameron & Trivedi, 2009).  All other 
services exceeded 100 cases. 
The estimation results suggest that there are differences in hospitalization and ED 
visit outcomes for certain levels of substance use severity, substance use type, and 
clinical service.  For interactions of covariate levels with the time period variable, two 
results were significant, and two trends were notable.  The first significant result 
suggested that people using illicit drugs accessed services at two-thirds the rate prior to 
their index hospitalizations (IRR = 0.669, p = .033, 95% CI .463, .968).  The second 
significant result suggested that people hospitalized under the care of the Medicine 
services, and on the Medicine units, were less than half as likely to need subsequent 
hospital or emergency care compared to the reference category, Burn patients 
hospitalized on-unit (Medicine on-unit IRR = 0.455, p = .012, 95% CI .247, .841).  The 
same was not evident for Trauma patients.  Two trends are worth mentioning.  People 
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using substances, but without misuse or disordered use, as well as Medicine patients 
hospitalized off unit, may be less likely to access hospital or emergency care following 
their hospital admissions (Use level IRR = 0.720, p = .103, 95% CI .485, 1.069; Medicine 
off-unit IRR = 0.540, p = .071, 95% CI .277, 1.054). 
For the three-way interaction of covariates, time period, and the SBIRT 
intervention, only one result was significant: the effect for people using alcohol.  This 
level of the substance use type category contained people at all levels of use severity.  
Those who received SBIRT interventions were about one-fourth as likely to need 
subsequent hospital or emergency care compared to people not receiving interventions 
and not using substances, although the moderate confidence interval suggests the 
incidence rate also may be close to one (IRR = 0.279, p = .038, 95% CI .084, .932). 
Table 8.  Results for Hypothesis 2 
   95% Confidence Interval 
 Incidence Rate Ratios   IRR   p   Min   Max  
Covariate x Time Period Interaction 
Severity      
Use  0.72 0.103 0.485 1.069 
Misuse  0.894 0.579 0.602 1.373 
Disorder  0.635 0.127 0.355 1.138 
Type      
Alcohol  0.789 0.418 0.444 1.401 
Illicit Drug  0.669 0.033* 0.463 0.968 
Both  0.801 0.381 0.489 1.315 
Service      
Burns off unit  (Not estimable) 
Medicine on unit  0.455 0.012* 0.247 0.841 
Medicine off unit  0.54 0.071 0.277 1.054 
Trauma on unit  1.085 0.795 0.584 2.017 
Trauma off unit  0.715 0.395 0.33 1.548 
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   95% Confidence Interval 
 Incidence Rate Ratios   IRR   p   Min   Max  
Covariate x Time Period x Intervention (binary) Interaction 
 Severity      
Use  1.433 0.391 0.63 3.259 
Misuse  0.921 0.856 0.38 2.234 
Disorder  1.171 0.778 0.391 3.509 
Type      
Alcohol  0.279 0.038* 0.084 0.932 
Illicit Drug  1.421 0.364 0.666 3.031 
Both  1.146 0.785 0.431 3.045 
Service      
Burns off unit  (Not estimable) 
Medicine on unit  0.788 0.707 0.227 2.734 
Medicine off unit  0.735 0.648 0.196 2.754 
Trauma on unit  0.506 0.280 0.147 1.741 
Trauma off unit  0.739 0.677 0.178 3.069 
*significant at α=.05 
Given these results, Hypothesis 2 that hospitalization and emergency department 
visit outcomes differ by substance use type, substance use severity, and/or inpatient 
service location is supported by the evidence.  Results are significant for alcohol use type 
and Medicine on-unit clinical service location. 
Post-Estimation Testing 
Postestimation testing was performed to compare the models used in the study to 
simpler models, as models with fewer variables are preferable in statistics (Raudenbush 
& Bryk, 2002). A second reason for comparison was to assess whether potentially 
collinear covariates should be included.  To test whether covariates added significance to 
the models, the unrestricted models were compared to restricted models.  For each 
negative binomial regression equation, a base model with intervention, time, the 
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intervention/time interaction, and propensity score was compared to all possible 
combinations of the severity, type, and service predictor variables and to the unrestricted 
model using Pseudo-R2 and Wald’s Chi-squared test statistics.  Higher values of the 
Pseudo-R2 and Wald’s tests are preferred (Cameron & Trivedi, 2009).  For generalized 
linear model equations, the base, restricted, and unrestricted models were compared using 
Akaike’s Information Criterion (AIC) and Bayesian Information Criterion (BIC) test 
statistics, with lower values preferred (Long & Freese, 2014).  For all equations, the full 
unrestricted models were the preferred models.  The service variable was particularly 
influential in increasing R2 and the Wald’s statistic, as well as reducing AIC and BIC.  
Table 9 provides the comparison results. 
Table 9.  Comparison of Count and Cost Models 
Predictor Variables 
Count Outcomes Cost Outcomes 
Pseudo R2 Wald’s Chi-
squared* 
AIC BIC 
Base model 0.003 17.71 18.210 (30,234.97) 
+ Severity 0.008 61.36 18.162 (30,215.05) 
+ Type 0.009 73.67 18.120 (30,209.10) 
+ Service 0.049 491.63 17.154 (29,947.95) 
+ Severity, Type 0.010 80.04 18.093 (30,189.03) 
+ Severity, Service 0.056 556.48 17.068 (29,888.80) 
+ Type, Service 0.056 566.09 17.783 (30,208.66) 
Full Model 0.059 582.20 16.994 (29,845.70) 
* significant at α=.05 for all models 
As expected, the predicted outcomes were not linear and the error terms for these 
models were not normally distributed.  An example of non-linearity was provided by 
plotting predicted and observed outcomes for hospitalization and ED visit costs, as in 
Figure 7.  This plot exhibits no pattern of linearity; the non-linear nature of the data is 
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obvious.  The plot also reveals the wide dispersion of observed cost outcomes from $0 to 
over $300,000 and the narrower range of predictions from $0 to about $50,000.  Thus, the 
error terms were widely dispersed as well. 
Figure 7.  Predicted vs Observed Outcomes for Costs 
 
An example of non-normality of the error terms is provided by plotting the 
Pearson residual values (error terms) against the predicted outcomes, as in Figure 8.  In a 
residual plot for normal linear data, no discernible pattern should be visible.  Clearly, a 
strong non-linear pattern of concavity is present in this data.  The choice of generalized 
linear modeling is justified by the non-normality and non-linearity of the outcomes data. 
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Figure 8.  Pearson Residuals vs Predicted Outcomes for Costs 
 
Summary 
The purpose of this chapter was to present results from data collection and 
analysis to test three research hypotheses: that counselor-provided SBIRT provided on 
integrated care units predicted subsequent reductions in hospitalizations and ED visits; 
that these outcomes differed by substance use severity, substance use type, or inpatient 
service location; and that counselor-provided SBIRT was associated with reductions in 
economic costs.  The results of this study were not significant for the first hypothesis but 
did trend in a supportive direction; were significant for the second hypothesis; and 
supported the third hypothesis with significance, but with caution relative to 
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inconsistency in the results.  In the next and final chapter, these results will be discussed 
in relation to the current SBIRT and integrated care literature along with their limitations.  
Implications for counselors and health system leaders will be addressed and suggestions 
for future research provided.
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CHAPTER V 
DISCUSSION 
This research study examined whether counselor-provided SBIRT in inpatient 
integrated care settings is an effective treatment intervention for alcohol and illicit drug 
misuse and disordered use.  Effectiveness was established by evaluating the association 
between interventions and subsequent hospitalizations and emergency department visits.  
Because counselor-provided SBIRT’s usefulness may depend on type (alcohol or illicit 
drugs), severity of substance use, and setting, this study also examined the associations of 
these variables with post-intervention hospitalizations and emergency department visits.  
Given the substantial financial burden of substance misuse and disordered use on health 
care systems, this study also evaluated whether counselor-provided SBIRT interventions 
reduce economic costs from the health system perspective. 
The first chapter presented the study rationale, statement of the problem, and need 
for the study, and introduced the research questions.  In the second chapter, a review of 
relevant literature was presented, suggesting that counselor-provided SBIRT in integrated 
care settings is a promising, innovative intervention for people with misuse or disordered 
use of alcohol and/or illicit drugs and may help reduce health system burdens from 
treating the effects of harmful substance use.  In the third chapter, the research 
methodology for examining counselor-provided SBIRT in a specific integrated care 
setting and population was provided and the research hypotheses stated.  The fourth
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chapter described the study sample, data procedures, model selection, and statistical 
analyses conducted to test the research hypotheses. 
In this chapter, the results of the study are discussed along with study limitations, 
relevance to the existing literature, implications, and recommendations for future 
research.  The chapter concludes with summary remarks. 
Discussion of Results 
The study tested a promising, novel substance use treatment model, counselor-
provided SBIRT, that previously had been examined in a single clinical trial (Veach et 
al., 2018).  This counselor model was tested in an inpatient setting and with a population 
using alcohol and/or illicit drugs at levels from unknown to severe.  Most prior research 
for inpatients settings and mixed-use populations involved SBIRT provided by medical 
staff rather than mental health professionals, with inconclusive results or results not 
supporting efficacy (Mdege & Watson, 2013).  The research outcomes of hospitalizations 
and emergency department visits had been lightly studied in the SBIRT literature, with no 
evidence that SBIRT by medical staff was associated with changes in these outcomes 
(Bray et al., 2017; Bray, Cowell, & Hinde, 2011).  This study featured a unique time-in-
session categorical variable, a valuable approach as SBIRT session times are rarely used 
in research. 
In this context, the study results offer some support, with caution, for counselor-
provided SBIRT as an effective treatment model for reducing the utilization and costs of 
subsequent hospitalizations and ED visits.  Increasing the amount of time counselors 
spend with patients may improve the likelihood of occurrences and costs.  Patients who 
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differ in substance use severity, substance use type, and the physician specialty providing 
their clinical care may also differ in their likelihood to be re-hospitalized and need 
emergency care. These collective findings point the way towards important future 
research. 
Discussion of Hypothesis 1 
The first hypothesis predicted that counselor-provided SBIRT interventions would 
be associated with subsequent reductions in numbers of hospitalizations and ED visits.  
The model explained 6% of the variance in count outcomes based on the pseudo R2 
statistic, which is a notable finding when considering the multitude of factors that affect 
patient health states, utilization of hospital services, and substance use patterns, and given 
the high degree of variability in the outcomes data.  For context, in nonlinear regression 
pseudo R2 values explaining 20% of variance indicate excellent model fit to the data 
(McFadden, 1977). 
Each coefficient of the predictor variables (time-intervention interactions) was 
non-significant but negative, a promising trend.  If these findings are eventually found to 
be significant and are representative of actual outcomes, the magnitude of savings could 
be quite large.  For the index admissions, the average costs of hospitalization exceeded 
the average insurance and patient payments per hospitalization by more than $4,000, 
which was the health system loss per admission.  For the 2,195 patients in the study, a 
22% reduction (derived from the coefficient for the intervention variable) in these 
hospitalizations alone would have saved the health system about $2,000,000. 
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Discussion of Hypothesis 2 
The second hypothesis predicted that substance use severity, substance use type, 
and clinical service location would be differentially associated with subsequent 
hospitalizations and ED visits.  Trends in the SBIRT literature indicated that severity led 
to worse outcomes and that only alcohol misuse was consistently responsive to SBIRT.  
This hypothesis was tested in two ways – first comparing occurrences before and after 
index hospitalizations without the impact of SBIRT interventions, then adding 
interventions to the comparison.  In a curious significant result, people using illicit drugs 
were predicted to access hospital and emergency care services at two-thirds the rate of 
people not using any substances.  A cross-tabulation revealed that a majority of these 
patients were on the Trauma service, with about half as many under the Medicine 
service’s care.  Discovering the drivers of this trend will require more refined analysis of 
the dataset.  In a second significant result, medicine patients hospitalized on-unit were 
half as likely to seek hospital or emergency care at the teaching hospital following their 
index admissions compared to Burns patients or Trauma patients.  This is another result 
that bears further investigation.  For the three-way interaction of covariates, time period, 
and the SBIRT intervention, only the intervention for people using alcohol was found to 
be significant.  This finding is consistent with previous research that SBIRT is most 
effective for alcohol misuse (Jones et al., 2012; Schmidt et al, 2015). 
An interesting but non-significant result was that people known to use alcohol or 
illicit drugs, but not misusing or with disordered use, may be less likely than patients who 
didn’t use substances to be re-hospitalized or visit emergency departments.  An 
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implication was that people not identified as consuming alcohol or drugs were less 
healthy and thus in greater need of hospital care than people who admitted to using drugs.  
To address this possibility, severity of illness and risk of mortality were cross-tabulated 
with substance use severity.  No differences in illness level or mortality risk between 
patients at different substance use severity levels were found, so this question remains 
open. 
Overall, these results support the hypothesis of differential effects on outcomes by 
substance use type, substance use severity, and clinical service location.  However, most 
of the findings require further analysis to identify drivers of trends and make sense of the 
data. 
Discussion of Hypothesis 3 
The third hypothesis predicted that counselor-provided SBIRT interventions 
would be associated with subsequent reductions in the economic costs of hospitalizations 
and ED visits.  This association may or may not exist, as the findings were not consistent 
enough to draw a conclusion.  The models explained 5.9% of the variance in cost 
outcomes based on Pseudo R2, which is akin to the 6% result for count outcomes and a 
meaningful result considering how many other conditions promote or restrict patient 
needs for hospital care.  SBIRT intervention times exceeding 60 minutes predicted 
average reductions in economic costs of 62%.  Counselor-provided SBIRT may be most 
effective when counselors have the opportunity to spend more time with patients 
developing rapport and trust, both central to the counseling relationship.  However, given 
instability among the other coefficients, this result should be interpreted with caution.  
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There may be anomalies in the data that were not uncovered during postestimation 
procedures, so this finding should continue to be explored. 
For the third hypothesis, then, the significant finding indicates that counseling 
time exceeding one hour is associated with substantial cost reductions.  However, until 
inconsistent data features are explored, this result of the cost model should be interpreted 
with caution. 
Discussion Across Hypotheses 
Given the significance of several coefficients and the negative direction of other 
coefficient signs, counselor-provided SBIRT may be associated with reductions in 
hospitalizations and ED visits and the associated economic costs.  The presence of 
unusual results in the cost models may reflect model instability.  As expected, outcomes 
differed for substance use severity, substance use type, and clinical service location, but 
understanding these differences will require more work with the data. 
Study Limitations 
Concerns with statistical conclusion validity, internal validity, construct validity, 
and external validity threaten this study’s results (Shadish et al., 2002).  The concerns 
will be explored in this section, with suggestions for how to mitigate them with further 
analysis and future research studies. 
Statistical Conclusion Validity 
Variability in measurement that is not controlled by a statistical model can affect 
statistical conclusions about the data (Shadish et al., 2002).  For this study, the SBIRT 
interventions themselves are a source of measurement variability.  Counselors were at 
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different levels of training and experience, from new practicum students to PhD 
counselors with many years of experience.  Counselors had considerable leeway in how 
they conducted the interventions, differing in their interpretations, clinical skills, choice 
of SBIRT components, and application of SBIRT.  Counselors were also supervised by 
people with differing levels of experience and training, such as masters-level counselors, 
doctoral students, or PhD faculty members. 
To control for these threats to statistical conclusion validity, a counselor-level 
variable could be added to the model.  Such a variable was considered for this study, but 
due to the substantial additional effort needed to obtain clean and complete data, it was 
not added.  Another option would be to introduce more standardization into the SBIRT 
process.  However, some experts propose that allowing clinicians to tailor interventions 
to clinical needs may lead to improved outcomes that would be prevented by 
standardization (Shadish et al., 2002). 
The known variability in the dataset itself can also threaten the validity of 
statistical conclusions.  Due to excess zeros, several outcome variables were combined, 
resulting in more heterogeneous data and increasing the chance that important findings 
could be obscured.  For future studies, selecting outcomes with more data available for 
modeling is recommended.  An example would be accumulating all health system costs 
during the pre-post years instead of just hospitalization and ED visit costs. 
Internal Validity 
Internal validity is the assurance that a study is designed and conducted such that 
its inferences are valid, and that other explanations for the outcomes are not equally valid 
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or more so (Shadish et al., 2002).  One of many threats to the internal validity of this 
study is simply events that may have occurred during the passage of time.  Patients may 
have experienced changes that were unrelated to their substance use and reduced their 
likelihood of needing hospital care.  They might have moved out of the area, sought care 
closer to their homes for less serious conditions, lost access to transportation, become 
unable to afford another hospital visit, or become dissatisfied with their care at the 
hospital in the study and chosen another.  A way to partially mitigate this threat would be 
to expand the study to include hospitalizations and emergency care received at other 
locations within the health system, many of which are in the surrounding smaller towns.  
These counts and costs are already available in the data analytics warehouse but require 
some staff programming time to retrieve them. 
A second threat to internal validity involves the cases that could not be added to 
the study due to critical missing data (outcome variables and key predictors) or because 
they were not recorded due to procedural decisions.  The effects of these missing cases 
are unknown.  As a follow-on to this study, the cases missing critical data could be 
analyzed using propensity scores and tested against the intervention and comparison 
groups.  The cases first must undergo substantial cleaning, however. 
A third threat to internal validity is the use of retrospective data, which precludes 
a planned and consistent data collection process.  Despite the application of extensive 
data cleaning processes, data errors may yet be present.  This limitation was mitigated 
through variable selection, which relied on the data analytics warehouse instead of 
counselor-recorded data when possible.  The analytics data were derived in part from 
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hospital billing and were subjected to several levels of system and human checks for 
verification (M. Matthews, personal communication, September 5, 2018; G. Carter, 
personal communication, February 7, 2019). 
A fourth threat to internal validity involves confounding variables not known or 
controlled for by the study.  The 6% of variance explained by the study, while 
noteworthy, means that other factors not included in the study may explain additional 
variance.  This study was designed to account for known and unknown covariates that 
might explain the outcomes.  Known covariates were included in the propensity score 
model, while the differences-in-differences design accounted for covariates that were 
stable over the two-year time periods before and after index hospitalizations.  However, 
unknown confounding variables might yet predict the outcomes.  Examples include prior 
substance use treatment experiences, family dynamics, or self-efficacy.  The randomized 
controlled trial model is best for controlling this threat to internal validity, but at the cost 
of being able to generalize processes and results to other settings (Shadish et al., 2002). 
Construct Validity 
Studies with construct validity are designed so that constructs are well-defined, 
that the constructs of interest are measured appropriately, and that the constructs explain 
the outcomes (Shadish et al., 2002).  For this study, standardized insurance identifiers and 
clinical disease coding were used to measure several of the constructs, specifically 
severity of illness, risk of mortality, substance use severity, and substance use type.  
Using these standardized measures helped define the constructs more precisely.  
Standardization also reduced variability in measurement that might have arisen from 
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using counselor data.  However, given that a level of substance use type was dropped 
from the model for collinearity, there may be overlapping constructs in the model. 
Another threat to construct validity is that a critical construct is present but not 
measured by the model.  In this study, an alternative explanatory construct is the 
therapeutic alliance between the counselor and the patient, which in previous studies in 
specialty treatment settings predicted reductions in self-reported substance use (Barber et 
al., 2001; Watts et al., 2018).  Another construct that may predict the outcomes but was 
not measured is readiness to change (DiClemente et al., 2004).  Future studies might 
incorporate measures of these constructs, perhaps by making assessments of these 
alternatives a standard operating procedure of the SBIRT counseling program. 
External Validity 
Inferences from a study with external validity can be extended to different 
populations, settings, treatment models, and outcomes from those in the study (Shadish et 
al., 2002).  There are aspects of this study that threaten external validity.  The patient 
population was served by a unique counseling program employing person-centered 
SBIRT and integrated with inpatient care teams of the hospital; this treatment program 
may not be generalizable to other locations.  The hospital is located within an academic 
health system that attracts physician specialties many hospitals do not offer; integrated 
care settings in less-specialized hospitals may be quite different.  To improve external 
validity, the counseling program could be tested in other hospitals within the health 
system to assess its portability and make necessary modifications, thus improving its 
generalizability to other health systems. 
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Relevance to Existing Literature 
This study offers several important contributions to the existing research 
literature.  The results are relevant to the theoretical frameworks guiding this research.  
The results also offer support for and extensions to prior research in SBIRT and in 
substance use treatment. 
Theoretical Frameworks 
The study results are informative for the Addiction Recovery Management 
([ARM], White & Kelly, 2011) and Texas Christian University (TCU) Treatment Model 
(Simpson, 2004) theoretical frameworks.  The ARM framework advocates for processes 
that bring interventions directly to people in their communities rather than waiting for 
them to reach out for help, and for surrounding people with multidisciplinary teams.  The 
program in this study is such a process, in that it brings needed SBIRT interventions and 
counseling directly to inpatients who have not requested help, and it surrounds people 
with integrated care teams.  The results of the study support the efficacy of these ARM 
process goals, assuming that reductions in hospitalizations and ED visits mean that 
people have been helped towards recovery from substance use.  The study results also 
support Fornili’s (2016b) modification of the ARM for SBIRT in integrated care.  Fornili 
recommended that mental health professionals in integrated care settings engage early 
with substance use and help people who need treatment find it.  The counselors in this 
study identified patients for SBIRT proactively and referred to treatment when warranted.  
Again, assuming that reductions in health care utilization indicate that people benefitted 
from SBIRT, the results support Fornili’s modification of SBIRT. 
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The TCU Model describes the patient, program, and treatment factors that are 
predictive of outcomes.  The model factors tested by the present study were patient 
substance use severity, program setting/location (clinical service), and treatment process 
(SBIRT).  Regarding severity, the TCU Model and Hser et al. (2004) recommend 
matching severe substance use with increased intensity of services.  The patients in this 
study were above average in severity of illness and of substance use, and the findings 
suggest that increased intensity of services (60+ minutes of counseling time) may be 
associated with more positive outcomes.  Regarding setting, the TCU model linked 
program factors such as staff and climate with outcomes (Simpson, 2004).  In this study, 
a program factor, clinical service, was tested against outcomes, with differing effects 
found among the clinical services.  Finally, the TCU Model associates the treatment 
process itself – interventions, time, the therapeutic relationship, and the like – with 
outcomes.  The treatment process in this study was counselor-provided SBIRT, which 
was significantly associated with outcomes in certain formats. 
Empirical Research Studies 
In integrated care settings like the clinical services tested in this study, SBIRT is 
provided by mental health professionals, the model most akin to counselor-provided 
SBIRT.  Accordingly, this study’s results are evaluated against four similar published 
studies involving SBIRT by mental health professionals.  In Barbosa et al. (2017), SBIRT 
was provided by ‘behavioral health specialists,’ a job performed by master’s level health 
educators, professional counselors, psychologists, social workers, or substance use 
counselors.  In Gryczynski et al. (2011), SBIRT was provided by ‘behavioral health 
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counselors’ who were psychologists, social workers, or substance use counselors.  The 
study by Veach et al. (2018) involved SBIRT by professional counselors and counseling 
trainees.  The SBIRT providers in Watkins et al. (2017) were ‘therapists’ who were 
professional counselors or social workers.  The present study’s data is from the program 
operated by Veach, so also was generated by professional counselors. 
Table 10 presents the characteristics and results for this study and the four 
comparison studies.  In the present study, the mean age of participants was slightly higher 
than in the compared studies, at 44.73 years.  However, the lowest mean age reported was 
37.02, so the difference was not large.  In all studies, the proportion of males exceeded 
that of females, from 60% to 82%.  This study is near the average at 74% male.  The 
studies varied widely in proportions of White participants, from 31% to 83% and 
averaging 62%.  It seems that the population surrounding each study site dictated the 
ethnicities of the participant group.  For example, the Watkins study took place in an 
urban Federally Qualified Health Center serving a majority non-White population.  
Overall, the participants of this study are reasonably similar to participants in the 
comparison studies. 
The settings for the five studies are varied, with two occurring in outpatient 
clinics, one in outpatient clinics and emergency departments, and two in inpatient units.  
The two studies on inpatient units are from the same program, however, which limits 
generalizability of the results of either study to other settings.  The studies included 
participants using alcohol and/or drugs except for Veach et al. (2018).  With the 
exception of the present study, all other studies used six months for the follow-up periods 
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and participant self-report of use for the outcomes.  This study distinguishes itself from 
others with its one-year follow-up period, as recommended by Gelberg et al. (2015), and 
the use of health record information in variable measurement and health utilization 
outcomes (although health record sourcing is not entirely foreign to the SBIRT literature; 
see Bray et al. (2017) and Bray et al. (2011)).  Selecting outcomes other than self-
reported usage was suggested by Glass et al. (2017) and Agley et al. (2014).  Therefore, 
this study breaks new ground on several fronts, providing a unique combination of 
setting, substance, follow-up period and outcomes not found in any comparison study 
with SBIRT by mental health professionals and not often found in the SBIRT literature. 
Across studies with SBIRT by mental health professionals, the results are quite 
promising for populations not helped by SBIRT when conducted by medical staff.  With 
one exception, the studies included both alcohol and drug use, and all studies accepted 
participants at any level of substance use severity.  All of the comparator studies found 
significant reductions in self-reported use, and the present study demonstrated 
significance for reductions in hospital and emergency care. 
Table 10.  Comparison of Study to Relevant Research 
Study Demographic 
Means 
Setting Substance Follow-
up 
Results 
Barbosa et 
al. (2017) 
Age 39.99 
Male .61 
White .48 
Outpatient, 
ED 
Alcohol, 
illicit 
drug 
Six-
month 
Significant self-
reported reductions 
in use at follow-up; 
brief intervention 
(BI) more cost-
effective than brief 
treatment (BT) 
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Gryczynski 
et al. 
(2011) 
Age 37.02 
Male .60 
White .83 
Outpatient Alcohol, 
illicit 
drug 
Six-
month 
Significant self-
reported reductions 
in use at follow-up: 
BT more effective 
than BI 
Veach et 
al. (2018) 
Age 37.02 
Male .82 
White .73 
Inpatient Alcohol Six-
month 
Significant self-
reported reductions 
in use at follow-up 
Watkins et 
al. (2017) 
 
Age 42.00 
Male .80 
White .31 
Outpatient Alcohol, 
opioids 
Six-
month 
Significant self-
reported reductions 
in use at follow-up; 
clinics used 
collaborative care 
model for treatment 
(SBIRT-like) 
Counselor-
provided 
SBIRT 
study 
Age 44.73 
Male .74 
White .73 
Inpatient Alcohol, 
illicit 
drugs 
One 
year 
Significant 
reductions in 
hospitalizations and 
ED visits 
Implications for Practice and Research 
This study suggests that counselor-provided SBIRT in integrated care settings 
may be effective for reducing healthcare services utilization and may demonstrate 
economic benefit as a treatment model for substance misuse and disordered use.  The 
results have implications for the counseling profession, for medical professionals and 
health systems, and for SBIRT research. 
Counselor Practice 
SBIRT session times vary considerably for each unique practitioner and patient, 
from a single brief intervention of five minutes or less to multiple brief treatment sessions 
totaling several hours (SAMHSA, 2013).  Given the study results, longer intervention 
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times may be associated with greater effectiveness.  When counselors have ample time to 
develop the rapport, trust, and therapeutic alliance at the heart of the counseling 
relationship, counselor-provided SBIRT may be very helpful for people struggling to 
control their substance use.  Therefore, counseling practitioners should consider how they 
might lengthen the time they spend conducting SBIRT, focusing on building the 
counseling relationship throughout the SBIRT process. 
The differential effects found by clinical service and substance use type have 
implications for practice.  Patients cared for by different physician specialties appear to 
have unique health care utilization patterns, most likely due to both patient and program 
attributes (Simpson, 2004).  These reasons for these effects are unknown, but counselors 
on integrated care teams should consider how their patients may differ from patients of 
other clinical services and how practice might need to differ as well. 
This study found that counselor-provided SBIRT is effective for alcohol use at all 
levels of severity.  This result contradicts the preponderance of findings from previous 
controlled trials that SBIRT is efficacious for alcohol misuse only (Jonas et al., 2012).  
Counselors should embrace treatment for patients with all levels of alcohol severity and 
ensure that alcohol remains a central focus of their SBIRT efforts. 
Counselor Education and Leadership 
The counseling profession has a long history and substantial collective wisdom 
regarding treating substance use.  Currently, nearly 3,400 members of the American 
Counseling Association (ACA) identify as addictions and substance abuse specialists, 
placing this specialty area 7th on a list of 43 such areas (Sites, R. A., personal 
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communication, February 19, 2019).  In contrast, there are no terms on the ACA specialty 
list remotely related to integrated care.  This oversight is evidence that counselor 
education and leadership has lagged behind educators and leaders in other professions in 
embracing the integration of mental health professionals into medical settings and in 
advocating for substance use interventions to those settings.  The foremost organization 
for integrated care professionals is the Collaborative Family Health Association, which is 
comprised largely of psychologists, social workers, and marriage and family therapists 
(CFHA, 2019).  Integrated care is the primary emphasis of the American Psychological 
Association’s Center for Psychology and Health (American Psychological Association, 
2019).  The marriage and family therapy profession offers graduate training and post-
graduate certification in Medical Family Therapy, training clinicians to work in medical 
settings (CFHA, 2019).  Yet there are no comparative organizations or programs for the 
counseling profession.  Many counseling professionals are working in integrated care 
settings; it is notable that professional counselors and/or substance abuse counselors were 
listed in all five studies to date involving SBIRT by mental health professionals.  An 
implication of this study and others is that counselor educators and leaders should harness 
the profession’s substantial expertise in substance use treatment by transferring that 
expertise to integrated care settings, which is where most people who need help with 
substance use can be found. 
Medical Professionals and Health Systems 
When SBIRT is conducted by medical providers, positive outcomes are limited to 
self-reported alcohol misuse by ambulatory clinic and emergency department patients.  
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Innovative interventions are imperative for hospitalized inpatients, for more severe 
alcohol use, and for illicit drug use.  Recent movement towards integrating mental health 
and medical care, with SBIRT conducted by mental health professionals, is extending 
SBIRT’s effectiveness to these populations and settings.  This study supports counselor-
provided SBIRT as an important new intervention within integrated care and within 
SBIRT practice. 
This study moves beyond outcomes of self-reported use to objective, verifiable 
health utilization measures.  Hospitalizations and emergency department visits are 
expensive services for health systems and therefore are of great interest to health system 
leaders.  This study’s findings suggest significant reductions in these events and their 
associated costs through counselor-provided SBIRT, particularly for extended session 
times.  This study is among the first to demonstrate health utilization reductions for 
SBIRT interventions.  
These findings should be considered alongside comparative studies of SBIRT by 
mental health professionals.  With the small body of existing literature and confirming 
research, health system administrators, physicians, and community leaders should 
become more supportive of integrating counselor-provided SBIRT into inpatient units 
and other medical settings, particularly if cost savings are convincingly demonstrated. 
SBIRT Research 
Despite decades of well-designed and executed studies, there remains substantial 
disagreement among SBIRT researchers regarding its utility, even for alcohol misuse 
(Glass et al., 2017).  Variability in SBIRT delivery further complicates comparison of 
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findings (Del Boca et al., 2017).  This study is both clarifying and muddying for SBIRT 
research.  It clarifies SBIRT utility by suggesting positive outcomes for inpatients, illicit 
drug use and severe alcohol use.  Also clarifying is the use of objective outcomes, 
obviating criticism from using self-reported outcomes.  The real-world data used to 
generate the outcomes is more generalizable to other real-world settings than data from 
randomized controlled trials, although internal validity suffers for the same reason. 
However, the study adds complexity to SBIRT research.  The counselor-provided 
SBIRT interventions vary widely in time, the only SBIRT component measured by this 
study.  It is unclear whether single, short SBIRT sessions with patients who are quickly in 
and out of the hospital should be compared to long, multiple SBIRT sessions for patients 
with extended stays.  The latter are perhaps not truly SBIRT, although there are no 
standard definitions for what is and what is not SBIRT (Del Boca et al., 2017).  Further 
analysis of this counselor-provided SBIRT dataset might reveal important differences 
along the time spectrum.  
Suggestions for Future Research 
Directions for future research are to use the existing study dataset to answer 
questions raised by the study; to add new data from the health system data warehouse and 
test hypotheses about it; and to conduct new research based on the findings of this study.  
Suggestions are sorted into these three areas. 
Research Studies Using the Dataset 
Two variables available to the dataset from the counseling program records are 
the training level of the counselor conducting SBIRT and the number of SBIRT sessions 
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each patient with an intervention received.  Incorporating a variable for counselor 
training would help mitigate the threat to internal validity from variability in how SBIRT 
was conducted with patients.  A variable for number of sessions offers another way to 
capture the intensity or ‘dose’ of services received.  This data is in rough form in the 
counselor spreadsheets but could be obtained and cleaned for use. 
To resolve some of the unexplained findings regarding substance use severity, 
substance use type and clinical service, new models could employ the existing variables 
in new ways.  Examples include introducing random effects, making models more 
specific to levels of categorical variables, and selecting a different statistical approach 
such as a hurdle model design (Long & Freese, 2014).  
Research Studies with New Variables 
The health system’s data warehouse offers opportunities to incorporate new 
outcome and predictor variables into regression models.  Coding for mental health 
comorbidities may explain additional variation in the model, as substance use often co-
occurs with other mental health conditions.  To reduce threats to internal validity from 
variability, outcome variables with fewer zero values, such as all costs for all encounters 
during the comparative time periods, could be obtained and tested.  Similarly, data could 
be extracted for all hospitals in the health system, not just the large teaching hospital.  A 
caveat is that a few of these hospitals are relatively new to the system; costs and other 
data may not be available or as reliable as the cost data from the teaching hospital. 
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New Research Studies 
The most compelling suggestion for new research is to conduct a prospective, 
randomized, controlled clinical trial using the constructs and variables in this study or 
modifying the constructs and variables based on expanded dataset analyses.  A controlled 
process with randomization will correct for many of the threats to validity arising from 
retrospective data that was generated in the course of program operations and not 
intended for use in research. 
New research studies could incorporate constructs not considered in the current 
study but likely salient for predicting substance use treatment outcomes, such as the 
therapeutic alliance, level of engagement, self-efficacy, and readiness to change.  
Examination of these factors may improve construct validity.  Confounding variables that 
may be predict outcomes, such as prior treatment experiences and strength of support 
networks, could be added to improve internal validity. 
Counselor-provided SBIRT could be studied in new settings.  As integrated care 
sites expand and hire more counselors, the opportunity to investigate the unique 
professional identities of counselors in integrated care will expand as well.  The 
counseling profession should be ready with ideas for research and program evaluation. 
A value-added research idea is to develop outcomes studies in partnership with 
health system transitional care teams.  In hospitals, these teams identify inpatients who 
are intensive users of health system services, then help them after hospital discharge to 
improve their health conditions, thus reducing their likelihood of hospitalizations and ED 
visits, among other factors.  Given that the patients in this study may also be patients 
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followed by transitional care teams, there may be a natural synergy between inpatient 
substance use counseling and transitional care. 
Conclusion 
The reason for conducting this study was to help people with substance use 
problems who weren’t getting help and to bring much-needed evidence of counselor 
effectiveness with substance use treatment to the medical community, specifically to 
health system leaders.  This study’s findings help set the stage for increased investment in 
counselor-provided SBIRT as a process, in integrated care, and in counseling positions in 
those settings.  While the conclusions of this study are not definitive, the evidence may 
be convincing enough (after follow-up analysis) to present to health leaders and to take 
this research in new directions.  Only through evidence can counselors convince medical 
professionals to support the professional mission of wellness for all.  This study is a 
positive step in that direction.
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APPENDIX A 
DISEASE CODING FOR SUBSTANCE USE 
Code Legend 
 
Substance Severity 
0=remission 
1=use 
2=misuse (abuse) 
3=disordered use (dependence) 
 
Substance Type 
0=remission 
1=alcohol 
2=drug 
(3=both, coded in dataset only) 
 
International Compendium of Diseases, Clinical Modification (ICD-CM), Ninth 
Version 
Code  Categorical Description Severity Type 
291.00  Alcohol withdrawal delirium 2 1 
291.10  Alcohol-induced persisting amnestic disorder 2 1 
291.20  Alcohol-induced persisting dementia 2 1 
291.30  Alcohol-induced psychotic disorder with hallucinations 2 1 
291.40  Idiosyncratic alcohol intoxication 1 1 
291.50  Alcohol-induced psychotic disorder with delusions 2 1 
291.80  Other specified alcohol-induced mental disorders 2 1 
291.81  Alcohol withdrawal 2 1 
291.82  Alcohol-induced sleep disorders 2 1 
291.89  Other alcohol-induced disorders 2 1 
291.90  Unspecified alcohol-induced mental disorders 2 1 
292.00  Drug withdrawal 2 2 
292.11  Drug-induced psychotic disorder with delusions 2 2 
292.12  Drug-induced psychotic disorder with hallucinations 2 2 
292.20  Pathological drug intoxication 1 2 
292.81  Drug-induced delirium 2 2 
292.82  Drug-induced persistent dementia 2 2 
292.83  Drug-induced persistent amnestic disorder 2 2 
292.84  Drug-induced mood disorder 2 2 
292.85  Drug-induced sleep disorders 2 2 
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Code  Categorical Description Severity Type 
292.89  Other drug-induced mental disorder 2 2 
292.90  Unspecified drug-induced mental disorder 2 2 
303.00  Acute alcohol intoxication 1 1 
303.01  Acute alcohol intoxication 1 1 
303.02  Acute alcohol intoxication 1 1 
303.03  Acute alcohol intoxication 1 1 
303.90  Other and unspecified alcohol dependence 3 1 
303.91  Other and unspecified alcohol dependence 3 1 
303.92  Other and unspecified alcohol dependence 3 1 
303.93  Other and unspecified alcohol dependence 3 1 
304.00  Opioid type dependence 3 2 
304.01  Opioid type dependence 3 2 
304.02  Opioid type dependence 3 2 
304.03  Opioid type dependence 3 2 
304.10  Sedatives, hypnotics, or anxiolytic dependence 3 2 
304.11  Sedatives, hypnotics, or anxiolytic dependence 3 2 
304.12  Sedatives, hypnotics, or anxiolytic dependence 3 2 
304.13  Sedatives, hypnotics, or anxiolytic dependence 3 2 
304.20  Cocaine dependence 3 2 
304.21  Cocaine dependence 3 2 
304.22  Cocaine dependence 3 2 
304.23  Cocaine dependence 3 2 
304.30  Cannabis dependence 3 2 
304.31  Cannabis dependence 3 2 
304.32  Cannabis dependence 3 2 
304.33  Cannabis dependence 3 2 
304.40  Amphetamines dependence 3 2 
304.41  Amphetamines dependence 3 2 
304.42  Amphetamines dependence 3 2 
304.43  Amphetamines dependence 3 2 
304.50  Hallucinogen dependence 3 2 
304.51  Hallucinogen dependence 3 2 
304.52  Hallucinogen dependence 3 2 
304.53  Hallucinogen dependence 3 2 
304.60  Other, specified drug dependence 3 2 
304.61  Other, specified drug dependence 3 2 
304.62  Other, specified drug dependence 3 2 
304.63  Other, specified drug dependence 3 2 
304.70  Combinations of opioids with any other 2 2 
304.71  Combinations of opioids with any other 2 2 
304.72  Combinations of opioids with any other 2 2 
304.73  Combinations of opioids with any other 2 2 
304.80  Combinations excluding opioids 2 2 
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304.81  Combinations excluding opioids 2 2 
304.82  Combinations excluding opioids 2 2 
304.83  Combinations excluding opioids 2 2 
304.90  Unspecified drug dependence 3 2 
304.91  Unspecified drug dependence 3 2 
304.92  Unspecified drug dependence 3 2 
304.93  Unspecified drug dependence 3 2 
305.00  Alcohol abuse 2 1 
305.01  Alcohol abuse 2 1 
305.02  Alcohol abuse 2 1 
305.03  Alcohol abuse 2 1 
305.20  Nondependent cannabis abuse 2 2 
305.21  Nondependent cannabis abuse 2 2 
305.22  Nondependent cannabis abuse 2 2 
305.23  Nondependent cannabis abuse 2 2 
305.30  Nondependent hallucinogen abuse 2 2 
305.31  Nondependent hallucinogen abuse 2 2 
305.32  Nondependent hallucinogen abuse 2 2 
305.33  Nondependent hallucinogen abuse 2 2 
305.40  Nondependent sedative, hypnotic, or anxiolytic abuse 2 2 
305.41  Nondependent sedative, hypnotic, or anxiolytic abuse 2 2 
305.42  Nondependent sedative, hypnotic, or anxiolytic abuse 2 2 
305.43  Nondependent sedative, hypnotic, or anxiolytic abuse 2 2 
305.50  Nondependent opioid abuse 2 2 
305.51  Nondependent opioid abuse 2 2 
305.52  Nondependent opioid abuse 2 2 
305.53  Nondependent opioid abuse 2 2 
305.60  Nondependent cocaine abuse 2 2 
305.61  Nondependent cocaine abuse 2 2 
305.62  Nondependent cocaine abuse 2 2 
305.63  Nondependent cocaine abuse 2 2 
305.70  Nondependent amphetamine abuse 2 2 
305.71  Nondependent amphetamine abuse 2 2 
305.72  Nondependent amphetamine abuse 2 2 
305.73  Nondependent amphetamine abuse 2 2 
305.90  Other, mixed or unspecified drug abuse 2 2 
305.91  Other, mixed or unspecified drug abuse 2 2 
305.92  Other, mixed or unspecified drug abuse 2 2 
305.93  Other, mixed or unspecified drug abuse 2 2 
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International Compendium of Diseases, Clinical Modification (ICD-CM), Tenth 
Version 
Code Description Severity Type 
F10.10 Alcohol abuse, uncomplicated 2 1 
F10.11 Alcohol abuse, in remission 0 0 
F10.120 Alcohol abuse with intoxication, uncomplicated 2 1 
F10.121 Alcohol abuse with intoxication delirium 2 1 
F10.129 Alcohol abuse with intoxication, unspecified 2 1 
F10.14 Alcohol abuse with alcohol-induced mood disorder 2 1 
F10.150 Alcohol abuse with alcohol-induced psychotic disorder 
with delusions 
2 1 
F10.151 Alcohol abuse with alcohol-induced psychotic disorder 
with hallucinations 
2 1 
F10.159 Alcohol abuse with alcohol-induced psychotic disorder, 
unspecified 
2 1 
F10.180 Alcohol abuse with alcohol-induced anxiety disorder 2 1 
F10.181 Alcohol abuse with alcohol-induced sexual dysfunction 2 1 
F10.182 Alcohol abuse with alcohol-induced sleep disorder 2 1 
F10.188 Alcohol abuse with other alcohol-induced disorder 2 1 
F10.19 Alcohol abuse with unspecified alcohol-induced disorder 2 1 
F10.20 Alcohol dependence, uncomplicated 3 1 
F10.21 Alcohol dependence, in remission 0 0 
F10.220 Alcohol dependence with intoxication, uncomplicated 3 1 
F10.221 Alcohol dependence with intoxication delirium 3 1 
F10.229 Alcohol dependence with intoxication, unspecified 3 1 
F10.230 Alcohol dependence with withdrawal, uncomplicated 3 1 
F10.231 Alcohol dependence with withdrawal delirium 3 1 
F10.232 Alcohol dependence with withdrawal with perceptual 
disturbance 
3 1 
F10.239 Alcohol dependence with withdrawal, unspecified 3 1 
F10.24 Alcohol dependence with alcohol-induced mood disorder 3 1 
F10.250 Alcohol dependence with alcohol-induced psychotic 
disorder with delusions 
3 1 
F10.251 Alcohol dependence with alcohol-induced psychotic 
disorder with hallucinations 
3 1 
F10.259 Alcohol dependence with alcohol-induced psychotic 
disorder, unspecified 
3 1 
F10.26 Alcohol dependence with alcohol-induced persisting 
amnestic disorder 
3 1 
F10.27 Alcohol dependence with alcohol-induced persisting 
dementia 
3 1 
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F10.280 Alcohol dependence with alcohol-induced anxiety disorder 3 1 
F10.281 Alcohol dependence with alcohol-induced sexual 
dysfunction 
3 1 
F10.282 Alcohol dependence with alcohol-induced sleep disorder 3 1 
F10.288 Alcohol dependence with other alcohol-induced disorder 3 1 
F10.29 Alcohol dependence with unspecified alcohol-induced 
disorder 
3 1 
F10.920 Alcohol use, unspecified with intoxication, uncomplicated 1 1 
F10.921 Alcohol use, unspecified with intoxication delirium 1 1 
F10.929 Alcohol use, unspecified with intoxication, unspecified 1 1 
F10.94 Alcohol use, unspecified with alcohol-induced mood 
disorder 
1 1 
F10.950 Alcohol use, unspecified with alcohol-induced psychotic 
disorder with delusions 
1 1 
F10.951 Alcohol use, unspecified with alcohol-induced psychotic 
disorder with hallucinations 
1 1 
F10.959 Alcohol use, unspecified with alcohol-induced psychotic 
disorder, unspecified 
1 1 
F10.96 Alcohol use, unspecified with alcohol-induced persisting 
amnestic disorder 
1 1 
F10.97 Alcohol use, unspecified with alcohol-induced persisting 
dementia 
1 1 
F10.980 Alcohol use, unspecified with alcohol-induced anxiety 
disorder 
1 1 
F10.981 Alcohol use, unspecified with alcohol-induced sexual 
dysfunction 
1 1 
F10.982 Alcohol use, unspecified with alcohol-induced sleep 
disorder 
1 1 
F10.988 Alcohol use, unspecified with other alcohol-induced 
disorder 
1 1 
F10.99 Alcohol use, unspecified with unspecified alcohol-induced 
disorder 
1 1 
F11.10 Opioid abuse, uncomplicated 2 2 
F11.11 Opioid abuse, in remission 0 0 
F11.120 Opioid abuse with intoxication, uncomplicated 2 2 
F11.121 Opioid abuse with intoxication delirium 2 2 
F11.122 Opioid abuse with intoxication with perceptual disturbance 2 2 
F11.129 Opioid abuse with intoxication, unspecified 2 2 
F11.14 Opioid abuse with opioid-induced mood disorder 2 2 
F11.150 Opioid abuse with opioid-induced psychotic disorder with 
delusions 
2 2 
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F11.151 Opioid abuse with opioid-induced psychotic disorder with 
hallucinations 
2 2 
F11.159 Opioid abuse with opioid-induced psychotic disorder, 
unspecified 
2 2 
F11.181 Opioid abuse with opioid-induced sexual dysfunction 2 2 
F11.182 Opioid abuse with opioid-induced sleep disorder 2 2 
F11.188 Opioid abuse with other opioid-induced disorder 2 2 
F11.19 Opioid abuse with unspecified opioid-induced disorder 2 2 
F11.20 Opioid dependence, uncomplicated 3 2 
F11.21 Opioid dependence, in remission 0 0 
F11.220 Opioid dependence with intoxication, uncomplicated 3 2 
F11.221 Opioid dependence with intoxication delirium 3 2 
F11.222 Opioid dependence with intoxication with perceptual 
disturbance 
3 2 
F11.229 Opioid dependence with intoxication, unspecified 3 2 
F11.23 Opioid dependence with withdrawal 3 2 
F11.24 Opioid dependence with opioid-induced mood disorder 3 2 
F11.250 Opioid dependence with opioid-induced psychotic disorder 
with delusions 
3 2 
F11.251 Opioid dependence with opioid-induced psychotic disorder 
with hallucinations 
3 2 
F11.259 Opioid dependence with opioid-induced psychotic 
disorder, unspecified 
3 2 
F11.281 Opioid dependence with opioid-induced sexual 
dysfunction 
3 2 
F11.282 Opioid dependence with opioid-induced sleep disorder 3 2 
F11.288 Opioid dependence with other opioid-induced disorder 3 2 
F11.29 Opioid dependence with unspecified opioid-induced 
disorder 
3 2 
F11.90 Opioid use, unspecified, uncomplicated 1 2 
F11.920 Opioid use, unspecified with intoxication, uncomplicated 1 2 
F11.921 Opioid use, unspecified with intoxication delirium 1 2 
F11.922 Opioid use, unspecified with intoxication with perceptual 
disturbance 
1 2 
F11.929 Opioid use, unspecified with intoxication, unspecified 1 2 
F11.93 Opioid use, unspecified with withdrawal 1 2 
F11.94 Opioid use, unspecified with opioid-induced mood 
disorder 
1 2 
F11.950 Opioid use, unspecified with opioid-induced psychotic 
disorder with delusions 
1 2 
F11.951 Opioid use, unspecified with opioid-induced psychotic 
disorder with hallucinations 
1 2 
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F11.959 Opioid use, unspecified with opioid-induced psychotic 
disorder, unspecified 
1 2 
F11.981 Opioid use, unspecified with opioid-induced sexual 
dysfunction 
1 2 
F11.982 Opioid use, unspecified with opioid-induced sleep disorder 1 2 
F11.988 Opioid use, unspecified with other opioid-induced disorder 1 2 
F11.99 Opioid use, unspecified with unspecified opioid-induced 
disorder 
1 2 
F12.10 Cannabis abuse, uncomplicated 2 2 
F12.11 Cannabis abuse, in remission 0 0 
F12.120 Cannabis abuse with intoxication, uncomplicated 2 2 
F12.121 Cannabis abuse with intoxication delirium 2 2 
F12.122 Cannabis abuse with intoxication with perceptual 
disturbance 
2 2 
F12.129 Cannabis abuse with intoxication, unspecified 2 2 
F12.150 Cannabis abuse with psychotic disorder with delusions 2 2 
F12.151 Cannabis abuse with psychotic disorder with 
hallucinations 
2 2 
F12.159 Cannabis abuse with psychotic disorder, unspecified 2 2 
F12.180 Cannabis abuse with cannabis-induced anxiety disorder 2 2 
F12.188 Cannabis abuse with other cannabis-induced disorder 2 2 
F12.19 Cannabis abuse with unspecified cannabis-induced 
disorder 
2 2 
F12.20 Cannabis dependence, uncomplicated 3 2 
F12.21 Cannabis dependence, in remission 0 0 
F12.220 Cannabis dependence with intoxication, uncomplicated 3 2 
F12.221 Cannabis dependence with intoxication delirium 3 2 
F12.222 Cannabis dependence with intoxication with perceptual 
disturbance 
3 2 
F12.229 Cannabis dependence with intoxication, unspecified 3 2 
F12.23 Cannabis dependence with withdrawal 3 2 
F12.250 Cannabis dependence with psychotic disorder with 
delusions 
3 2 
F12.251 Cannabis dependence with psychotic disorder with 
hallucinations 
3 2 
F12.259 Cannabis dependence with psychotic disorder, unspecified 3 2 
F12.280 Cannabis dependence with cannabis-induced anxiety 
disorder 
3 2 
F12.288 Cannabis dependence with other cannabis-induced 
disorder 
3 2 
F12.29 Cannabis dependence with unspecified cannabis-induced 
disorder 
3 2 
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F12.90 Cannabis use, unspecified, uncomplicated 1 2 
F12.920 Cannabis use, unspecified with intoxication, 
uncomplicated 
1 2 
F12.921 Cannabis use, unspecified with intoxication delirium 1 2 
F12.922 Cannabis use, unspecified with intoxication with 
perceptual disturbance 
1 2 
F12.929 Cannabis use, unspecified with intoxication, unspecified 1 2 
F12.93 Cannabis use, unspecified with withdrawal 1 2 
F12.950 Cannabis use, unspecified with psychotic disorder with 
delusions 
1 2 
F12.951 Cannabis use, unspecified with psychotic disorder with 
hallucinations 
1 2 
F12.959 Cannabis use, unspecified with psychotic disorder, 
unspecified 
1 2 
F12.980 Cannabis use, unspecified with anxiety disorder 1 2 
F12.988 Cannabis use, unspecified with other cannabis-induced 
disorder 
1 2 
F12.99 Cannabis use, unspecified with unspecified cannabis-
induced disorder 
1 2 
F13.10 Sedative, hypnotic or anxiolytic abuse, uncomplicated 2 2 
F13.11 Sedative, hypnotic or anxiolytic abuse, in remission 0 0 
F13.120 Sedative, hypnotic or anxiolytic abuse with intoxication, 
uncomplicated 
2 2 
F13.121 Sedative, hypnotic or anxiolytic abuse with intoxication 
delirium 
2 2 
F13.129 Sedative, hypnotic or anxiolytic abuse with intoxication, 
unspecified 
2 2 
F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced mood disorder 
2 2 
F13.150 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, with 
delusions 
2 2 
F13.151 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, with 
hallucinations 
2 2 
F13.159 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, 
unspecified 
2 2 
F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced anxiety disorder 
2 2 
F13.181 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced sexual dysfunction 
2 2 
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F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, 
hypnotic or anxiolytic-induced sleep disorder 
2 2 
F13.188 Sedative, hypnotic or anxiolytic abuse with other sedative, 
hypnotic or anxiolytic-induced disorder 
2 2 
F13.19 Sedative, hypnotic or anxiolytic abuse with unspecified 
sedative, hypnotic or anxiolytic-induced disorder 
2 2 
F13.20 Sedative, hypnotic or anxiolytic dependence, 
uncomplicated 
3 2 
F13.21 Sedative, hypnotic or anxiolytic dependence, in remission 0 0 
F13.220 Sedative, hypnotic or anxiolytic dependence with 
intoxication, uncomplicated 
3 2 
F13.221 Sedative, hypnotic or anxiolytic dependence with 
intoxication delirium 
3 2 
F13.229 Sedative, hypnotic or anxiolytic dependence with 
intoxication, unspecified 
3 2 
F13.230 Sedative, hypnotic or anxiolytic dependence with 
withdrawal, uncomplicated 
3 2 
F13.231 Sedative, hypnotic or anxiolytic dependence with 
withdrawal delirium 
3 2 
F13.232 Sedative, hypnotic or anxiolytic dependence with 
withdrawal with perceptual disturbance 
3 2 
F13.239 Sedative, hypnotic or anxiolytic dependence with 
withdrawal, unspecified 
3 2 
F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced mood disorder 
3 2 
F13.250 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, with 
delusions 
3 2 
F13.251 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, with 
hallucinations 
3 2 
F13.259 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced psychotic disorder, 
unspecified 
3 2 
F13.26 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced persisting amnestic 
disorder 
3 2 
F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced persisting dementia 
3 2 
F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced anxiety 
3 2 
F13.281 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced sexual disorder 
3 2 
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F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced sleep disorder 
3 2 
F13.288 Sedative, hypnotic or anxiolytic dependence with other 
sedative, hypnotic or anxiolytic-induced disorder 
3 2 
F13.29 Sedative, hypnotic or anxiolytic dependence with 
unspecified sedative, hypnotic or anxiolytic-induced 
disorder 
3 2 
F13.90 Sedative, hypnotic, or anxiolytic use, unspecified, 
uncomplicated 
1 2 
F13.920 Sedative, hypnotic or anxiolytic use, unspecified with 
intoxication, uncomplicated 
1 2 
F13.921 Sedative, hypnotic or anxiolytic use, unspecified with 
intoxication delirium 
1 2 
F13.929 Sedative, hypnotic or anxiolytic use, unspecified with 
intoxication, unspecified 
1 2 
F13.930 Sedative, hypnotic or anxiolytic use, unspecified with 
withdrawal, uncomplicated 
1 2 
F13.931 Sedative, hypnotic or anxiolytic use, unspecified with 
withdrawal delirium 
1 2 
F13.932 Sedative, hypnotic or anxiolytic use, unspecified with 
withdrawal with perceptual disturbances 
1 2 
F13.939 Sedative, hypnotic or anxiolytic use, unspecified with 
withdrawal, unspecified 
1 2 
F13.94 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced mood disorder 
1 2 
F13.950 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced psychotic 
disorder 
1 2 
F13.951 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced psychotic 
disorder, with delusions 
1 2 
F13.959 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced psychotic 
disorder, with hallucinations 
1 2 
F13.96 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced persisting 
amnestic disorder 
1 2 
F13.97 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced persisting 
dementia 
1 2 
F13.980 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced anxiety disorder 
1 2 
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F13.981 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced sexual 
dysfunction 
1 2 
F13.982 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced sleep disorder 
1 2 
F13.988 Sedative, hypnotic or anxiolytic use, unspecified with 
other sedative, hypnotic or anxiolytic-induced disorder 
1 2 
F13.99 Sedative, hypnotic or anxiolytic use, unspecified with 
unspecified sedative, hypnotic or anxiolytic-induced 
disorder 
1 2 
F14.10 Cocaine abuse, uncomplicated 2 2 
F14.11 Cocaine abuse, in remission 0 0 
F14.120 Cocaine abuse with intoxication, uncomplicated 2 2 
F14.121 Cocaine abuse with intoxication with delirium 2 2 
F14.122 Cocaine abuse with intoxication with perceptual 
disturbance 
2 2 
F14.129 Cocaine abuse with intoxication, unspecified 2 2 
F14.14 Cocaine abuse with cocaine-induced mood disorder 2 2 
F14.150 Cocaine abuse with cocaine-induced psychotic disorder 
with delusions 
2 2 
F14.151 Cocaine abuse with cocaine-induced psychotic disorder 
with hallucinations 
2 2 
F14.159 Cocaine abuse with cocaine-induced psychotic disorder, 
unspecified 
2 2 
F14.180 Cocaine abuse with cocaine-induced anxiety disorder 2 2 
F14.181 Cocaine abuse with cocaine-induced sexual dysfunction 2 2 
F14.182 Cocaine abuse with cocaine-induced sleep disorder 2 2 
F14.188 Cocaine abuse with other cocaine-induced disorder 2 2 
F14.19 Cocaine abuse with unspecified cocaine-induced disorder 2 2 
F14.20 Cocaine dependence, uncomplicated 3 2 
F14.21 Cocaine dependence, in remission 0 0 
F14.220 Cocaine dependence with intoxication, uncomplicated 3 2 
F14.221 Cocaine dependence with intoxication delirium 3 2 
F14.222 Cocaine dependence with intoxication with perceptual 
disturbance 
3 2 
F14.229 Cocaine dependence with intoxication, unspecified 3 2 
F14.23 Cocaine dependence with withdrawal 3 2 
F14.24 Cocaine dependence with cocaine-induced mood disorder 3 2 
F14.250 Cocaine dependence with cocaine-induced psychotic 
disorder with delusions 
3 2 
F14.251 Cocaine dependence with cocaine-induced psychotic 
disorder with hallucinations 
3 2 
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F14.259 Cocaine dependence with cocaine-induced psychotic 
disorder, unspecified 
3 2 
F14.280 Cocaine dependence with cocaine-induced anxiety 
disorder 
3 2 
F14.281 Cocaine dependence with cocaine-induced sexual 
dysfunction 
3 2 
F14.282 Cocaine dependence with cocaine-induced sleep disorder 3 2 
F14.288 Cocaine dependence with other cocaine-induced disorder 3 2 
F14.29 Cocaine dependence with unspecified cocaine-induced 
disorder 
3 2 
F14.90 Cocaine use, unspecified, uncomplicated 1 2 
F14.920 Cocaine use, unspecified with intoxication, uncomplicated 1 2 
F14.921 Cocaine use, unspecified with intoxication delirium 1 2 
F14.922 Cocaine use, unspecified with intoxication with perceptual 
disturbance 
1 2 
F14.929 Cocaine use, unspecified with intoxication, unspecified 1 2 
F14.94 Cocaine use, unspecified with cocaine-induced mood 
disorder 
1 2 
F14.950 Cocaine use, unspecified with cocaine-induced psychotic 
disorder with delusions 
1 2 
F14.951 Cocaine use, unspecified with cocaine-induced psychotic 
disorder with hallucinations 
1 2 
F14.959 Cocaine use, unspecified with cocaine-induced psychotic 
disorder, unspecified 
1 2 
F14.980 Cocaine use, unspecified with cocaine-induced anxiety 
disorder 
1 2 
F14.981 Cocaine use, unspecified with cocaine-induced sexual 
dysfunction 
1 2 
F14.982 Cocaine use, unspecified with cocaine-induced sleep 
disorder 
1 2 
F14.988 Cocaine use, unspecified with other cocaine-induced 
disorder 
1 2 
F14.99 Cocaine use, unspecified with unspecified cocaine-induced 
disorder 
1 2 
F15.10 Other stimulant abuse, uncomplicated 2 2 
F15.11 Other stimulant abuse, in remission 0 0 
F15.120 Other stimulant abuse with intoxication, uncomplicated 2 2 
F15.121 Other stimulant abuse with intoxication delirium 2 2 
F15.122 Other stimulant abuse with intoxication with perceptual 
disturbance 
2 2 
F15.129 Other stimulant abuse with intoxication, unspecified 2 2 
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F15.14 Other stimulant abuse with stimulant-induced mood 
disorder 
2 2 
F15.150 Other stimulant abuse with stimulant-induced psychotic 
disorder with delusions 
2 2 
F15.151 Other stimulant abuse with stimulant-induced psychotic 
disorder with hallucinations 
2 2 
F15.159 Other stimulant abuse with stimulant-induced psychotic 
disorder, unspecified 
2 2 
F15.180 Other stimulant abuse with stimulant-induced anxiety 
disorder 
2 2 
F15.181 Other stimulant abuse with stimulant-induced sexual 
dysfunction 
2 2 
F15.182 Other stimulant abuse with stimulant-induced sleep 
disorder 
2 2 
F15.188 Other stimulant abuse with other stimulant-induced 
disorder 
2 2 
F15.19 Other stimulant abuse with unspecified stimulant-induced 
disorder 
2 2 
F15.20 Other stimulant dependence, uncomplicated 3 2 
F15.21 Other stimulant dependence, in remission 0 0 
F15.220 Other stimulant dependence with intoxication, 
uncomplicated 
3 2 
F15.221 Other stimulant dependence with intoxication delirium 3 2 
F15.222 Other stimulant dependence with intoxication with 
perceptual disturbance 
3 2 
F15.229 Other stimulant dependence with intoxication, unspecified 3 2 
F15.23 Other stimulant dependence with withdrawal 3 2 
F15.24 Other stimulant dependence with stimulant-induced mood 
disorder 
3 2 
F15.250 Other stimulant dependence with stimulant-induced 
psychotic disorder with delusions 
3 2 
F15.251 Other stimulant dependence with stimulant-induced 
psychotic disorder with hallucinations 
3 2 
F15.259 Other stimulant dependence with stimulant-induced 
psychotic disorder, unspecified 
3 2 
F15.280 Other stimulant dependence with stimulant-induced 
anxiety disorder 
3 2 
F15.281 Other stimulant dependence with stimulant-induced sexual 
dysfunction 
3 2 
F15.282 Other stimulant dependence with stimulant-induced sleep 
disorder 
3 2 
F15.288 Other stimulant dependence with other stimulant-induced 
disorder 
3 2 
 
 187 
Code Description Severity Type 
F15.29 Other stimulant dependence with unspecified stimulant-
induced disorder 
3 2 
F15.90 Other stimulant use, unspecified, uncomplicated 1 2 
F15.920 Other stimulant use, unspecified with intoxication, 
uncomplicated 
1 2 
F15.921 Other stimulant use, unspecified with intoxication delirium 1 2 
F15.922 Other stimulant use, unspecified with intoxication with 
perceptual disturbance 
1 2 
F15.929 Other stimulant use, unspecified with intoxication, 
unspecified 
1 2 
F15.93 Other stimulant use, unspecified with withdrawal 1 2 
F15.94 Other stimulant use, unspecified with stimulant-induced 
mood disorder 
1 2 
F15.950 Other stimulant use, unspecified with stimulant-induced 
psychotic disorder with delusions 
1 2 
F15.951 Other stimulant use, unspecified with stimulant-induced 
psychotic disorder with hallucinations 
1 2 
F15.959 Other stimulant use, unspecified with stimulant-induced 
psychotic disorder, unspecified 
1 2 
F15.980 Other stimulant use, unspecified with stimulant-induced 
anxiety disorder 
1 2 
F15.981 Other stimulant use, unspecified with stimulant-induced 
sexual dysfunction 
1 2 
F15.982 Other stimulant use, unspecified with stimulant-induced 
sleep disorder 
1 2 
F15.988 Other stimulant use, unspecified with other stimulant-
induced disorder 
1 2 
F15.99 Other stimulant use, unspecified with unspecified 
stimulant-induced disorder 
1 2 
F16.10 Hallucinogen abuse, uncomplicated 2 2 
F16.11 Hallucinogen abuse, in remission 0 0 
F16.120 Hallucinogen abuse with intoxication, uncomplicated 2 2 
F16.121 Hallucinogen abuse with intoxication with delirium 2 2 
F16.122 Hallucinogen abuse with intoxication with perceptual 
disturbance 
2 2 
F16.129 Hallucinogen abuse with intoxication, unspecified 2 2 
F16.14 Hallucinogen abuse with hallucinogen-induced mood 
disorder 
2 2 
F16.150 Hallucinogen abuse with hallucinogen-induced psychotic 
disorder with delusions 
2 2 
F16.151 Hallucinogen abuse with hallucinogen-induced psychotic 
disorder with hallucinations 
2 2 
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F16.159 Hallucinogen abuse with hallucinogen-induced psychotic 
disorder, unspecified 
2 2 
F16.180 Hallucinogen abuse with hallucinogen-induced anxiety 
disorder 
2 2 
F16.183 Hallucinogen abuse with hallucinogen persisting 
perception disorder (flashbacks) 
2 2 
F16.188 Hallucinogen abuse with other hallucinogen-induced 
disorder 
2 2 
F16.19 Hallucinogen abuse with unspecified hallucinogen-
induced disorder 
2 2 
F16.20 Hallucinogen dependence, uncomplicated 3 2 
F16.21 Hallucinogen dependence, in remission 0 0 
F16.220 Hallucinogen dependence with intoxication, 
uncomplicated 
3 2 
F16.221 Hallucinogen dependence with intoxication with delirium 3 2 
F16.229 Hallucinogen dependence with intoxication, unspecified 3 2 
F16.24 Hallucinogen dependence with hallucinogen-induced 
mood disorder 
3 2 
F16.250 Hallucinogen dependence with hallucinogen-induced 
psychotic disorder with delusions 
3 2 
F16.251 Hallucinogen dependence with hallucinogen-induced 
psychotic disorder with hallucinations 
3 2 
F16.259 Hallucinogen dependence with hallucinogen-induced 
psychotic disorder, unspecified 
3 2 
F16.280 Hallucinogen dependence with hallucinogen-induced 
anxiety disorder 
3 2 
F16.283 Hallucinogen dependence with hallucinogen persisting 
perception disorder (flashbacks) 
3 2 
F16.288 Hallucinogen dependence with other hallucinogen-induced 
disorder 
3 2 
F16.29 Hallucinogen dependence with unspecified hallucinogen-
induced disorder 
3 2 
F16.90 Hallucinogen use, unspecified, uncomplicated 1 2 
F16.920 Hallucinogen use, unspecified with intoxication, 
uncomplicated 
1 2 
F16.921 Hallucinogen use, unspecified with intoxication with 
delirium 
1 2 
F16.929 Hallucinogen use, unspecified with intoxication, 
unspecified 
1 2 
F16.94 Hallucinogen use, unspecified with hallucinogen-induced 
mood disorder 
1 2 
F16.950 Hallucinogen use, unspecified with hallucinogen-induced 
psychotic disorder with delusions 
1 2 
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F16.951 Hallucinogen use, unspecified with hallucinogen-induced 
psychotic disorder with hallucinations 
1 2 
F16.959 Hallucinogen use, unspecified with hallucinogen-induced 
psychotic disorder, unspecified 
1 2 
F16.980 Hallucinogen use, unspecified with hallucinogen-induced 
anxiety disorder 
1 2 
F16.983 Hallucinogen use, unspecified with hallucinogen persisting 
perception disorder (flashbacks) 
1 2 
F16.988 Hallucinogen use, unspecified with other hallucinogen-
induced disorder 
1 2 
F16.99 Hallucinogen use, unspecified with unspecified 
hallucinogen-induced disorder 
1 2 
F18.10 Inhalant abuse, uncomplicated 2 2 
F18.11 Inhalant abuse, in remission 0 0 
F18.120 Inhalant abuse with intoxication, uncomplicated 2 2 
F18.121 Inhalant abuse with intoxication delirium 2 2 
F18.129 Inhalant abuse with intoxication, unspecified 2 2 
F18.14 Inhalant abuse with inhalant-induced mood disorder 2 2 
F18.150 Inhalant abuse with inhalant-induced psychotic disorder 
with delusions 
2 2 
F18.151 Inhalant abuse with inhalant-induced psychotic disorder 
with hallucinations 
2 2 
F18.159 Inhalant abuse with inhalant-induced psychotic disorder, 
unspecified 
2 2 
F18.17 Inhalant abuse with inhalant-induced dementia 2 2 
F18.180 Inhalant abuse with inhalant-induced anxiety disorder 2 2 
F18.188 Inhalant abuse with other inhalant-induced disorder 2 2 
F18.19 Inhalant abuse with unspecified inhalant-induced disorder 2 2 
F18.20 Inhalant dependence, uncomplicated 3 2 
F18.21 Inhalant dependence, in remission 0 0 
F18.220 Inhalant dependence with intoxication, uncomplicated 3 2 
F18.221 Inhalant dependence with intoxication delirium 3 2 
F18.229 Inhalant dependence with intoxication, unspecified 3 2 
F18.24 Inhalant dependence with inhalant-induced mood disorder 3 2 
F18.250 Inhalant dependence with inhalant-induced psychotic 
disorder with delusions 
3 2 
F18.251 Inhalant dependence with inhalant-induced psychotic 
disorder with hallucinations 
3 2 
F18.259 Inhalant dependence with inhalant-induced psychotic 
disorder, unspecified 
3 2 
F18.27 Inhalant dependence with inhalant-induced dementia 3 2 
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F18.280 Inhalant dependence with inhalant-induced anxiety 
disorder 
3 2 
F18.288 Inhalant dependence with other inhalant-induced disorder 3 2 
F18.29 Inhalant dependence with unspecified inhalant-induced 
disorder 
3 2 
F18.90 Inhalant use, unspecified, uncomplicated 1 2 
F18.920 Inhalant use, unspecified with intoxication, uncomplicated 1 2 
F18.921 Inhalant use, unspecified with intoxication with delirium 1 2 
F18.929 Inhalant use, unspecified with intoxication, unspecified 1 2 
F18.94 Inhalant use, unspecified with inhalant-induced mood 
disorder 
1 2 
F18.950 Inhalant use, unspecified with inhalant-induced psychotic 
disorder with delusions 
1 2 
F18.951 Inhalant use, unspecified with inhalant-induced psychotic 
disorder with hallucinations 
1 2 
F18.959 Inhalant use, unspecified with inhalant-induced psychotic 
disorder, unspecified 
1 2 
F18.97 Inhalant use, unspecified with inhalant-induced persisting 
dementia 
1 2 
F18.980 Inhalant use, unspecified with inhalant-induced anxiety 
disorder 
1 2 
F18.988 Inhalant use, unspecified with other inhalant-induced 
disorder 
1 2 
F18.99 Inhalant use, unspecified with unspecified inhalant-
induced disorder 
1 2 
F19.10 Other psychoactive substance abuse, uncomplicated 2 2 
F19.11 Other psychoactive substance abuse, in remission 0 0 
F19.120 Other psychoactive substance abuse with intoxication, 
uncomplicated 
2 2 
F19.121 Other psychoactive substance abuse with intoxication 
delirium 
2 2 
F19.122 Other psychoactive substance abuse with intoxication with 
perceptual disturbances 
2 2 
F19.129 Other psychoactive substance abuse with intoxication, 
unspecified 
2 2 
F19.14 Other psychoactive substance abuse with psychoactive 
substance-induced mood disorder 
2 2 
F19.150 Other psychoactive substance abuse with psychoactive 
substance-induced psychotic disorder with del 
2 2 
F19.151 Other psychoactive substance abuse with psychoactive 
substance-induced psychotic disorder with hal 
2 2 
F19.159 Other psychoactive substance abuse with psychoactive 
substance-induced psychotic disorder, unspeci 
2 2 
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F19.16 Other psychoactive substance abuse with psychoactive 
substance-induced persisting amnestic disorde 
2 2 
F19.17 Other psychoactive substance abuse with psychoactive 
substance-induced persisting dementia 
2 2 
F19.180 Other psychoactive substance abuse with psychoactive 
substance-induced anxiety disorder 
2 2 
F19.181 Other psychoactive substance abuse with psychoactive 
substance-induced sexual dysfunction 
2 2 
F19.182 Other psychoactive substance abuse with psychoactive 
substance-induced sleep disorder 
2 2 
F19.188 Other psychoactive substance abuse with other 
psychoactive substance-induced disorder 
2 2 
F19.19 Other psychoactive substance abuse with unspecified 
psychoactive substance-induced disorder 
2 2 
F19.20 Other psychoactive substance dependence, uncomplicated 3 2 
F19.21 Other psychoactive substance dependence, in remission 0 0 
F19.220 Other psychoactive substance dependence with 
intoxication, uncomplicated 
3 2 
F19.221 Other psychoactive substance dependence with 
intoxication delirium 
3 2 
F19.222 Other psychoactive substance dependence with 
intoxication with perceptual disturbance 
3 2 
F19.229 Other psychoactive substance dependence with 
intoxication, unspecified 
3 2 
F19.230 Other psychoactive substance dependence with 
withdrawal, uncomplicated 
3 2 
F19.231 Other psychoactive substance dependence with withdrawal 
delirium 
3 2 
F19.232 Other psychoactive substance dependence with withdrawal 
with perceptual disturbance 
3 2 
F19.239 Other psychoactive substance dependence with 
withdrawal, unspecified 
3 2 
F19.24 Other psychoactive substance dependence with 
psychoactive substance-induced mood disorder 
3 2 
F19.250 Other psychoactive substance dependence with 
psychoactive substance-induced psychotic disorder wit 
3 2 
F19.251 Other psychoactive substance dependence with 
psychoactive substance-induced psychotic disorder wit 
3 2 
F19.259 Other psychoactive substance dependence with 
psychoactive substance-induced psychotic disorder, un 
3 2 
F19.26 Other psychoactive substance dependence with 
psychoactive substance-induced persisting amnestic di 
3 2 
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F19.27 Other psychoactive substance dependence with 
psychoactive substance-induced persisting dementia 
3 2 
F19.280 Other psychoactive substance dependence with 
psychoactive substance-induced anxiety disorder 
3 2 
F19.281 Other psychoactive substance dependence with 
psychoactive substance-induced sexual dysfunction 
3 2 
F19.282 Other psychoactive substance dependence with 
psychoactive substance-induced sleep disorder 
3 2 
F19.288 Other psychoactive substance dependence with other 
psychoactive substance-induced disorder 
3 2 
F19.29 Other psychoactive substance dependence with 
unspecified psychoactive substance-induced disorder 
3 2 
F19.90 Other psychoactive substance use, unspecified, 
uncomplicated 
1 2 
F19.920 Other psychoactive substance use, unspecified with 
intoxication, uncomplicated 
1 2 
F19.921 Other psychoactive substance use, unspecified with 
intoxication with delirium 
1 2 
F19.922 Other psychoactive substance use, unspecified with 
intoxication with perceptual disturbance 
1 2 
F19.929 Other psychoactive substance use, unspecified with 
intoxication, unspecified 
1 2 
F19.930 Other psychoactive substance use, unspecified with 
withdrawal, uncomplicated 
1 2 
F19.931 Other psychoactive substance use, unspecified with 
withdrawal delirium 
1 2 
F19.932 Other psychoactive substance use, unspecified with 
withdrawal with perceptual disturbance 
1 2 
F19.939 Other psychoactive substance use, unspecified with 
withdrawal, unspecified 
1 2 
F19.94 Other psychoactive substance use, unspecified with 
psychoactive substance-induced mood disorder 
1 2 
F19.950 Other psychoactive substance use, unspecified with 
psychoactive substance-induced psychotic disorder 
1 2 
F19.951 Other psychoactive substance use, unspecified with 
psychoactive substance-induced psychotic disorder 
1 2 
F19.959 Other psychoactive substance use, unspecified with 
psychoactive substance-induced psychotic disorder 
1 2 
F19.96 Other psychoactive substance use, unspecified with 
psychoactive substance-induced persisting amnesia 
1 2 
F19.97 Other psychoactive substance use, unspecified with 
psychoactive substance-induced persisting dementia 
1 2 
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F19.980 Other psychoactive substance use, unspecified with 
psychoactive substance-induced anxiety disorder 
1 2 
F19.981 Other psychoactive substance use, unspecified with 
psychoactive substance-induced sexual dysfunction 
1 2 
F19.982 Other psychoactive substance use, unspecified with 
psychoactive substance-induced sleep disorder 
1 2 
F19.988 Other psychoactive substance use, unspecified with other 
psychoactive substance-induced disorder 
1 2 
F19.99 Other psychoactive substance use, unspecified with 
unspecified psychoactive substance-induced disorder 
1 2 
 
